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ABSTRACT
The Development and Characterization of Markers For the Variable Regions 
of Mouse DNP Binding Antibodies
Jerome Bernard Zeldis
Yale University, 1973
To study the expression and inheritance of immunoglobulins, methods 
must be developed to identify specific variable regions (V-regions). 
V-regions of 2,4 dinitrophenyl (DNP) binding antibodies were identi­
fied by two approaches based on three properties: a) serological
determinants (idiotypic markers); b) antigen specificities; and c) the 
isoelectric point of the antibodies.
For the "idiotypic” approach, rabbit anti-idiotypic antibodies 
complementary to the combining region of two distinct DNP and menadione 
binding myeloma proteins, 315 (a, A) and 460 (a, k ), were generated. 
These antibodies were characterized as follows; both anti-460 and anti- 
315 antibodies are composed of two populations: a) antibodies with
public specificities, that is, they bind equally well to the three 
distinct DNP binding myeloma proteins, S23, 315, and 460; b) anti­
bodies with private specificities which bind determinants only present 
on the myeloma proteins to which the antibodies were made. All three 
anti-idiotypic antibodies (public and two private specificities) recog­
nize determinants on the heavy chains of the idiotype positive myeloma 
proteins. While the light chain is required for the full expression of 
the public idiotypic marker, there is no requirement for the type of 
mouse light chain in the idiotype positive protein. With both private 
460 and private 315 idiotypic determinants, the type of light chain in 
the immunoglobulin modulates the expression of these markers such that
'I
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the idiotypic determinants may be completely, partially, or not expressed.
In a survey of 18 inbred mouse strains, no serum was found to contain 
immunoglobulins that were positive for the private 315 idiotype. All 
strains of inbred mice produced DNP binding antibodies that are positive 
for the public and private 460 idiotypic determinants. The concentration 
of these idiotype positive immunoglobulins and the number of splenic 
lymphocytes with public idiotype positive surface markers increases 
after DNP-BGG immunization. The shape of the inhibition curves in radio­
immunoassays (RIAs) of the private 460 idiotype positive immunoglobulins 
divides the mouse strains into two groups: a) mice with the heavy chain
£-f-allotypic locus of Balb/c (Ig-1 ); and b) mice with any other allotypic
locus. The private 460 idiotypic determinants of mouse immunoglobulins 
from both sets of mice seem antigenically different from protein 460.
In a Balb/cN (Ig-la+) x C57BL/6 (Ig-1^) mating, the Balb/c-like private 
460 idiotypic marker appears to be inherited as an autosomal dominant 
trait. Two idiotype positive immunoglobulins have been isolated from 
Balb/c sera. One immunoglobulin is an IgA that has both public and 
private 460-like idiotypes and which has an identical isoelectric point 
to protein 460. The other is an IgGl that only has the private 460 
idiotype. Like protein 460, both mouse immunoglobulins bind DNP and 
menadione.
For the second approach, V-regions were identified by their ability 
to bind more than one antigen and by their isoelectric points in poly­
acrylamide gels using autoradiography. The sequential immunization with 
DNP and menadione containing proteins and with RNase and DNP-BGG elicits 
double binding antibodies. Only menadione containing proteins that are 
able to be bound by proteins 460 and 315 are antigenic for an anti­
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
menadione response in Balb/c mice. Even after identical immunization 
protocols, individual BaIjg/c mice yield distinct and different iso­
electric focusing banding patterns of DNP binding antibodies. Further­
more, it was not possible to identify the isotype and idiotype of 
individual immunoglobulins cross-linked inside these gels. Thus, ad­
ditional techniques are needed to characterize the immunoglobulins 
identified by the polyacrylamide analytical isoelectric focusing technique.




the memory of 
my father
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INTRODUCTION
The Problem: The Elucidation of the Expression and Inheritance of
Immunoglobulin Genes Is Difficult Because of the Complexity of 
the Immune Response
The inheritance and expression of immunoglobulin genes still remains 
one of the great problems of immunology. The major reason is that the 
immune response while highly specific is also exceedingly complex. It 
is complex from the standpoint of the number of different antigens that 
can elicit an immune response; complex in the number of different ways, 
humoral and cellular, in which an organism can react to antigenic chal­
lenge; and complex in the number of different antibodies which are speci­
fic for the same antigen. For example, it has been estimated that over 
2 x 10^ different antigens can induce a humoral response (140). Comple­
tely different antibody populations can be elicited to chemical moieties 
that differ by as little as a hydroxyl or nitro group (102, 7, 133).
Yet only rarely is a humoral response composed of highly restricted antibody 
species directed against the antigen to which an animal is challenged.
Fundamental to the problem of the inheritance of immunoglobulin 
genes is the question of whether the genome of the fertilized ovum 
contains the information to code for all the antibodies which an adult 
animal is able to express during its lifetime. This problem has been 
investigated both at the level of the DNA content and organization of 
the genome and at the level of the phenotypic expression of specific 
immunoglobulin molecules. Implicit to the study of any protein's 
genetics is the problem of the lack of expression of structural genes 
that are present in the genome. Thus a combination of both levels of 
evaluation are required to ascertain the inheritance and control of 
expression of immunoglobulin genes.
1
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Evaluations of the Number and Organization of Immunoglobulin Genes
In the first approach labeled mRNAs and labeled cDNA transcripts 
of mRNAs of immunoglobulin light chains were hybridized to an organism's 
genome derived from various tissues and the hybridization kinetics 
(CQt plot) were measured. These probes of the light chain genome 
contained the sequence for the entire immunoglobulin chain or just the 
sequences of the constant (C) or variable (V) regions. Presumably, 
these polynucleotides are able to hybridize to all DNA sequences that 
are similar or identical to that of the probe. If the genome codes 
for all the V-regions which an animal is capable of synthesizing, then 
the hybridization kinetic data should indicate this by demonstrating a 
large number of sequences complementary to the probe. In these studies, 
however, only between three and five copies of the sequences for both 
the C-region (105, 106, 166) and the V-region (106, 166, 179) of light 
chains were found.
While these results appear to support the hypothesis that the 
genome does not contain enough information to code for all possible 
immunoglobulin molecules an animal is able to produce, the validity and 
interpretation of these experiments are being debated (179, 157) .
Before a molecular probe derived from the mRNA of a myeloma protein 
may be used to determine the number of V-region DNA gene copies in exis­
tence, it must be established that the probes are able to hybridize to the 
DNA which codes for other V-regions with the same kinetics as the probe is 
able to anneal to its homologous genome. The variability of the tripli­
cate code third base must be taken into account as a source of variation 
among mRNA's that code for the immunoglobulin chains, even in cases in 
which the amino acid compositions of the chains are similar or identical
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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(179, 106). The investigators who do these experiments often present 
hybridization data to demonstrate that good cross-hybridization occurs 
between cDNA or mRNA for one myeloma protein and the DNA for another. 
Williamson states that these results actually show that the kinetics of 
cross-hybridization (in a CQt plot) are different from those obtained 
when the molecular probes are used against the homologus genome. He 
concludes that the data obtained to date may actually only describe the 
number of germ line genes that are very similar or identical to the 
probe. Melting data of homologous and heterologous hybrids lend support 
to this contention (179). Thus the conclusion that there are three to 
five V-region genes per haploid genome is consistent either with: a) a
model of few V-region genes with expansion of the V-region genetic 
repertoire during ontogeny; or b) a model for the number of V-region 
genes equal to that which an animal is able to express. Smith (157) has 
suggested that small experimental errors in the data or in plotting the 
CQt curves can greatly change the estimation of the number of different 
genes hybridizable with the molecular probe.
The use of nucleotide probes has also provided information about 
the organization and expression of immunoglobulin genes. Ever since Dreyer 
and Bennett (34) proposed that separate genes for the V and C regions 
code for single immunoglobulin chain structures, have studies been 
performed to investigate this hypothesis. A number of studies have 
demonstrated that the mRNAs from myeloma cells are large enough to code 
for both the C and V regions of the heavy and light chains (105, 166). 
Furthermore, Milstein et al. (80) have demonstrated a nucleotide sequence 
in the mRNA of the light chain of the mouse myeloma protein HOPC 21 which 
codes for the amino acid sequence that bridges the variable and constant
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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regions of the light chain molecule. Thus if there are few C-region gen's 
and many V-region genes, the pairing of V and C region sequences 
probably occurs before the translation of the immunoglobulin molecule.
This conclusion is substantiated by the work of Milstein and Kohler 
(95) who demonstrated that hybrid cell lines of two myeloma protein 
producing plasmacytomas failed to synthesize immunoglobulins that had 
exchanged V and C regions of the two tumor proteins (i.e., all gene 
expression was cis to the genome which codes for the structural genes 
in these cell lines).
In a provocative paper, Tonegawa et al. (66) labeled the mRNA for 
the k chain of MOPC 321 plasmacytoma and measured the probe's ability 
to hybridize to restriction enzyme digestion fragments of DNA from the 
genome of "early" (12, 13 day old) mouse embryos and to the DNA fragments 
from the plasmacytoma MOPC 321. With the genome of the early mouse 
embryo, the probe annealed to two fragments— one 6 x 10^ dalton segment 
containing the C-region gene sequence, while the other fragment (3.4 x 
106 dalton) had the V-region sequence. In contrast, the plasmacytoma 
DNA produced only a single fragment (2.4 x 10^ dalton) which contained 
both V and C region sequences. The authors maintained that this result 
was highly suggestive of the separation of V and C region genes in the 
embryo which eventually pair during ontogeny. The validity of these 
results has been questioned (180). The authors failed to account for 
the aneuploidy of the plasmacytoma cell line. While the data indicated 
that the plasmacytoma line was either haploid or homozygous in its 
immunoglobulin gene composition, it is unclear how the genetic organi­
zation of this myeloma line relates to that of an adult mouse. No 
hybridization data was presented using the mRNA probe with adult mouse
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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tissue DNA.
The Two Gene —  One Polypeptide Theory
While the data from the above experiment for the translocation of 
V and C region genes of the light chain is questionable, investigations 
of the phenotypic expression of immunoglobulin genes have led to the 
generalized acceptance of the concept that there are separate genes 
that code for the variable and constant regions of light and heavy 
chains of immunoglobulins (34). Some plasmacytomas produce more than 
one immunoglobulin. A few of these have been reported to secrete 
paraproteins that differ only by the subclass of the heavy chain, not 
by the proteins' light chains or V^ region (156, 65, 58). Other sug­
gestive evidence for the two gene-one polypeptide theory is that single 
lymphocytes have on their surface IgM and IgD with the same antigenic 
specificity (131) and idiotypic serological markers (47). Furthermore 
a single spleen cell clone is able to produce more than one class of 
laimunoglobulins with the same V region (51). Thus part of the diversity 
of the physical properties of immunoglobulins depends upon the class of 
Immunoglobulin which is paired to a particular V-region. The fact that 
anti-y serum can suppress the production of IgM, IgG, and IgA anti­
bodies is indirect evidence that a "switch" of V-regions from one C- 
region to another is an integral part of the maturation of the immune 
response (104).
The molecular mechanism by which variable and constant region 
sequences can be paired is now under intensive investigation. Using 
the genetic code to translate the amino acid sequence of the light 
chain of the MOPC 41 plasmacytoma into triplicate codon sequences,
i
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Leder et al. (106) postulated that the region of the V-C junction may 
be coded by a 25 base palindrome which might serve as a signal for 
restriction and modification-like enzymes. Wuilmart ej: al. (181) 
substantiated this analysis with sequence data from other myeloma 
proteins. Furthermore, the genomes for ovalbumin, the X light chain of 
myeloma protein HOPC 2020, the 8-chain of globin (81, 10, 103) have 
recently been found not to be coded by a single continuous cistron, but 
the structural genes contain at least a 600 base pair untranslated 
sequence which must be deleted in order to produce the mRNA for these 
proteins. This means that the mechanism of joining genetic material to 
produce message may be a common molecular process of eukaryotic organ­
isms, a process not only restricted to immunoglobulin genes.
Recently techniques have been developed to clone eukaryotic message 
and to isolate and clone eukaryotic structural genes (103, 165). This 
may allow the production of chemically homogeneous probes of genes for 
the light chains and for the heavy chains of immunoglobulins. This is 
especially important since much of the data for the genetic organization 
and number of V-region genes has been based upon RNA-DNA hybridization 
curves which are not as reliable as cDNA-DSA hybridization data (106, 166). 
Thus while the data on the number and organization of the immunoglobulin 
genes that is based on the work with polynucleotide probes of the genome 
of eukaryotic cells remains preliminary and controversial, the technology 
being developed will in the near future allow the determination of this 
important information about the genome of the light and heavy immuno­
globulin chains.
i
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Phenotypic Markers Used To Detect Immunoglobulin Gene Products
Another fruitful approach to the problem of immunoglobulin in­
heritance has been the characterization of markers that are able to 
distinguish the expression of specific antibody molecules in the low 
concentrations in which they can be found in serum. Phenotypic, as 
well as, genotypic information is needed to study the expression and 
inheritance of immunoglobulins. There is ample evidence which suggests 
that immunoglobulin genes are present in the genome which are not 
expressed during the life of the organism. Even after investigations 
using DNA hybridization have elucidated the molecular organization of 
the immunoglobulin genes, well characterized immunoglobulin markers 
will be required to study the mechanisms by which antibodies are 
expressed.
Undoubtedly the amino acid sequence is the most reliable means, of 
identifying the presence of a particular V-region. However, the immune 
response has a large number of the antibodies with specificity for the 
same antigen. This diversity of the immune response makes the purifi­
cation of specific anti-hapten antibodies extremely difficult in most 
cases. For example, Kreth and Williamson (98) estimated that in CBA/H 
mice, each mouse is capable of producing between 3000 and 30,000 dif­
ferent antibodies directed against a synthetic hapten, (5-iodo-4- 
hydroxy-3-nitrophenyl) acetyl (NIP), an antigen to which it is 
doubtful the organism had exposure during its evolution. This conclu­
sion is based on the results of an experiment in which irradiated mice’s 
immunological responses were reconstituted with single clones of immuno­
globulin producing cells. On the average each recipient mouse possessed 
one clone of anti-NIP antibody producing cells which could be
i
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5̂
8
identified by the unique banding pattern of the antibody after iso­
electric focusing (its spectrotype). Of 337 mice studied, only five 
pairs of identical isoelectric focusing spectrotypes were recorded. 
Statistically the incidence of finding this many identical clones among 
337 mice enabled the calculation that the genetic repertoire of anti- 
NIP antibodies was in the order of thousands. The estimation of the 
number of different antibodies which a mouse can make was based on a 
number of assumptions which may or may not be correct. First of all, 
it was assumed that all clones of anti-NIP antibodies had an equal 
opportunity to be expressed. If one clone had a tendency to be expressed 
more often than others, the repeat frequency of identical clones would 
be artificially elevated which would lower the estimation of different 
anti-NIP antibodies that the animal is capable of producing. More than 
one antibody that binds the same hapten can have identical isoelectric 
focusing spectrotypes (183), so the scoring of identical antibodies 
only by spectrotype analysis may falsely lower the estimation of 
different antibodies coded in the genome that can bind NIP.
In a similar experiment, Pink and Askonas (133) sequentially 
immunized mice with antigens containing DNP (2, 4 dinitrophenyl-) and 
TNP (2, 4, 6 trinitrophenyl-), a procedure that had been demonstrated 
to produce a less heterogeneous anti-DNP response (158). Using an 
isoelectric focusing spectrotype analysis, the authors were able to 
estimate that the number of DNP binding antibodies that a mouse can 
make is in the order of thousands. It must be emphasized that the 
conclusions of both Kreth and Williamson's and Pink and Askonas' 
experiments are underestimates not only due to the objections already 
put forward, but also because in these studies it was assumed that the
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entire repertoire of hapten binding V-regions is able to be expressed ;t 
the time of antigenic challenge. Much evidence has been produced which 
has demonstrated that as an organism matures the repertoire of antibody 
producing cells changes (154, 152, 33). Thus in most immune responses 
the large number of different antibodies and their low concentrations in 
sera precludes the identification of naturally raised antibodies only by 
primary sequence analysis.
The primary sequences of myeloma proteins produced by plasmacytomas 
have been studied as prototype immunoglobulin molecules. An example of 
the many studies performed with myeloma proteins which demonstrated the 
large heterogeneity of their V-regions is the investigation by Quattrochi, 
Cioli, and Baglioni (135). Of 102 Bence Jones proteins, no two were 
found which had an identical peptide map of their tryptic digests.
Despite the difficulty in obtaining reproducible results by this technique, 
these results indicated to the authors that there are at least a few 
thousand V^-region sequences encoded in the genome. The authors assumed 
that the expression of particular myeloma proteins by plasmacytomas is 
random and that each V-region sequence is encoded in the genome.
These results of Quattrochi ejt al. (135) are even more impressive 
when they are examined in the light of other data which indicate that 
the transformation of lymphoid cells to myeloma protein producing 
plasmacytomas is not a random process. NZB and Balb/c strains of mice 
are the only strains in which myeloma protein producing plasmacytomas 
can be consistently induced. Table 1 summarizes the work of Morse et 
al. (173) and Loh jet al. (173) with Balb/c and NZB pristane induced 
plasmacytomas. These studies show that different populations of V- 
regions are expressed by the NZB and Balb/c plasma cell tumors. While
...I
§
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TABLE 1
A COMPARISON OF NZB AND BALB/c MYELOMA PROTEINS (173, 64)
Balb/c Protein NZB Protein
Antigen specificity . PC, DNP, a(l-<-3) Dextran, only anti-DNA Antibodies
o(l->6) galactan, also bind DNP;
8(2-*-l) levans DNA, RNA, ct(l->6) dextran,
3 (2-i-l) levan
Z H chain blocked rarely about 2/3 of all myelomas
Class Distribution Z Z z Z
IgM 1.1 2 1.7 2
IgA 45.7 69 20.9 27.
IgG
1 6.4 10 9.1 12
2a 4.5 7 15.2 20
2b 8.1 12 25.7 34
3 0.7 1 2.2 3
looz loo;
ic chains only 2.0 0.
X chains only 0.2 1.7
more than one Immuno­
globulin 6.6 9.6
no paraprotein detected 24.9 3.9
untypable 0. 10.
100Z 100Z
total 9 of tumors
studied 558 230
N-terminal analysis 




2 with same sequences 5
3 ii H it
4 H n ii ^










] only one sequence is common to the 
k chains of both NZB and Balb/c 
proteins
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many Balb/c myeloma proteins bind DNP and phosphorycholine (PC), no NZB 
protein has been found which does. Instead the NZB proteins bind RNA 
tumor viruses and DNA, which no Balb/c protein does. Balb/c tumor 
proteins are predominately of the IgA subclass, while the class distri­
bution of NZB tumors resembles more closely that found in normal NZB 
sera. Rarely are the H chains of Balb/c tumors blocked by the pyrroli- 
done carboxylic acid (PCA) residue. Two-thirds of the H chains of NZB 
mice are blocked. Furthermore, of 25 NZB k  chains sequenced, only one 
light chain has its 23 N-terminal amino acid sequence identical to one 
of the Balb/c < chains. These results indicate that there is probably
a difference in the Vu and VT gene pools from which the NZB and Balb/cfci L
myeloma proteins are elicited. Also, the process of myelomatosis in 
general therefore is not a random transformation process involving the 
entire immunoglobulin germ line. Thus it seems likely that any esti­
mation of the number of germ line immunoglobulin genes based on the 
diversity of the V-region sequences of myeloma proteins will be an 
underestimate.
This conclusion is especially relevant to the analysis of the 
primary structure of the X light chains of mouse myeloma proteins (2, 
171, 172). Of 21 X chains sequenced to position 113, twelve had 
identical amino acid sequences. The other nine X chains differed by 
less than four residues. The lack of variability of the X chains’ 
primary sequences may reflect either the preferential induction of a 
sub-population of X chains encoded by the genome, or a limited genetic 
repertoire for X chain sequences. Leder eit £l (106) found that the 
hybridization kinetics of the cDNA transcript of the mRNA for the RPC 
20 plasmacytoma's X chain to the DNA of this tumor is consistent with
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the presence of one copy of the A structural gene per haploid genome.
Thus this cDNA probe may be a valid marker for the structural genes of 
the A chains of this plasmacytoma. It is not known how diverse the 
natural mouse A chains are; therefore, this cDNA probe may not hybridize 
to all A-like V-region structural genes. It will be interesting to 
compare the V-region sequences of the A chains of natural mouse immuno­
globulins to those of the 21 myeloma proteins sequenced.
A series of properties of immunoglobulins have been employed to 
identify specific V-regions in sera because it is not practical to 
isolate and sequence the V-regions of antibodies in small samples of 
serum. These properties are the antibodies' binding constant for more 
than one hapten (fine specificity) (71), the physical properties of the 
immunoglobulin (e.g. isoelectric focusing spectrotype) (28), and sero­
logical markers for the V-region (idiotype) (99). These three properties 
of immunoglobulins can be used as markers for the variable region because: 
a) antibodies of the same immunoglobulin class should have identical 
physicochemical properties except for the variability inherent to the V- 
region; b) the constant region of an antibody does not contribute to the 
binding of an immunoglobulin for its haptens; and c) the constant region 
is not involved directly with serological markers that distinguish one V- 
region from another.
Allotypic Markers in Mice
Until recently, serological markers have only been described for 
the C-region of immunoglobulins. These "allotypic" markers have been 
shown to represent inheritable amino acid sequence differences in the 
C-region, presumably marking germ line genes. In mice, allotypic 
markers have been extensively developed for H chain determinants (63,
i
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125). Only recently have efforts to detect serological markers for the
C and V regions of L chains been made (173). Before, the L chains of
mice had been only identified by the C-region isotype, as either
X or k constant regions. On the other hand, each heavy chain class has
its own set of allotypic serological markers. The largest set of
determinants are the markers for the IgG2a subclass which is represented
by the Ig-1 genetic locus. In over 2000 matings and backcrosses, no
recombinants have ever been detected among the various mouse allotypic
loci (63, 164). Thus the C„-region genes are assumed to be tightlyrl
linked in the chromosome and any mouse allotypic marker for any C^- 
region can be employed to study the linkage of each of the C^-region 
gene to any other genetic marker. Since the Ig-1 locus has the most 
extensive repertoire of allotypic determinants, most studies use this 
set of alleles to test the linkage of V-region markers to the CH~ 
region genes. Table 2 identifies the Ig-1 allotypic loci of the more 
commonly used strains of inbred mice.
The Use of Fine Antigenic Specificity Preferences to Identify 
V-Region Gene Products
The fine specificity of an immunoglobulin for various haptens has 
been used as a marker for particular V-regions in a number of studies 
by MMkel'd and associates (71, 116, 114, 73, 74, 77, 137) and recently 
by Dutton and McCarthy (173). Fine specificity characteristics of a 
serum are measured by determining a serum’s relative avidity for one 
hapten compared to a series of other haptens. Certain strains of mice 
produce antibodies with a unique fine specificity compared to other 
strains. Genetic studies are then performed to follow the inheritance 
of these antigenic preferences. MMkelh and associates have developed
i
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TABLE 2
The Ig-1 Allotypic Loci of the More Commonly
Employed Inbred Strains of Mice (173 , 37)
a+ a b c d e
Balb/c CBA C57BL DBA AL/N A/J
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three sets of V„ markers based on the fine specificity of immunoglobu- H.
lins: V„NP; V„NBrP; and V^ABA-HOP, summarized in Table 3.H n ti
In the V„NP system, certain strains of mice immunized with (4- H
hydroxy-3-nitrophenyl) acetyl (NP) produce a "heteroclitic" response 
for NIP and NNP*, i.e., the anti-NP antibodies have a higher avidity 
for NIP and NNP than for NP. These assays were performed on whole 
serum by a very sensitive phage-inhibition assay which measures the 
ability of antibodies to inactivate bacteriophage T4 that has hapten 
conjugated to it (116, 71). Only the strains of mice which have the 
Ig-1*5 allotype produced a heteroclitic response for NNP and NIP in 
their anti-NP sera (137, 73). Furthermore, in the sera of Ig-1^ mice 
the anti-NP antibodies of the IgM, IgA, and IgG subclasses were all 
heteroclitic. Using isoelectric focusing it was determined that one 
spectrotype, "N-l", composed of heteroclitic IgGl antibodies could be 
detected in 92% of C57BL mouse anti-NP sera. The "N-l" spectrotype was 
found to coinherit with the Ig-1*5 allele. Since an antibody's specificity 
is both a function of the V-regions of heavy and light chains, it was 
somewhat surprising that the anti-NP heteroclitic response inherited 
with a H chain marker, until Jack et al. (77) demonstrated that the 
heteroclitic anti-NP antibodies in the Ig-1^ strains all contained X 
light chains. Consistent with this finding is that one strain, SJL, 
which has the Ig-1** allele lacks both X chains and the ability to make 
heteroclitic antibodies to NP. In a Balb/c (Ig-la+) x SJL (Ig-1^) 
mating, the offspring were able to respond to a NP antigenic challenge 
with the same fine specificity of other Ig-l^ strains. This result
*NIP is (5-iodo-4-hydroxy-3 nitrophenyl) acetyl and NNP is (4-hydroxy- 
3,5 dinitrophenyl) acetyl.
















anti - NP C57BL/6
anti-NBrP Balb/c + 
C57BL/6 -
a,?e,?c,?f
anti-ABA-HOP C3H, CBA - I 
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suggests that the heavy chain was provided by the SJL parent and the A
chain by the Balb/c parent.
Although not as extensively characterized, Makela's group was able
to demonstrate that heteroclitic responses to two other antigens were
Ig-1 allotype linked: NBrP ((5-Bromo-4-hydroxy-3 nitrophenyl) acetyl)
(74) and ABA-HOP (azobenzenearsonate coupled to carbon atom 3 of 4-
hydroxyl phenylacetic acid) systems (117). These results are summarized
in table 3, as well as those of the fine specificity marker, V ESE, ofrl
Dutton and McCarthy (142) which is based on the ability of anti-SRBC 
sera of certain strains to "discriminate" in specificity between two 
antigenically different types of SRBCs.
The difficulty in employing fine specificity alone as a marker for 
V-region gene products was first demonstrated by Pincus ej: al (132).
They found that rabbit sera directed against pneumococcal polysaccharides 
(type III or VIII) had homogeneous binding characteristics (Sips hetero­
geneity index of 1.0), yet the sera were heterogeneous in their compo­
sition of immunoglobulin molecules as demonstrated by electrophoresis. 
Thus just because a preparation binds an antigen with homogeneous 
characteristics, it does not mean the antibodies are identical. Claflin 
and Davie were able to demonstrate the same point with different mouse 
myeloma proteins that have the same fine specificity for PC and related 
antigens (22, 24, 26). Thus the linkage of fine specificity to Ig-1 
allotype might represent the genetics of a single V„ gene or the
inheritance of a family of V genes representing anywhere from one torl
hundreds of different antibodies with similar antigen binding specifi­
cities. The use of other markers in conjunction with the fine speci­
ficity characteristics of the V-region, such as isoelectric focusing
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spectrotype (114), limits the set of different antibodies which can have 
the same specificity and charge; however, two different rabbit anti­
bodies with the same antigenic specificities and isoelectric focusing 
patterns have been reported (183).
The Application of Isoelectric Focusing Patterns To Identify V- 
Region Gene Products
Despite the limitations mentioned above, numerous workers have 
attempted to use isoelectric focusing to distinguish different antibody 
V-regions. Gibson (53) has demonstrated that the isoelectric focusing 
pattern of light chains of sera from unimmunized mice can be stained to 
produce a very complicated set of over 50 bands. Of the different mouse 
strains surveyed, he could divide the strains into two groups: those
that had a certain pattern of bands; and those which did not. The FI 
generation of matings of mice from each group produced a codominance 
of each isoelectric focusing pattern. Although Gibson did show that one 
banding pattern appeared to be linked to a genetic locus that codes for a 
lymphocyte surface marker (the Ly-2,3 marker), he failed to determine 
whether V or C region differences accounted for the various banding 
patterns observed. In addition, this study employed the sera from un­
immunized mice. "Unimmunized" mice are constantly being immunized by 
their environment. The different populations of antibodies in each 
strain's sera may have reflected the different antigenic histories of 
the mice. Hence, the use of sera from unimmunized mice also lends doubt 
to the validity of these results.
Another study which employed only isoelectric focusing to disting­
uish different V-regions was that of Cramer and Braun (32). They 
characterized the spectrotypes of various strains of mice hyperimmunized
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
19
with Group A streptococcal polysaccharides (A-CHO). After performing 
the appropriate matings, the isoelectric focusing patterns were found 
not to segregate with hair color, sex, H-2 type, or Ig-1 allotype.
The banding patterns however were very complicated and it is not clear 
what the bases of the spectrotypic differences were.
Claflin (28,29,146) used the isoelectric focusing banding patterns 
of the L chains of four Balb/c phosphorylcholine (PC) binding myeloma 
proteins to analyze the isoelectric focusing patterns of the L chains 
of PC binding antibodies from various strains of mice. The anti-PC re­
sponse is very amenable to such a study because this immune response 
is very restricted in terms of the subclass of immunoglobulins induced 
and the number of different V-regions present. Each strain had a charac­
teristic banding pattern that could be depicted in terms of overlapping 
bands of the L chains of the PC-binding myeloma proteins. Claflin and 
colleagues, however, extended this analysis by looking at the fine speci­
ficity, idiotypic determinants, and N-terminal amino acid sequences of 
these naturally raised PC binding antibodies.
The Concept of Idiotypic Markers
The idiotypic markers of V-regions provide a very sensitive set of 
determinants which in conjunction with fine specificity and the physical 
properties of antibodies can be used to distinguish one immunoglobulin 
from another. The term "idiotype" was coined by Oudin (127) in 1965 to 
describe the set of characteristics, serological or otherwise, that were 
thought to distinguish two antibodies with the same antigenic specificity 
from each other. By 1965 abundant evidence was produced that demonstrated 
that antibodies to the same antigens were heterogeneous. For example,
|
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Kunkel, Mannik, and Williams (100) had demonstrated that rabbit antiser i 
directed against human antiserum to hog gastric A substance would only 
recognize the human serum that was used to induce the rabbit antiserum. 
These rabbit anti-human sera would not bind to any other individual's 
serum or with the pre-immune serum from the same individual. Thus the 
rabbit antisera recognizes idiotypic determinants in the human serum.
With time, however, it was recognized that anti-idiotypic antibodies 
could bind to subsets of antibodies with similar antigenic specificities. 
Kunkel ^t al (101) demonstrated that rabbit anti-idiotypic sera to human 
cryoglobulins (anti-y-globulin IgM) would bind to different human cryo­
globulins, but not with other human IgM's. Similarly Williams et al 
(176) isolated a rabbit antiserum that could distinguish cold agglutinins 
from other human IgM's.
Myeloma proteins were demonstrated to share idiotypic determinants 
with naturally raised antibodies by the work of Cohn £t al (30). They 
isolated an A/J mouse antiserum to the Fab of S63, a Balb/c myeloma 
protein which bound the pneumococcal C carbohydrate (C-CH0). Only 
one of 160 Balb/c myeloma proteins tested were bound by this antiserum. 
Interestingly, this idiotype positive myeloma protein (S107) also bound 
C-CHOl Positive idiotypic determinants were also detected in six 
of ten sera of individual Balb/c mice immunized with pneumococci. The 
high frequency of idiotype positive sera in the Balb/c mice implied 
that inbred animals would probably be more amenable to the study of 
the genetics and expression of immunoglobulins than outbred animals 
like rabbits and human beings. (125)
L
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Whether the source of the anti-idiotypic serum was derived from 
another species (xeno- or hetero- anti-idiotypic serum), from another 
strain of' the same species (alio- anti-idiotypic serum) or from the 
same strain or animal (iso-anti-idiotypic serum), the properties of 
the antisera are similar (62, 97, 161, 132a). For example, Cohn- et 
al (30) demonstrated that a rabbit anti-idiotypic serum to the Fab 
fragments of S63 recognized only four of 160 Balb/c myeloma proteins 
surveyed. One of the four proteins was the same as that recognized 
by the A/J anti-idiotypic serum. Undoubtedly, the mouse and rabbit 
anti-idiotypic sera were highly specific for the Fab fragments of S63, 
but they recognized different determinants on S63. Iverson (76) and 
Sirisinha and Eisen (155) were the first to demonstrate that inbred 
strains of mice could produce anti-idiotypic sera against myeloma 
proteins derived from the same strain. Rodkey (143) later demonstrated 
that a rabbit was able to make anti-idiotypic sera' against its own anti­
bodies. For the purposes of this thesis, the term "anti-idiotypic 
sera" will be used to describe sera with anti-idiotypic properties 
regardless of the animal source of the sera (37).
Sirisinha and Eisen (155) and Brient et. al̂  (12) showed that hapten
could inhibit the binding of some anti-idiotypic antibodies to the
reference myeloma proteins. Since haptens are bound in the V-regions of
immunoglobulins, this inhibition of antibody anti-idiotypic serum binding 
by hapten is suggestive that anti-idiotypic antibodies are directed to V- 
region determinants. However the work of Cohn et al (30) and Wells et el 
(174) was the first to physically localize the region of the immuno-
1 globulin to which the anti-idiotypic antibodies are directed.
if
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While Cohn al̂  (30) demonstrated that the idiotypic determinants 
of the myeloma protein, S63, resided in the Fab portion of the immuno­
globulin molecule, the investigation of Wells ej: al (174) was the first 
to demonstrate that the specificity of an anti-idiotypic serum is 
directed against the V-region of an antibody. Wells et al determined 
that all the idiotypic determinants on protein 315 were present on its 
Fv fragment which contains only the V-region of the molecule. The 
binding of hapten by protein 315 and by its Fv prevented any interaction 
of these proteins with the anti-idiotypic sera. Thus the anti-idiotypic 
sera used in this experiment were directed against the V-region of the 
protein 315 and had an interaction which was suppressed by antigen 
binding to the combining region of the antibody molecule.
The Structure of the V-Region as it Relates to Idiotypic 
Determinants and to the Multispecific Binding of Antigens 
by Immunoglobulins
In order to understand the molecular basis of the serological 
interactions observed with anti-idiotypic sera, the structure of the 
combining region and the V-region of immunoglobulins must first be 
understood. In the late 1960's after the amino acid sequences of many 
myeloma proteins were established it became evident that certain amino 
acid positions within the V-regions of the H and L chains were more 
variable than others. Wu and Kabat (87) decided to quantitate this 
variability of amino acid composition as a function of sequence posi­
tion in the V-regions of L chains. They defined variability "as the 
number of different amino acids at a given position divided by the 
frequency of the most common amino acid at that position." They found 
that the variable region had statistically certain areas of "hyper- 
i variability" (Hv) in which many different amino acid residues can be
ft-'*'
teĵj
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found among the various myeloma proteins. Other parts of the variable 
region had much less variability or none and were called "framework" 
or non-Hv residues. It should be emphasized that the distinction 
between positions designated as hypervariable and as non-hypervariable 
is statistical. There are very few positions of the V-region of- the 
different immunoglobulin chains that are completely invariant in amino 
acid composition. Capra and Kehoe also performed this type of analysis 
with the V regions of H chains (14). In the ensuing six years, more 
sequences confirmed this hypothetical analysis of the structure of the 
V-region of immunoglobulins (88), thus defining in humans and mice three 
Hv regions in the light chain at amino acid residues 24 to 34, 50 to 56, 
89 to 97 and four Hv-regions in the H chain at residues 31 to 35, 50 
to 56, 81 to 84, and 95 to 102. Haber eĵ  jlL (68) performed a similar 
analysis with the H and L chains of natural rabbit antibodies and found 
different positions of hypervariability than that found in human and 
mouse immunoglobulins. Wu and Kabat argued that the amino acid side 
chains found in the Hv regions composed a "complementarity" region some­
how involved with antigen binding in the combining site of an antibody. 
Not until x-ray crystnllographic studies of the Fab fragments of myeloma 
proteins (140, 141, 150) revealed the tertiary structure of immunoglobu­
lin V-regions could an explanation be advanced for the possible asso­
ciation of Hv regions with antibody specificity and idiotype.
The tertiary structure of immunoglobulin molecules is composed of 
a series of two polypeptide chains closely associated in a series of 
polypeptide folds called "domains". This basic structure is schema­
tically diagrammed in Figure 1. The variable regions of the H and L 
chains make up a domain; the constant region of the L chain and the
1
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FIGURE 1
A Hypothetical Model Of An Immunoglobulin Molecule
r i
jf ôc° aW / ’V  /“"0J v,
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This drawing is a hypothetical model of the domain groupings of the 
chains of an immunoglobulin molecule. The bends and folds shown 
are not descriptive of the actual tertiary folding except that it 
shows that the domains of the immunoglobulin molecules consist of 
the V-regions of the H and L chains (V and V ), the C-region of 
the L Chain and the first 120 amino acid residues of the H chain
C-region (C and C l ) , the second 120 amino acids of the H chain
(Cy3) and tne third 120 amino acids of the H chain (C^4). In actuality
these domains are folded into compact structures.
Figure from reference 48.
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first 110 amino acids of the constant region of the H chain provides 
another domain; and two more domains are composed of the two H chains 
being associated with one another. Despite sequence differences, 
every immunoglobulin studied to date has this basic domain structure.
(67) At the end of the domain created by the association of the two 
V-regions of the H and L chains, a cleft or cavity exists which provides 
a solvent channel between these chains. The walls of this cleft are 
almost entirely composed of amino acid residues which compose the Hv 
regions of Wu and Rabat and Capra and Kehoe. While many of these Hv 
residues are located at the surface of the immunoglobulin molecule at 
the opening of the cleft, not all of the Hv regions are represented 
about the cleft. Insertions and deletions of amino acids in the Hv 
regions can be demonstrated to modify the dimensions of the cavity, there­
by, changing the amino acid side chains that are exposed to the interior
O
of the cleft. For example in the 3.1 A model of the Fab of McPC 603,
Segal al (150) demonstrated that five of the seven Hv regions are 
located in this cavity. One Hv region of the H chain is at a bend away 
from the cavity and one light chain Hv region is also not part of this 
region. Compared to the tertiary structure of the Fab of the human 
myeloma protein, NEW, a six amino acid insertion in one of the light 
chain loops of McPC 603 results in a different structure of the cavity 
from NEW's.
Crystallographic studies have demonstrated that hapten is bound by 
the immunoglobulin in this cleft at the solvent exposed end of the V- 
region domain. Antigen is bound by multiple interactions with many 
amino acid side chains which line the combining region cavity. Thus 
in the combining region of McPC 603, phosphorylcholine (PC) molecule
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has contact with more residues of the H than the L chain (150) and in 
the Fab of NEW (140,141,1) the hapten Vitamin makes contact with at 
least twelve residues equally distributed in the L and H chain of the 
combining region cleft. It is therefore incorrect to refer to an 
antibody's combining "site", but rather, antibodies have combining 
regions whose architecture is determined by the folding of the Hv 
regions at the fluid channel at the end of the V-region domain.
In the two examples known (NEW and McPc 603) not all Hv regions 
affect the shape of the antigen binding cleft. Thus it is possible that 
immunoglobulins with some differences in primary sequence of their V- 
region may bind the same hapten with identical affinity. Similarly 
differences in the architecture of the cavity and in the number of 
contact residues may be the basis for different affinities and fine 
specificities observed amongst different antibodies which bind the same 
hapten (72).
If the combining region is able to bind more than one structurally 
distinct antigen, the antibody is said to be multispecific. Many pairs 
of different antigens have been described in the literature as being 
bound by the same antibodies (13, 149, 121, 83, 46). For example, a 
sub-population of antibodies to streptococcal cell walls has been demon­
strated to bind to myocardial cells (142) and some DNP binding antibodies 
can also bind vitamin K (menadione) (121, 83). Cameron and Erlanger (13) 
demonstrated that three different rabbit M P  binding antibodies bind 
different sets of unrelated antigens. Rosenstein and Richards (144, 145, 
120) by a variety of techniques demonstrated that a mouse myeloma protein 
460, binds both DNP and vitamin in two non-overlapping locations in 
the antigen binding region. Furthermore, they were able to selectively
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denature protein 460 so that it could bind one hapten and not the other. 
The multispecificity of antibodies has been used in arguments that limit 
the repertoire of antibody genes. It is proposed that each antibody V- 
region coded in the genome can bind overlapping sets of different anti­
gens (162, 140). Using the three dimensional models of the Fab frag­
ments of the immunoglobulins, the ability of an antibody to bind more 
than one antigen in different parts of the V-region now can be interpret- 
ted in terms of the antigens having different contact residues in the 
cleft at the solvent exposed end of the V-region domain.
Based on the common tertiary structure of the myeloma proteins 
determined to date, various groups have attempted to create models of 
the combining regions of immunoglobulins that have not been examined by 
x-ray crystallography. These models were built in order to determine 
which amino acid residues might be involved with antigen binding. An 
example of this approach is the work of Padlan et al. (128) for MOPC
315, a DNP and menadione binding mouse myeloma protein, based on the
O
3.1 A model of McPC 603. The obvious difficulty with such analyses is 
that verification of their conclusions can only be made by x-ray crystal- 
lographic studies.
Since the V-region domains appear to have similar folding patterns, 
many investigators believe that the non-ELv residues determine the common 
domain structure and the Hv residues determine the fine structure of the
combining region. These assumptions are born out with the recent work of
Capra and Nisonoff (17, 173) which show that two immunoglobulins which 
bind the same antigen (jv-azophenylarsonate) may have very different non- 
Hv residues in the V-region of the L chain, but identical Hv residues.
I The sequences of the Hv-regions of the H chains of these two immunoglobu-ft '■
I'. .
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lins were identical. Vrana al. (173) have demonstrated a similar 
situation with the sequences of two Balb/c myeloma proteins that bind 
fructosans with B (l->2) linkages.
Since many Hv region residues are exposed to solvent at the surface 
of the immunoglobulin and these residues represent the largest amount of 
structural diversity amongst the immunoglobulins, it would not be sur­
prising if these Hv differences were the molecular bases for anti- 
idiotypic sera’s ability to distinguish one V-region from another. If 
the amino acid residues of the Hv region were the antigenic determinants 
for anti-idiotypic sera, then the ability of antisera to bind to myeloma 
proteins with the same antigenic specificity can be explained.
It must be emphasized that just as any antiserum is heterogeneous 
in its composition, anti-idiotypic serum contains more than one antigenic 
specificity. Many studies (130, 148) have demonstrated the heterogeneity 
of the population of antibodies which compose "highly" specific anti- 
idiotypic serum. Thus the complete binding of an anti-idiotypic serum 
with an antibody may be a function of the different portions of the immuno­
globulin molecule which each individual anti-idiotypic antibody of the 
antiserum recognizes. The complete binding of an antiserum to two anti­
bodies is a very sensitive measure of the two antibodies similarity.
The identity of the two V-regions must however be demonstrated by sequence 
since an antiserum may not have specificity for all the differences which 
exist between two molecules. Even in the case of TEPC 15 and H0PC8, two 
Balb/c myeloma proteins that have identical interactions with anti- 
idiotypic antibodies, identical isoelectric focusing patterns, and 
identical antigen binding characteristics, there is one amino acid dif­
ference in residue #99 of the H chain (in the third Hv region) (88, 109,
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23, 27).
Anti-idiotypic serum can be described in terms of the quality of 
its interactions with immunoglobulins. Anti-idiotypic sera can be classi­
fied into those whose interactions with the V-regions of the antibody is 
inhibitable by the reference antibody binding a hapten and those whose 
interactions are not inhibitable by the antibody binding a hapten.
Brient et al. (12) and Sirisinha and Eisen (155) were the first investi­
gators to demonstrate the hapten inhibitable nature of the antibody - 
anti-idiotypic serum interaction. Inhibition by antigen can occur for 
the following reasons: a) antigen binding in the combining region cleft
can mask (sterically hinder) certain amino acid residues that an anti- 
idiotypic serum may recognize; or b) antigen binding may cause subtle 
changes in the tertiary structure such that certain Hv-loops are no 
longer exposed to the surface of the molecule. For the purposes of this 
thesis, the group of anti-idiotypic sera whose interaction with antibody 
are hapten inhibitable will be labeled "combining region complementary" 
anti-idiotypic antibodies in recognition of the fact that the binding of 
antigen by the combining region affects the expression the idiotypic 
determinants. The term, "combining region complementary" anti-idiotypic 
serum is therefore both a functional and a structural description of the 
interaction between antibody and anti-idiotypic serum.
Claflin and Davie (25, 23) have used the ability of the hapten to 
inhibit anti-idiotypic sera binding as a means to isolate combining region 
complementary anti-idiotypic sera. Antibodies to a reference myeloma 
protein are passed through a column containing the reference antibody 
bound to a solid support such as Sepharose. After exhaustive washings, 
antigen is passed through the column and a population of immunoglobulins
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are eluted which can be demonstrated to be combining region complementary 
anti-idiotypic antibodies.
No study to date has correlated a specific idiotypic determinant 
with specific amino acid residues in the V-region of an immunoglobulin. 
This is probably because the population of antibodies and specificities 
in an anti-idiotypic serum is heterogeneous (130, 148). Thus no one 
amino acid sequence is solely recognized by the serum. Using a variety 
of approaches, investigators have demonstrated that the anti-idiotypic 
specificity of a serum can be directed against determinants of the V- 
regions of the H chain, the L chain, or a combination of both chains 
(125, 173, 179, 37).
The Application of Anti-Idiotypic Antibodies To Identify V-Region 
Determinants
Intensive investigations are currently underway to correlate amino 
acid sequences to the presence of idiotypic determinants. This is es­
pecially true in those instances in which idiotypic markers of individual 
mouse immunoglobulins have been demonstrated to be genetically linked to 
C-region allotypic loci (173). In such studies, a reference immuno­
globulin is injected into an animal and an anti-idiotypic serum is iso­
lated from the immune serum. The anti-idiotypic serum is used to deter­
mine whether an immune response of an organism contains antibodies both 
which are bound by the anti-idiotypic serum and which bind the same 
antigens that the reference immunoglobulin does. At present, it is un­
predictable whether a given anti-idiotypic serum will bind ?o antibodies 
from just a few individuals, from a specific strain, or from a particular 
species (37). For example Eichman (35) isolated clones of immunoglobulins 
from A/J mice: A5A, a single clone which binds streptococcal group A
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carbohydrate (A-CHO); and A2C, a mixture of immunoglobulins which bind 
pneumococcal C carbohydrate (C-CHO). Guinea pig anti-idiotypic sera 
specific for each clone were purified. Eichman found that in the anti-A- 
CHO response greater than 80% of A/J mice contain immunoglobulins that 
were bound by the anti-idiotypic sera to A5A. On the other hand, less 
than 20% of the A/J anti-C-CHO responses contain immunoglobulins which
0were bound by the anti-idiotypic sera to A2C. Only mice with the Ig-1 
allotypic locus produced anti-A-CHO antibodies which were A5A idiotype 
positive.
Both myeloma proteins and naturally raised antibodies have been used 
as reference proteins for idiotypic sera employed in investigating the 
immune response to different antigens. Tables 4 and 5 summarize the dif­
ferent immune responses in mice studied by idiotypic analysis. Occasion­
ally an idiotypic determinant is found to have a strain distribution that 
was linked to the Ig-1 allotypic locus. The three most characterized 
immune responses in the mouse are those to phosphorylcholine (or the 
pneumococcal C-CHO), to 2 ,-azophenylarsonate (ARS), and to ct(l->3) dextran.
Before discussing these immune responses, a few points about this 
method of analyzing immune responses must be emphasized. The method of 
inducing and purifying the anti-idiotypic sera and the assay employed 
to detect the presence of the idiotypic marker affects the specificity of 
the serological marker. While most assays quantitate the amount of immuno­
globulin that is bound by an antiserum, only a radioimmunoassay (RIA) 
gives both quantitative and qualitative information about the interaction 
between the antibodies and the anti-idiotypic serum (22). In a RIA, the 
binding of a radioactive antigen to an antiserum is measured in the pres­
ence of varying concentrations of inhibitor. Each antiserum consists of
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more than one antibody directed against the antigen. Each antibody has 
a different affinity for the antigen. At lower concentrations of un­
labeled inhibitor, only the antibodies with the greatest affinity for 
the inhibitor will bind the cold competitive antigen. At higher concen­
trations of unlabeled inhibitor a greater proportion of labeled haptens 
will no longer be bound because of competition for the combining 
regions of the antibodies. Thus the inhibition curve of the binding of 
radioactive antigen generated by varying the concentration of unlabeled 
inhibitor is a reflection of the aggregate affinities of the antibodies 
for that inhibitor. If two different inhibitors are bound with dif­
ferent binding constants by the antibodies that compose an antiserum, 
the concentration of inhibitor required to effectively compete with the 
same radioactive antigen will differ with each inhibitor. Thus the "shape" 
of the inhibition curve produced by each inhibitor will differ. A RIA, 
therefore, measures both the extent of inhibition (the percentage of 
radioactive antigen binding immunoglobulins that also bind the un­
labeled competitor) and the nature of the inhibition. It can only be 
implied of two inhibitors that have identically shaped inhibition curves 
that all antibodies in the antiserum bind the two inhibitors with the 
same affinity. That is, the two inhibitors are antigenically identical.
No conclusion can be made about these inhibitors structural identity 
because antibodies in the antiserum may not be directed against all 
structural features of the antigen. On the other hand, two inhibitors 
that produce differently shaped inhibition curves are definitely anti­
genically dissimilar, even if the two inhibitors produce the same extent 
of inhibition. Thus the RIA provides information about both the ability 
of an antiserum to bind an inhibitor and the nature of this binding.
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Berek et al. (7) used the shape of the inhibition curves produced 
by mouse anti-A-CHO immune sera in a RIA with anti-idiotypic sera to
crdistinguish two sets of idiotypic markers. The S117 and S117 and the 
A5A and A5Acr idiotypic markers were distinguished by both the extent of 
inhibition and the shape of the inhibition curves in the RIAs. Only 
identical inhibition curves produced by mouse sera were used to imply that 
the anitserum employed to identify the idiotype recognized the same deter­
minants on the V-regions of the sera.
The RIA, per se, gives no information about sequence identity. Any 
other assay of idiotypic determinants provides less information about the 
quality of the interaction between the anti-idiotypic sera and an anti­
body. Conclusions about the idiotypic identity of two V-regions based on 
any assay but a RIA must be tempered by the lack of knowledge about the 
nature of the interaction between the anti-idiotypic antibodies and the 
two V-regions.
Another important aspect of many of the studies which employed idio­
typic markers to analyze an immune response is that there is an under­
lying assumption that the anti-idiotypic sera are directed against 
"complementarity" determinants of the V-region. In most instances, there 
is no definitive demonstration that this is the case. In addition, some 
of these markers such as the Ig-1 locus linked TEPC 15 idiotype (109) 
are not combining region complementary, i.e. hapten does not inhibit the 
binding of the reference antibody by the anit-idiotypic serum. In this 
case, Claflin and Davie (27) demonstrated that while hapten would not 
inhibit the binding of anti-idiotypic sera to TEPC 15, very large anti­
gens would. This is presumably so because of steric hindrance of the 
bulky antigen near the V-region of TEPC 15.
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In many of these studies, the antisera were presumed to be anti- 
idiotypic because the sera will bind to only one or two of a few myeloma 
proteins which all bind the same antigen. The authors often failed to 
screen large numbers of myeloma proteins to rule out in the antisera the 
presence of "spurious" specificities for immunoglobulins that bind dif­
ferent antigens than the reference antibody does. This point was empha­
sized by the investigations of Bosma jet al. (9, 173) in which the binding 
125of I-labeled U-10, a Balb/c myeloma protein, to a rabbit antiserum for 
the Balb/c myeloma protein, MOPC 173, was measured in a RIA. Of 58 Balb/c 
myeloma proteins surveyed, thirteen antibodies had identical inhibition 
curves to that of U-10. Furthermore, these "idiotype positive" anti­
bodies bound different haptens. All of these antibodies had similar se­
quences in the 27 N-terminal amino acids of the H chain. By recombining 
the H and L chains of different immunoglobulins to construct new 7S immuno­
globulin molecules, the authors demonstrated that both H and L chains were 
required for the full expression of this serological determinant. Thus 
Bosma et al have isolated a V-region serological marker that is unrelated 
to antigenic specificity and may be related to "non-complementarity" 
residues of the V-region. This result may be analogous to the V-region 
"a" allotypic marker of rabbits (160). A major implication of this study 
is that before an antiserum can be used as a probe for the entire V-region 
of an immunoglobulin, it must first be demonstrated that the antiserum 
recognizes only those immunoglobulins with the same specificity, or better 
yet, it recognizes only those immunoglobulins with identical amino acid 
sequences. The latter of course is more difficult to demonstrate.
Another important point which must be kept in mind when studying the 
phenotypic expression of immunoglobulin V-regions is that just because a
Vi;.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
38
particular V-region is not expressed in an immune response of a strain 
does not mean that genes for that particular V-region are absent from the 
genome. Strosberg ̂ t al. (159, 160) and Mudgett ^t al̂ . (123, 173) have 
demonstrated that rabbits hyperimmunized with Micrococcus lysodeikticus 
expressed V-region "a" locus allotypic determinants which breeding experi­
ments had demonstrated did not exist in those particular rabbits studied. 
The expression of these "forbidden" allotypes implied that the allelism 
observed for the "a" locus was not real, but rather, a regulatory mechanism 
for the expression of "a" allotypes was most likely operative. In a 
similar study, Bosma and Bosma (8) demonstrated the transient expression 
of the Balb/c allotype in a congenically inbred mouse strain that had been 
selected to contain only C57BL allotypes.
No substantiative conclusion can yet be made regarding whether the 
difference in expression of one particular immunoglobulin gene product 
among the various strains of mice is due to structural or regulatory genes. 
This is especially pertinent because regulatory loci have been mapped that 
modulate the maturation of an immune response (147) and that modulate the 
amount of immunoglobulin produced depending on the carrier employed (169) 
and depending on the adjuvant used (170). Thus it should always be born 
in mind that serological markers such as idiotypic and allotypic deter­
minants are phenotypic, but not necessarily genotypic.
The R36 Pneumococcal Polysaccharide Idiotypic System
Probably the best understood immune response is that of the mouse 
to the C-polysaccharide (C-CHO) of the strain R36A pneumococci. The 
initial work of Cohn et al. (30) was extended in a series of studies that 
demonstrated: 1) of 70 Balb/c myeloma proteins assayed, only six could
bind C-CHO (134); 2) anti-idiotypic sera could distinguish a subset of
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C-CHO binding myeloma proteins (134); and 3) the C-CHO binding immuno­
globulins also bind the simple hapten, phosphorylcholine (PC) (108).
Table 4 summarizes the sources and specificities of the different anti- 
idiotypic sera made against the myeloma proteins which bind PC. The 
myeloma proteins, HOPC 8 (H8) and TEPC 15 (T15), are idiotypically 
identical. The anti-T15 idiotypic antibodies have varied specificities: 
some anti-T15 (H8) idiotypic antibodies bind all PC binding myeloma 
proteins and other anti-T15 (H8) idiotypic antibodies bind only to a 
subset of the PC-binding myeloma proteins (27). The idiotypic differences 
seen between T15 and H8 and the other PC binding myeloma proteins are 
reflected in other properties of these proteins. For example, the fine 
specificity of T15 and H8 for a variety of PC-related compounds, such as 
phosphoglycerolcholine and choline, differed from that of other PC 
binding myeloma proteins which do not have identical idiotypic profiles 
(21).
In an important paper Barstad et al. (6) compared the first 41 N- 
terminal amino acids of the H and L chains of five of these PC binding 
proteins. These sequences included the first Hv regions of both H and 
L chains. Three myeloma proteins (T15, H8, S107) were identical by fine 
specificity antigenic preferences and by idiotypic interactions with anti­
sera. The light chains of these three immunoglobulins had identical se­
quences. These sequences were markedly different from the two other PC 
binding myeloma proteins, McPC 603 and M167 (88). Surprisingly, the amino 
acid sequences of the H chains of all five proteins were identical except 
; for one residue in M167 (valine at position 4). This result was the first
demonstration that antibodies isolated from different animals could have 
| similar antigen specificity, idiotypic determinants and amino acid sequences.
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Furthermore, the identity of the H chain sequences and the differences 
of the L chain sequences of the five proteins were used to predict that 
the residues of the H chain of PC binding antibodies were mostly involved
O
with the binding of PC. The 3.1 A Fourier difference map of PC bound to 
McPC 603 has confirmed this prediction (150).
In a related study, Claflin et al. (26, 31) characterized a PC binding 
myeloma proteins, CBPC-2, derived from a congenic inbred strain which 
possessed most of the genome of Balb/c but the Ig-1 locus of C57BL.
CBPC-2 contains the allotype for C57BL, but it is identical to H8 and 
T15 by its fine specificity for PC-related antigens. CBPC-2 also has 
identical idiotypic interactions as T15 does with two different binding 
region complementary anti-T15 idiotypic sera, but CBCP-2 lacked the idio­
typic determinants specified by a non-binding region directed antiserum to 
T15. As with the Barstad study (6), the L chain sequence of CBPC-2 was 
identical to that of T15, H8, and S107 to the thirty-fifth N-terminal 
residue (which includes the first Hv region). The first 36 N-terminal 
amino acids of the H chain of CBPC-2 differ from the Balb/c PC binding 
proteins by two amino acids (residues #14 and #16) that were both non-Hv 
residues. In this study a difference in the non-Hv region of the V- 
region of the H chain was presaged by idiotypic differences. Based on 
fine specificity characteristics CBPC-2, T15, and H8 are identical. This 
study emphasizes that while fine specificity and the idiotypic deter­
minants are extremely sensitive markers for the V-region, only the amino 
acid sequence is the final arbiter as to the identity of two V-regions.
Even T15 and H8 differ by one amino acid iu the third Hv region (88).
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Armed with the various anti-idiotypic sera for the V-region of 
T15-like myeloma proteins, many investigators have analyzed the immune 
response to pneumococcal C-CHO in mice- Claflin and Davie (21, 22, 23) 
and Kluskens at al. (94) demonstrated that the immune response to C-CHO 
in mice involves solely the IgM class of immunoglobulins. Host strains 
of mice produce PC binding antibodies that have the same fine specificity 
to PC-related antigens as the reference PC-binding myeloma proteins.
While many anti-T15 (H8) sera binds to anti-PC antibodies from most 
mouse strains, one serum, A/He anti-T15, a non-combining region complemen­
tary anti-idiotypic serum, only binds to the PC binding antibodies from
cL"t"strains of mice with the Ig-1 allotypic locus (109) . Anti-PC sera from 
animals other than mice did not contain immunoglobulins with the idio­
typic or fine specificity properties of T15 (H8) (22) .
In a series of elegant studies, Claflin (28, 29), Rudikoff (146, 173) 
and Kluskens and Kohler (94) demonstrated that the L chains of an anti-PC 
response of each mouse strain could be analyzed in terms of the isoelectric 
focusing spectrotypes of the L chains from the three PC binding Balb/c 
myelomas, T15, M167, and McPc 603. The L chain spectrotypes of each mouse 
strain was characteristic for that strain. Anti-idiotypic sera were 
employed to isolate the anti-PC antibodies from the anti-C-CHO sera of 
45 A/J mice. The 36 N-terminal amino acid residues of the isolated H 
chains yielded a single homogeneous sequence identical to that of the 
Balb/c proteins T15, H8, and M511, except for a single amino acid dif­
ference at a non-Hv residue (#22). The N— terminal amino acid sequence of 
the L chains gave evidence for the presence of three sequences. This 
composite sequence of the isolated L chains is identical to what would be 
obtained if the L chains of the PC binding proteins, T15, M167, and McPC
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603, were pooled and sequenced. Thus, based on isoelectric focusing 
patterns, idiotypic analysis, and N-terminal sequences, the V-regions of 
A/J mice are very similar to the V-regions of both the H and L regions of 
myeloma proteins from Balb/c mice. This is especially interesting since 
A/J and Balb/c mice have different allotypic loci and the PC binding 
antibodies of these two strains differ idiotypically using a non-binding 
region complementary A/He anti-T15 sera which marks an allotypically 
linked determinant of the V-region of T15. The large amount of sequence, 
isoelectric focusing, and idiotypic homologies observed among the different 
strains of mice argues for a common origin of their V-region genes with ' 
late evolutionary divergence of the non-binding region related idiotypic 
sequences. An analysis of the sequences of antibodies obtained from a 
pool of 45 mice can only be valid, if it is kept in mind that the 
sequences found were that of the majority of immunoglobulins present. 
Antibodies present in small concentrations or in a few mice would not be 
detected.
Recent work by a number of groups has demonstrated that the PC 
binding antibodies induced by pneumococcal C-CHO are only a subset of the 
repertoire of PC binding V-regions present in the genome and capable of 
being elicited. While mice only have an IgM class response to C-CHO 
with little or no maturation of the response (21, 94), Gearhart et al.
(52, 51) have demonstrated that PC attached to a tripeptide spacer linked 
to the carrier, Keyhole Limpet Hemocyanin (KLH), will also induce PC 
binding antibodies of both the IgM and IgG classes. Some of these PC 
binding antibodies lack the T15 idiotypic determinants. Furthermore,
Julius ̂ t al. (31, 86, 173) demonstrated that neonatal Balb/c mice 
treated with A/J anti-T15 idiotypic sera were rendered unable to produce 
immunoglobulins with these T15 idiotypic determinants. These "suppressed"
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mice produced PC binding antibodies which lack the T15 idiotypic but have 
as great an avidity for PC as the T15 idiotype positive PC binding anti­
bodies produced by non-suppressed mice. Thus regulatory factors not yet 
understood determine which set of PC binding V-regions are expressed in 
an immune response.
The js-Azophenylarsonate Idiotypic System
Another well characterized immune response in mice is that of A/J 
mice to j>-azophenylarsonate (ARS) which was characterized by Nisonoff- 
and associates (99, 167, 16, 17, 15, 56, 18, 179, 118). In the A/J mouse, 
from 20% to 70% of its anti-ARS response is bound by a rabbit anti- 
idiotypic serum made against A/J mouse anti-ARS sera (167). Presumably 
only common idiotypic determinants served to sensitize the immunized 
rabbits. The mouse immunoglobulins that are bound by this rabbit anti- 
serum are termed to have the "cross-reactive idiotype" (CRI). To date 
no myeloma protein has been isolated which binds ARS. Only mouse strains 
with the Ig-1 allotypic locus produce CRI positive anti-ARS antibodies 
(99). Although the CRI marker is linked to the H chain allotype, both 
H and L chains are required for the expression of this determinant(s)
(15). While antibodies of every subclass can be found to have the cross- 
reactive idiotype, two major bands of IgGl anti-ARS antibodies were iso­
lated by isoelectric focusing and were found to constitute a major compo­
nent of anti-ARS sera. These two bands were isolated from pools of sera 
of many immunized mice and from the ascites of a single immunized mouse 
(167). When these isolated immunoglobulins were sequenced, results 
similar to those described above for the PC binding antibodies were found. 
The H chain was sequenced to position 54 and yielded a unique amino acid
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seqeunce for both anti-ARS fractions obtained from an individual mouse 
and from pools of mouse sera (15, 16). The H chain of anti-ARS anti­
bodies which did not have the cross-reactive idiotype had a very hetero­
geneous sequence, almost as varied as that of immunoglobulins from whole 
serum. Sequence data for the L chains implied that as few as two se­
quences to as many as 20 different L chains could be found (18). The 
sequences of the L chains were found to differ not at the Hv region but 
in the non-Hv (or "framework") residues. It is interesting that the Hv 
regions of the L chains of guinea pig anti-ARS antibodies have almost 
identical sequences to those of the mice but almost completely different 
non-Hv residues (18). These results are very suggestive that a unique 
H chain sequence and a unique sequence of the Hv regions of the L 
chain are required for the cross-reactive idiotype. The large array of 
different L chains that have similar Hv regions apparently allows the 
genetics of the cross-reactive idiotype to appear to be that of just the 
H chain. It should be remembered that these sequence studies were only 
performed on immunoglobulins isolated from two major peaks on isoelectric 
focusing of anti-ARS sera. Nisonoff and colleagues did not sequence the 
pool of all CRI positive antibody. More than one immunoglobulin was 
present in each peak and the sequence obtained was that of the majority 
immunoglobulin present.
Nisonoff*s group demonstrated that the repertoire of anti-ARS V- 
regions is diverse despite the fact that the CRI positive antibodies 
compose the major part of the anti-ARS response in mice that have the
gIg-1 heavy chain allotype (56). By immunizing neonatal A/J mice with 
rabbit anti-CRI sera, the anti-ARS response obtainable does not contain 
antibodies with the cross-reactive idiotype. Rabbit anti-idiotypic sera
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to the anti-ARS antibodies which lacked the CRI were used to survey the 
anti-ARS response of these neonatally suppressed mice. While some anti- 
idiotypic' sera did not bind to any immunoglobulins of 181 A/J 
anti-ARS sera from neonatally suppressed mice, one anti-idiotypic serum 
bound to only three sera and another to 51 sera. These results support 
the concept that either there is a very large repertoire of V-regions of 
anti-ARS antibodies or that each animal is capable of generating unique 
antibodies for specific antigens. As in the case of the anti-PC response, 
the regulatory controls involved in the preferential expression of one 
idiotype over another must be understood in the anti-ARS response.
The a(l->3) Dextran and 8(2->l) Levan Idiotypic Systems
A third well characterized mouse immune response is that to a(l->3) 
dextrans. This immune response has been analyzed in terms of the anti- 
idiotypic sera to three Balb/c mouse myeloma proteins that bind ct(l->3) 
dextrans, J558, M104e, and U102. Anti-idiotypic antibodies have been 
isolated from goat and A/He sera that are specific only for each indivi­
dual myeloma protein. These specific anti-idiotypic sera are called 
"private" or "Idl" anti-idiotypic sera since the sequences which 
they recognize appear to be unique for each of these anti-dextran anti­
bodies. One goat anti-idiotypic serum to J558 has been studied which also 
binds M104e and U102. This cross-reactive determinant has been labelled 
a "public" or "IdX" marker by these investigators, since the idiotypic 
determinants bound by this antiserum appear to be associated with a number 
of different V-regions with the same antigenic specificity (173, 60, 61).
The difficulty in classifying determinant as Idl or IdX is that not
enough myeloma proteins have been studied to indicate whether many immuno­
globulins will be found that possess Idl determinants. As stated above,
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therefore, the relationship of Idl and IdX determinants to the reper­
toire of all a(l->-3) dextran binding immunoglobulins is not known.
Using these sera, it was determined that all anti-dextran immuno­
globulins in mice have L chains of the A„ type (173). Mouse strains
3*"̂that have the Ig-1 allotypic locus can produce antibodies that are 
bound by these anti-idiotypic sera (136). Furthermore, a(l->3) dextran
3,"4*binding antibodies from Ig-1 positive strains consist of three types: 
a) those that do not interact with anti-idiotypic antibodies directed 
against proteins J558, U102 and MIOAe; b) those which have only the IdX 
determinant; and c) those that have both the IdX marker and one of the 
three Idl determinants. The dextran binding immunoglobulins which have 
both the IdX and Idl determinants for M104e and J558 share the same fine 
specificity for antigens as the reference immunoglobulins. It is also 
clear that the M104e and J558-lilce. immunoglobulins are composed of more 
than one class of immunoglobulin (IgM and IgG). While not all strains 
make the X 0 L chain isotype (e.g. C57BL), the presence of this light 
chain is not the sole requirement for the idiotypic determinants. Even 
though dextran binding immunoglobulins of NZB (Ig-1^) mice make the X Q 
chain, these immunoglobilins have idiotype negative dextran binding 
antibodies.
The immune response to 8(2->l) levans is similar to that of the 
a (1+3) dextrans. A whole series of IdX and Idl mouse anti-idiotypic 
sera have been isolated and characterized (110). The take home lesson 
from this work with the C-CHO, ARS, a(l->3) dextran, and f3(2-KL) lexan 
idiotypic systems is that very well defined anti-idiotypic sera are able 
to bind to natural immunoglobulins which the same antigenic specifities
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as the reference proteins to which the anti-idiotypic antibodies were 
made.
Table 4 summarizes the data concerning the immune responses that 
have used myeloma proteins as reference immunoglobulins in performing 
an idiotypic analysis of the immune response. Table 5 summarizes the 
data concerning the immune responses that were analyzed by using anti- 
idiotypic sera directed to native antibodies found in immune sera. In 
general the work summarized in Table 5 is unsatisfactory because the 
homogeneity of the isolated V-regions must be demonstrated before the 
specificity of the anti-idiotypic sera is believable. Usually this has 
not been demonstrated. For example, Jack at al. (77) isolated a non­
binding region complementary anti-idiotypic serum for heteroclitic anti-NP 
antibodies in the sera of C57BL mice. While the idiotypic determinants 
co-inherit with the heteroclitic anti-NP response, it is unclear how 
specific the anti-idiotypic serum is, i.e., whether the antiserum is 
directed against many different determinants found on many different 
V-regions or the antiserum is directed against determinants found on 
just one V-region. This problem is now being approached by using the 
cell fusion techniques developed by KShler and Milstein (96,107,175). 
Normal spleen cells from immunized mice are fused to a myeloma cell 
line which can be grown in culture. The hybrid cells secrete immuno-
I
globulins, some of which bind the antigen for which the animal was 
primed. In this fashion, KShler and Milstein were able to establish 
new cell lines that produce immunoglobulins with the antigen specifi­
city that they desired and which can be carried in tissue culture. 
Presently, a number of groups are creating stable cell lines in order 
to obtain homogeneous antibodies of a given antigen specificity so that
,L
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idiotypic markers can be generated and used to analyze various immune 
responses (107,175). This approach is a satisfactory extension of the 
anti-idiotypic analysis that used myeloma proteins as references.
The major advantage of the hybrid cell technique is that homogeneous 
antibodies from any strain of mouse and to any antigen may now be iso­
lated.
By employing the various V-region markers of the H chains of
different immune responses of inbred and congenic strains, a linkage
map of these determinants to loci for the Ig-1 allotypes and for a serum
protein called pre-albumin has been derived (164, 173, 137, 136, 37).
This linkage data is summarized in Tables 2, 4, and 5 and in Figure 2.
As emphasized earlier, it is still unclear whether the inheritance of
these markers represents the inheritance of regulatory or structural
genes and it is unclear whether many of the determinants represents one
V.,-region or families of V-regions. It is also curious that all idio- n
typic determinants of mouse immunoglobulins that have been serologically 
defined are found on the H chain or require both the H and L chains for 
expression. Many of these idiotypic markers of mouse V-regions appear to 
be genetically linked to H chain allotypic markers. No idiotypic deter­
minant has been found to be located solely on the L chain. Very few 
investigations to date (19, 70) have employed RIA's to determine the 
effect of the L chain in modulating the expression of idiotypic deter­
minants located on the H chain. Until it is determined how the H and L 
chains affect the expression of the idiotypic determinants which are 
studied as markers for the presence of specific V-regions, the signi­
ficance of these "inheritable" idiotypic determinants is unclear.
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FIGURE 2
Linkage Order of V Region Markers That Have Been Demonstrated To Be
Linked To The Ig-1 Locus (173)
Ig-1 - NaseA - [T15, Dex, S117] - [InuldX, ARS] - A5A°r- [A5A, ABA-HOP, ESE]
i
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The Anti-DNP Response of Rabbits, Guinea Pigs and Mice
The immune response in mice to the simple hapten, 2,4-dinitro- 
phenyl (DNP), is also one of the most studied immunological phenomena, 
yet little work has been performed to develop idiotypic markers in this 
system or to determine the genetics of DNP binding V-regions. The 
ability to easily synthesize chemically defined haptens, antigens, and 
reagents for detecting DNP binding antibodies has made this immune 
response a very popular one for those who study the cellular modulation 
of B cells (50). The immune response to DNP containing antigens in­
volves antibodies of every immunoglobulin subclass.
Eisen and Siskind (38) and Steiner and Eisen (158) have demonstrated that
in rabbits the average affinity of DNP binding antibodies in an immune
response increases with time. By sequentially immunizing rabbits with
DNP, followed by TNP (2,4,6-trinitrophenyl) or vice versa, different and
more homogeneous populations of DNP-binding antibodies are induced.
Little and Eisen (112) continued this analysis and demonstrated that the
population of antibodies induced by TNP immunization are different from
those raised to DNP. In the early stages of an anti-DNP or anti-TNP
response, as little as 50% of the antibodies directed to one hapten will
bind the other. With maturation of the response, the percentage of dual
specific immunoglobulins increases in the antisera. Klinman and Press
(93) demonstrated that in the neonatal mouse non-overlapping populations
of spleen cells exist which produce immunoglobulins that bind either DNP
or TNP. Each type of clone can only be stimulated by one antigen, but
not the other. It should be emphasized that a DNP binding antibody that is
said not to bind TNP (or vice versa), actually represents an antibody
3 -1whose affinity for TNP is low (in the order of 10 M or less) and which
.L
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is many orders of magnitude less than the antibody’s affinity for DNP. 
Pink and Askonas (133) estimated that the number of different V-regions 
in the mouse that bind DNP is in the order of thousands. This estimate 
was based on the number of different isoelectric focusing patterns of 
DNP binding antibodies induced by the sequential immunization with DNP 
and TNP containing antigens.
Normally the immune response to DNP antigenic challenge is too 
heterogeneous for an analysis of individual antibodies. A number of 
groups have demonstrated that the immune response to DNP conjugated to 
certain carriers is greatly restricted in heterogeneity. For example, 
when Richards and Haber (138) injected rabbits with DNP conjugated with 
the "L" peptide, a synthetic polypeptide, a relatively homogeneous 
antibody response with very high affinity for DNP was induced. This 
response did not "mature", i.e., the average affinity and Sips hetero­
geneity index did not change with time. DNP-deca-lysine (179) elicits 
a very homogeneous response in guinea pigs. Each animal averages less 
than two clonal products of DNP binding immunoglobulins based on iso­
electric focusing patterns. Of 53 guinea pigs surveyed, only 19 dif­
ferent isoelectric focusing patterns were distinguishable and seven of 
these patterns constituted the majority of the DNP binding antibodies 
detected. Similarly, Montgomery et al. (122) demonstrated that rabbits 
after somewhat prolonged immunization with (DNP)^-gramicidin S will 
produce a very restricted anti-DNP response that does not change for 
the entire life of the animal. Thirty five percent of the rabbits 
will not respond to antigenic challenge at all, and about 20% of the 
rabbits produce monoclonal antibodies. While these techniques have 
demonstrated means of inducing limited anti-DNP responses, no studies
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have correlated these restricted responses to an idiotypic analysis, 
nor have these relatively homogeneous responses been employed to study 
the inheritance of the V-regions of DNP-binding immunoglobulins.
Another method of studying a limited population of DNP binding 
antibodies was developed by Varga £t al. (168). As explained earlier, 
immunoglobulins can be demonstrated to have multispecificity for 
distinctly different chemical moieties (13, 149, 121, 83, 46). Varga 
et al. (168) screened rabbit anti-DNP sera for its ability to bind 
144 other haptens and found that four sub-populations of DNP binding 
antibodies also bound inosine, uridine, menadione (Vitamin K^) and 
ribonuclease. When rabbits were sequentially immunized with antigens 
containing one of these haptens followed by DNP-BGG, the early phase of 
the anti-DNP response had a preferential stimulation of those clones of 
immunoglobulins that bind both haptens. Later in the anti-DNP response, 
the increase in concentration of "monospecific": antibodies for DNP 
prevented the detection of these double binding immunoglobulins. This 
experiment not only showed that sequential immunization could limit 
the diversity of a normally complicated response, but also it demonstra­
ted that the multispecificity of immunoglobulins may play a physio­
logical role in the induction of specific clones of antibodies.
The specificity of some DNP binding antibodies for menadione (or 
vitamin Ks) had already been described by Jaffe at al (79) for two 
Balb/c myeloma proteins, MOPC 460 (IgA2 » K) and MOPC 315 (IgA^, X^).
The relative affinity of protein 460 for DNP-lysine, menadione, and 2,4 
dinitronaphthol differs from that of protein 315. Michaelides and 
Eisen (121, 40) showed that the naphthoquinone ring "resembles" the 
structure of DNP and they argued that the multispecificity observed
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
53
among the different DNP binding antibodies for menadione was due to 
both haptens being bound to the same site of the combining region. 
However, as described above, Rosenstein and Richards (144, 145, 120) 
have subsequently presented evidence that DNP and menadione are bound 
in different parts of the combining region of Protein 460.
Not all immunoglobulins bind both DNP and menadione in an immune 
response to antigens containing either hapten. Johnston and Eisen 
(83) demonstrated that between 46 and 66% of the anti-DNP response in 
rabbits also bind menadione. These double binding antibodies have a 
higher affinity for DNP than menadione. Similarly, menadione conjuga­
ted antigens induced menadione binding antibodies of which 33 to 49% 
also bind DNP. These menadione binding antibodies have a higher af­
finity for menadione than for DNP. Thus the population of antibodies 
induced by each hapten contains a significant fraction of double binding 
antibodies, but the double binding immunoglobulins are drawn from dif­
ferent V-region gene pools. This result is reminiscent of the proper­
ties of the different populations of TNP and DNP binding antibodies 
induced in rabbits (158, 112).
A few preliminary experiments with anti-idiotypic sera to DNP 
binding myeloma proteins have been employed to analyze this complex 
immune response. Sigal (153) employed rabbit and mouse anti-T15 
idiotypic sera to analyze the DNP binding antibodies produced in 
spleen cultures. Of 680 anti-DNP clones studied, only two clones 
produced antibodies that bound both DNP and phosphorylcholine (PC). 
Antibodies from one of these clones was bound by the rabbit anti-T15 
serum, but not by the mouse anti-T15 serum. The other double binding 
clone failed to be bound by either sera. A major criticism of this type
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of study is that the author failed to describe the shapes of the inhi­
bition curves in the RIA used to detect the interaction between the 
double binding antibody and the rabbit anti-idiotypic sera. It is 
therefore unclear how the antigenicity of this DNP and PC double bind­
ing immunoglobulin relates to that of protein T15.
Hunkapiller e_t al. (173) have studied the first 38 N-terminal 
sequences of the L and H chains of six Balb/c myeloma proteins that 
bind DNP. The amino acid sequences of five of the six light chains 
were distinctly different from each other. Only J604 and J688 
had similar sequences. The heavy chain sequences, however, could be 
divided into two groups (or families) consisting of MOPC 460, MOPC 
315, and S23 in one family, and of XRPC25, J604, and J688 in the other. 
The validity of this division of DNP binding myeloma proteins into two 
groups awaits the elucidation of the entire amino acid sequence of these 
and other DNP binding myeloma proteins.
A number of groups have succeeded in making anti-idiotypic sera to 
these DNP-binding myeloma proteins. Despite the sequence homologies 
in the H chains of proteins 460 and 315, many studies have failed to 
detect idiotypic antigenic identity between these two proteins (155,
163, 62). In other studies, protein 46Q was used to absorb out the 
allotypic similarities between proteins 315 and 460 from an anti-315 
i sera (12). Thus any idiotypic cross-reactions that may have existed
in these antisera were lost.
While demonstrating that a strain could make anti-idiotypic anti­
bodies against its own myeloma proteins, Eisen and Sirisinha (35) demon­
strated that normal Balb/c sera was bound by Balb/c anti-idiotypic sera 
to protein 460, but normal Balb/c sera does not interact with Balb/c
A
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antisera to protein 315. These results suggested that 460-like deter­
minants and not 315-like determinants may be found in Balb/c sera.
It also explained why Wells et aJL. (174) failed to detect an interaction 
between protein 460 and a rabbit anti-315 idiotypic sera. This antisera 
had been absorbed against "normal" Balb/c immunoglobulins and this may 
have removed the immunoglobulins with specificities directed to 460-like 
determinants. Thus while it is clear that proteins 315 and 460 have 
distinct idiotypic determinants, it is unclear whether they share any.
Unlike the MOPC 460 tumor which is a Balb/c myeloma, the MOPC 315 
plasmacytoma was derived from the seventh generation of a congenic inbred 
strain derived from a mating of Balb/c and C57BL mice (39). Although 
protein 315 has Balb/c H-chain allotypic markers, it is not clear from 
what strain the information for the L chain and the V-region of 315 was 
derived. Furthermore, the L chain of 315 has a sequence in its V-region 
that is unique from any other X chain sequenced. It is therefore inter­
esting, but not surprising, that Sirisinha and Eisen (155) were unable 
to detect 315-like determinants in the sera from fourteen different 
strains including Balb/c and C57BL and in fifteen different Balb/c 
myeloma proteins including protein 460.
These results are to be contrasted to those of Granata at al. (55) 
who demonstrated that protein 315-immunized Balb/c mice produced a 
binding region complementary anti-idiotypic serum which was specific for 
protein 315 and which also bound to Balb/c anti-DNP sera. Balb/c mice 
immunized against protein 315 had a less heterogeneous anti-DNP response 
than the untreated Balb/c mice. These authors concluded that the pro­
tein 315 Immunized mice produced anti-idiotypic antibodies that sup­
pressed the production of DNP binding antibodies which have idiotypic
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j; determinants similar to protein 315. Furthermore, by a hemagglutin­
ation inhibition assay, Granata €it al. (55) demonstrated that a signi- 
f ficant percentage of DNP binding antibodies of Balb/c mice contained
immunoglobulins that contained X chains. The authors, however, failed 
to consider that a non-specific suppression of the DNP response may have 
occurred due to the prior immunization with protein 315 (i.e., anti­
genic competition limited the anti-DNP response).
In a brief paper by Jorgenson and Hannestad (84), a Balb/c 
anti-idiotypic response to protein 315 was weakly enhanced by priming 
the mice with protein 460. While this result appears to imply that 
proteins 315 and 460 may share idiotypic determinants, the recenti
papers of Helman e£ al. (62) and Tanykanak and Sirisinha (163) failed to 
report any idiotypic antigenic identity between the two DNP binding 
immunoglobulins. Tanykanak and Sirisinha (163) found that A/J and Balb/c 
anti-idiotypic sera made against protein 315 or its Fv fragment were 
similar in terms of specificity and in terms of the amount of antiserum 
: which was hapten inhibitable. The only difference between the four
sets of mouse antisera was that the A/J anti-315 serum had a higher 
percentage of non-binding region complementary anti-idiotypic anti­
bodies than the other anti-idiotypic sera, 
i  In a similar paper, Helman edt al. (62) compared the properties
! of anti-idiotypic sera from rabbits and Balb/c mice made against
proteins 315 and XRPC 25, another myeloma protein that binds DNP.
Even though the first 38 N-terminal amino acids of the H and L chain of 
XRPC 25 and MOPC 460 differ (173), rabbit anti-XRPC 25 idiotypic serum 
also bound protein 460. Furthermore, mouse anti-XRPC 25 and rabbit 
and mouse anti-idiotypic sera to protein 315 did not bind to protein
i
,L
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460. Helman et^ al. observed that while 60 to 70% of the Balb/c anti­
sera had their binding to the reference myeloma proteins inhibited by 
hapten (i.e. they were combining region complementary), greater than 
| 90% of the rabbit sera were non-combining region complementary. Hence
the subpopulation of combining region complementary anti-idiotypic anti­
bodies of rabbits directed to mouse myeloma proteins may represent a more 
homogeneous population of anti-idiotypic antibodies.
Thus to date no study has developed a series of V-region markers 
for DNP binding immunoglobulins that have been employed to study the 
inheritance of DNP binding antibodies.
The Present Investigation: To Develop A Set of V-Region Markers
For DNP Binding Immunoglobulins Which May Be Used To Study The 
Expression and Inheritance of V-region Gene Products
In this thesis, two approaches were taken to develop sets of V- 
region markers which may be used to study the expression and inheritance 
i of DNP binding immunoglobulins.
In the first approach a series of serological markers were developed 
to detect and characterize particular DNP binding V-regions. The fol- 
; lowing questions were asked:
1. Can rabbit combining region complementary anti-idiotypic anti­
bodies be isolated to the DNP and menadione binding mouse myeloma pro­
teins 315 and 460?
2. Are these anti-idiotypic antibodies directed against a single 
determinant or can these anti-idiotypic antibodies be separated into 
two groups: those that recognize common determinants (IdX) of many 
different DNP binding immunoglobulins; and those that recognize unique 
determinants (Idl) of individual immunoglobulins?
i
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i 3. On what chains are the amino acid residues that comprise the
i idiotypic determinants found? Are specific L and H chain residues
| required for the idiotype's expression? Does one chain modulate the
expression of idiotypic determinants found on the other chain?
4. Using these anti-idiotypic sera in RIAs, can idiotype positive
bI mouse immunoglobulins be found? Are the idiotype positive immuno­
globulins found in the serum of a few mice, in the serum of all mem­
bers of an inbred strain, in the serum of all mice, and/or in the
i- •
serum of more than one species? Are these idiotypic markers inheri­
ted in a recessive or dominant fashion?
| 5. What antigens are able to induce idiotype positive immuno­
globulins in mice?
j 6. What are the properties of the idiotype positive mouse immuno­
globulins?
t
7. May these anti-idiotypic reagents be employed to examine antigen 
binding receptors on the surface of lymphocytes?
In the second approach, the anti-DNP response was analyzed using 
j the isoelectric focusing patterns of double binding immunoglobulins
i'
j induced by the sequential immunization of pairs of antigens. The
I;
! following questions were explored:
1. After isoelectric focusing and cross-linkage in polyacrylamide 
gels, is the antigen binding specificity of an immunoglobulin altered?
2. Can the isoelectric focusing banding patterns of the double 
binding immunoglobulins be detectable in analytical isoelectric focusing 
gels by incubating the gels with radioactive hapten in the presence
and absence of a cold competitor?
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3. In mice can the sequential immunization of DNP and menadione 
preferentially induce DNP and menadione double binding immunoglobulins? 
Are all menadione conjugated proteins antigenic for mice?
4. In mice can the sequential immunization of RNase and DNP- 
BGG preferentially induce DNP and RNase double binding antibodies in 
the early immune response?
5. Among individual mice of the same inbred strain, is there a 
variability in the expression of specific clonal immunoglobulin products 
of double binding antibodies? What are the bases for the variation in 
banding patterns observed among mice of the same inbred strain?
Below investigations based on these questions are discussed.
L




All rabbits were New Zealand White males. Balb/cN and C57B1/6 mice 
were from a breeding colony maintained at Yale by Dr. M.Y.K. Armstrong. 
All other strains were gifts of Dr. R. Riblet of the Institute for 
Cancer Research, Philadelphia.
B. Buffers
Phosphate Buffered Saline (PBS) was a 0.01 M phosphate buffered 
solution of saline adjusted to pH 7.4. Borate Buffered Saline (BBS) is 
a 0.01 M solution of buffered borate in saline adjusted to pH 8.2. Tris 
buffers were also employed.
C. Haptens
DNP-glycine was a gift of Dr. R.W. Rosenstein. e-DNP-lysine was 
prepared as described by Rosenstein .and Richards (145) by the reaction 
of flourodinitrobenzene (FDNB) in ethanol with the copper chelate of L-
3lysine in 0.1 M NaHCO^. H-DNP-lysine (New England Nuclear) was
purified by electrophoresis at pH 1.5 prior to use. It was diluted to 
a specific activity of 67 Ci/mole by the addition of DNP-lysine.
e-DNP-caproic acid was synthesized by a cognate synthesis of DNP-
_3BGG of Eisen (41). 2 g of DNB-sulfonic acid (Eastman) (7.4 x 10
_3moles) was added to 0.5 g of e-amino caproic acid (3.8 x 10 moles) in 
50 ml of 2% ^COj solution. Reaction occurred at room temperature in 
the dark for 4 hours. The reaction mixture was passed through a Dowex 
1 column and washed with distilled water. The Dowex containing the 
DNP-caproic acid was extracted with ether. The ether extract was
60
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dried under ^  and the yellow material was recrystallized 3 times with 
ethanol and water.
^C-phosphory1-choline (specific activity 56.81 Ci/mole, New 
England Nuclear, t-boc-glycine (Lot #7145, Pierce Chemicals), t-boc- 
tyrosine (Pierce Chemicals), menadione (2-methyl-l,4-napthoquinone,
Mann Research Laboratories), and menadione bisulfite (Lot #8746,
Nutritional Biochemical Corp.) were used without further treatment.
Vitamin Rs (menadione thiopropionic acid) was synthesized by the 
procedure of Hanna (59). The purity of the product was checked by m.p. 
(161-162° C, uncorrected— literature value 161° C).
Bovine pancreatic ribonuclease-A (RNase, E.C.3.1.4.22, Worthington 
Laboratories, 12 times recrystallized) was stored at 4° C until use.
a-N-tyrosyl-e-(2,4-dinitrophenyl)-lysine hydrocholoride (TLD) was 
synthesized by the method of Dr. P. Jackson (unpublished). e-DNP-lysyl 
ethyl ester was reacted with t-boc-tyrosine by dicyclohexylcarbodiimide
(DCC, Eastman) and the ethyl- and t-boc-protecting groups were removed.
-3In a typical synthesis, 10 moles of DNP-lysyl ethyl ester was synthesized 
by dissolving DNP-lysine in a minimal volume of dry absolute ethanol 
(USP grade). While cooling the reaction vessel on ice, HC1 gas was 
slowly bubbled through the solution. The solution was dried under a 
vacuum. The dry product (DNP-lysl ethyl ester) was twice dissolved in 
ether and dried under a vacuum with NaOH. The product was checked for 
purity on polyamide TLC plates (Eastman) using 1-butanol: acetic acid:
water: pyridine (15:3: 12: 10). No trace of DNP-lysine was found.
After recrystallizing in ethanol and ether, the product was dissolved 
in 4 ml of redistilled acetonitrile (Eastman) and an equal molar amount 
of triethylamine and a further aliquot of acetonitrile (about 4 ml) was
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t- added. Care was taken to avoid an excess of triethylamine. 0.181 g t- 
-3boc-tyrosine (10 moles, Cyclo) was dissolved in 2 ml of acetonitrile
and added to the DNP-lysy1-ethyl ester solution. The coupling reaction
-3was performed in a glass stoppered reaction vessel. 0.206 g (10 
moles) of dicyclohexylcarbodiimide (Eastman) was dissolved in 2 ml of 
acetonitrile and added to the reaction vessel. The reaction was 
stirred at room temperature in the dark for 24 hours.
The solution was filtered and white-yellowish crystals were 
collected. The filtrate was dried under vacuum. 150 ml of 5% NaHCO^ 
solution was added and the reaction product suspension was extracted 6 
times with ether. To the ether layer was added an equal volume of 
water and solid citric acid was added slowly with shaking. This caused 
frothing. When the pH was lowered to 3.0, the ether layer was ex­
tracted and then two times more with a saturated citric acid solution. 
The product N-t-boc-tryosyl-e-DNP-lysyl-ethyl ester remained in the 
ether layer which was washed 3 times with water to remove all citric 
acid. The ether layer was dried with anhydrous Na2S0 ^, filtered and 
dried under N^.
The yellow residue was dissolved in benzene with warming in as 
small a volume as possible, and was placed on a Biosil A column (Bio- 
Rad 100-200 mesh) 2 cm x 30 cm previously equilibrated with benzene.
The column was washed with benzene (2 liters). The one yellow fraction 
(DNP-OH) was eluted and one major yellow band remained at the top of 
the column. The column was eluted with methanol. Most yellow material 
was eluted at the solvent front, and two minor bands of yellow were
r
1 left on the column. This eluted yellow material is t-boc-tyrosyl-e-DNP
i .  ,
; lysine ethylester which was chromatographed to check purity on silica
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TLC (Eastman) plates in benzene: acetic acid (9:1) or 1-butanol:
acetic acid: water: pyridine (15:3:12:10).
NaOH was used to remove the ethyl ester blocking group. The 
compound was dried in vacuo, and then suspended in 1 N NaOH (15 ml).
The suspension was stirred for one hour at room temperature and then 
extracted three times with ether. The aqueous layer was made acidic by 
adding citric acid slowly to avoid frothing until the solution was satu­
rated (pH 3). The color of the reaction mixture became dirty brown and 
cloudy and was extracted with water saturated ethyl acetate. The ethyl 
acetate extract was washed 4 times with water to remove the citric acid, 
then anhydrous Na^SO^ was added to dehydrate the ethyl acetate. In a 
rotary evaporator the volume was reduced to almost dryness and the product, 
N-t-boc-tyrosyl-e-DNP-lysine was washed out in ethanol and dried under N^.
To remove the t-boc-blocking group, the product was dissolved in 
4 N HC1 in dioxane (10 ml). The solution was kept at room temperature for 
1 hour with stirring. The HC1 was blown off with ^  and the solution was 
dried overnight in vacuo. A small quantity of ethanol was added to the 
dried product and again dried in vacuo over NaOH pellets to remove any 
excess HC1. This was repeated 2 times for 24 hours. Orange crystalline 
powder was produced which chromatographed as a single species in two 
solvents (described above). The final product was dissolved in 0.1 M
_3NaHCO^ adjusted to pH 6.8 and this saturated solution (about 2 x 10 M) 
was stored at 20°C in the dark. The final product was also stored as a 
dry powder in a desiccator and rechromatographed before use. The melting 
point of the TLD was not sharp at 110°C.
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C. Antigens
Bovine Serum Albumin Fr. V (BSA) and Bovine Gamma Globulin (BGG) 
were obtained from Nutritional Biochemical Corp. and used without 
further treatment. Rabbit Gamma Globulin (RGG) was obtained by ammonium 
chloride precipitation of rabbit serum from unimmunized New Zealand White 
males. Human Serum Albumin (HSA) was obtained from Miles Laboratories 
without further treatment.
DNP-KLH was a gift of Dr. P. Askenase and had about 50 residues of 
DNP per mole of KLH. DNP-Ficoll was prepared by the method of Inman 
(75). DNP-BSA, DNP-RGG, and DNP-BGG were prepared by the method of 
Eisen (41). Assuming the E^j^ of BGG is 14.0 and the of DNP is 17340,
the average number of DNP residues per mole of BGG was found to be 18 to 
30, depending on the preparation. Similarly, the number of residues per 
mole of protein for residues per mole of protein for DNP-BSA was 23 and 
for DNP-RGG was 20.
Men-RGG was prepared by the method of Rosenstein (unpublished).
2 g of BGG was dissolved in 50 ml of 0.2 M Tris pH 8.4. 350 mg of dithio-
threital (DTT, Sigma) was added and the reaction stirred at room tempera­
ture for 2 hours. 2 g of menadione was added and the reaction was stirred 
overnight at 4°C in the dark. The suspension was dialyzed against 6 
liters of PBS for 8 hours, then filtered, and dialyzed two more times
against 6 liters of PBS for 12 hours at 4°C in the dark. Based on an
335O.D.2gQ/O.D.335 ratio of 3.6 and an of 2200 for menadione, and a
negligible absorbance of BGG at 335 nm, the number of menadione moieties 
per mole of BGG was about 50 to 60. Men-RGG, Men-HSA, and Men-BSA were 
similarly prepared.
L
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Menadione-acetyl homocysteine-BGG (Men-Spacer-BGG) and menadione- 
acetyl homocysteine HSA (Men-Spacer-HSA) were synthesized by the method 
of Johnston and Eisen (82). The number of menadione residues per mole 
of protein for Men-Spacer-HSA was 20 and for Men-Spacer-BGG was 25.
This was determined by the dry weight of the protein which had been 
dialyzed against water and by the optical density at 335 nm for the 
concentration of menadione moieties.
D. Protein Coated Sheep Red Blood Cells
Proteins were conjugated to Sheep Red Blood Cells (SRBCs) by the 
method of Evans et al. (44). Typically, SRBCs stored for two to eighteen 
weeks in Alsever's solution at 4°C were washed 4 times with PBS. 0.4 ml 
of packed SRBCs were added to 9 ml of PBS and 1 ml of 1 to 5 mg/ml 
solution of protein. Over a period of 15 minutes 1 ml of 2.5% glutar- 
aldehyde (electron microscope grade) was added and the reaction was 
stirred at room temperature for an additional 45 minutes. The cells were 
then centrifuged and washed 3 times with PBS. Protein conjugated SRBCs 
were used for up to one month. Before each use the protein conjugated 
SRBCs are washed once with PBS.
E. Myeloma Tumors and Proteins
MOPC 315 and MOPC 460 tumor lines were the generous gift of Drs.
H.N. Eisen and E. Simms and were maintained by passage in Balb/cN mice. 
Protein 460 and protein 315 were isolated from the serum and ascitic 
fluid of tumor bearing mice by the DNP-affinity column procedure of 
Goetzl and Metzger (54). Some preparations omitted the reduction and
I:
alkylation step. Evidence has been presented (145, 120) that the puri­
fied proteins were indeed proteins 315 and 460 based on M.W., affinity 
3constants for H-DNP-lysine and menadione, and N-terminal amino acid
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residues. DNP-lysine is bound to protein 460 with an affinity constant
inhibition assay at room temperature.
Serum from mice with the McPC 603 tumor was the gift of Dr. W.
Konigsberg. Protein 603 was purified from the serum by a modification
of the method of Jaffe et al. (78). McPC 603 serum was treated with 50-%
saturated (NH^^SO^ at room temperature. The protein precipitate was
centrifuged, redissolved in distilled water, and applied to a 2.4 x 30 cm
DEAE-Sephadex A25 column, equilibrated with PBS. Elution of the column
with PBS yielded a single peak, which upon Ouchterlony double diffusion
analysis versus rabbit anti-mouse H-chain subclass sera was found to
contain immunoglobulins of the y^, Y2a > Y2b s Y3 * a ^ P 63 ^  was not
tested). The column was then eluted with 0.1 M phosphate-0.3 M NaCl,
pH 8 , yielding a single protein fraction. This fraction upon testing
by Ouchterlony analysis was found to contain only a heavy chains. This
fraction was concentrated, dialyzed into 0.2 M Tris pH 8.0 containing
0.075 M NaCl, and reduced with 0.01 M DTT (1 hour) and alkylated with
0.025 M iodoacetamide. The reaction mixture was dialyzed against PBS
and chromatographed on Sephadex G-200 to separate monomeric IgA (7S)
from unreduced multimers and albumen. The 7S fraction was concentrated 
14and tested for C-phosphory1-choline binding by equilibrium dialysis.
The 7S IgA fraction so obtained bound ^^C-phosphory1-choline with a Ka - 
1.2 x 10"* M \  saturation being achieved at 1.85 moles of hapten bound 
per mole 7S IgA, close to the theoretical 2.0. N-terminal analysis of 
this 7S IgA revealed glutamic acid on the H chain and aspartic acid on
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of 1 x 10"* M at room temperature and protein 315 yielded a constant of
1 x 10^M \  Menadione (vitamin Ka) competes with DNP-lysine to be
-4 -1bound by protein 460 with a of 2 x 10 M  at 4 C. Similarly, the
3 -1of protein 315 for vitamin Ks was found to 3 x 10 M by phage
the L chain, exactly as previously described for McPC 603 (6).
Purified myeloma proteins MOPC 104, UPC 10, MOPC 195, RPC 5, MOPC 
41, and FLOPC 21 were obtained from Litton Bionettics. Purified myeloma 
protein T15 was a gift of Dr. S. Pierce (Univ. of Penn.) Myeloma proteins 
XRPC-25, J604, and S194 were gifts of Dr. M.W. Hunkapiller (Cal. Inst.
Tech.) Protein S23 were a gift of Dr. W. Geckler (Salk Institute).
These proteins were used as supplied, as 7S monomers (prepared as described 
for Protein 603), or as Fab fragments. Fab fragments were prepared by 
the papain digest ion as previously described (49).
F. Affinity Labeled Proteins 460 and 315
Various affinity labeled protein 315 and protein 460 molecules were
gifts of Dr. R.W. Rosenstein. These are summarized in Table 7 of the
RESULTS with the different amino acid residues to which these DNP-
affinity labeling reagents were attached. Table 2 of reference 139
summarizes the techniques employed to prepare these affinity labeled
myeloma proteins. By difference spectroscopy at 360 nm, by fluorescence
3quenching, and by site titration by equilibrium dialysis using H-DNP-
lysine the extent of reaction of the different affinity labeled reagents
with the proteins was determined (analyses were kindly performed by Dr.
R.W. Rosenstein). All reagents but MNBDF abolish the ability of the
protein to bind hapten. MNBDF only lowers the affinity of protein 315
for DNP-lysine by fifty fold (182).
3 3H-DNP-azide labeled protein 460 and H-DNP-azide labeled mouse 
immunoglobulins were prepared by a cognate synthesis of Yoshioka et al. 
(184), using 1.0 mCi of 2, 4-dinitroflourobenzene [3,5-^H (N)] (New England 
Nuclear, lot #929-123). 0.25 ml of dimethylformamide (DMF, sequanol
3grade, Pierce Chemicals) was added to the H-FDNB which had been dried
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under N£. 14.7 mg of cold FDNB (7.86 x 10 ^ moles, Eastman) was added.
10 mg of NaN^ was added to the reaction mixture. After two hours of 
stirring in the dark at room temperature, the reaction was terminated by 
drying in vacuo at room temperature. DNP-azide (DNP-N^) was separated 
from this reaction mixture by chromatography on polyamide thin layers 
(Chen-Chin Trading Company), pre-run in chloroform. The sample was 
exposed to NH^ gas for 5 seconds before chromatography in chloroform, 
in order to change the unreacted FDNB to nitroaniline. The DNP-azide 
moved with the solvent front. The material was eluted with chloroform, 
dried under and redissolved in 1 ml of absolute ethanol (USP grade) 
and stored in the dark at -20°C. The UV absorption spectrum for the
purified DNP-N^ was as previously described (184). The approximate
3 13specific activity of the H-DNP-azide was 10 cpm/mole and the concen­
tration was 7.86 x 10 ^M.
Protein 460 and mouse immunoglobulins were photoaffinity labeled 
by adding 0.01 to 0.001 ml of the DNP-N^ ethanol solution to a 1 ml
solution of a 2 mg/ml solution of protein in PBS. This results in a 
-3 -410 to 10 M solution of the affinity label. The reaction mixture 
was stirred on ice for 15 minutes in the dark and then irradiated for 
60 minutes under UV lamps, as previously described (184). The reaction 
was terminated by dialyzing against PBS. 5 x 10 solution of DNP- 
glycine was demonstrated to reduce the labeling of the affinity labeled 
protein by 3-fold if the DNP-glycine was added before irradiation.
G. Enzymatic Digestion Fragments of Immunoglobulins 
Pepsin digestion of rabbit immunoglobulins from antisera was per­
formed by the method of Nisonoff et al. (124). The (Fab) 2 was converted 
to Fab^ by mild reduction in 0.005 M DTT followed by alkylation with
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0.015 M iodoacetamide. Papain digestion of mouse myeloma proteins were 
prepared as previously described (49).
H. Hapten Affinity Columns
Sepharose 4B (Pharmacia) was activated with cyanogen bromide according 
to the procedure of Axen, et al. (5). The activated Sepharose was 
washed with ice cold water, followed by 0.1 M NaHCL^. It was then stirred
_3with either DNP-lysine (1 x 10 M); protein 315 (4 mg/ml); protein 460
(4.8 mg/ml); or immunoglobulin from rabbit antisera (1 mg/ml) at 4°C for 
12 hours, before washing with PBS and using. Menadione affinity columns 
were a gift of Dr. R.W. Rosenstein and were synthesized as previously 
described (145).
I. Antisera
Rabbit anti-mouse Fab sera (gift of S. Pierce), goat anti-rabbit 
Fc sera (GAR, gift of Dr. B.N. Manjula), sheep anti-rabbit immunoglobulin 
(SAR, gift of Dr. P. Askenase), rabbit ant-mouse immunoglobulin (RAM, 
Behring Diagnostics), rabbit anti-H chain subclass sera specific for the 
a> Vi Y-̂  Y2a> Y2b > Y^ isotypes (Litton Bionettics) were used without 
modification or as the Fab^ fragments obtained by papain digestion (49).
Rabbit antisera to myeloma proteins were obtained by immunizing New 
Zealand White male rabbits with 1.0 mg of protein 315 or protein 460 
(7S monomers) in complete Freunds adjuvant (Difco) by foot pad injection. 
Two weeks later the rabbits were immunized s.c. with 1.0 mg of the myeloma 
protein in complete Freund adjuvant, and bled by cardiac puncture. Sub­
sequently the rabbits were bled at two week intervals and boosted intra­
venously with 0.1 mg of the reference protein in PBS.
Rabbit antibodies directed against the combining region of proteins 
315 and 460 were purified by a modification of the procedure of Claflin
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and Davie (23). In a typical experiment, 5.0 ml of rabbit anti-315 
serum or anti-460 serum was filtered through a 10 ml column of protein 
315-Sepharose or protein 460-Sepharose, previously equilibriated with 
PBS. The column excluded volume was collected and tested for the dis­
appearance of precipitating antibody to proteins 315 and 460. The
columns were washed with five column volumes of PBS or until the O.D.~onZoU
of the eluate was less than 0.015. Elution was performed with 5.0 ml 
of 0.05 M DNP-glycine in PBS. The DNP-glycine fraction was dialyzed 
exhaustively with PBS to remove DNP-glycine. Yields of purified anti- 
315 or anti-460 antibody, as judged by O.D.^gg measurements usually fell 
between 100 and 200 ugm per ml. The purified anti-315 and anti-460 
antibodies were stored at 4°C in the presence of 0.01% NaN^.
Mouse anti-hapten sera were induced by the subcutaneous injection 
of 0.1 ml of antigen in complete Freunds adjuvant containing 1 mg of 
protein, except for DNP-Ficoll. DNP-Ficoll immunizations were performed 
as described (129) and consisted of intraperitoneal injections of 1 mg/ml 
solution in PBS. Mice were bled from the sub-orbital fossa or were 
exsanguinated by cutting the aorta. If the immunization protocol re­
quired a second injection, 0.1 ml (containing 1 mg of antigen) was 
administered subcutaneously in complete Freunds adjuvant.
J. Iodinated Compounds and Proteins
All iodinations were performed by the Chloramine T procedure (69).
Typically, 50 ugm of protein or 2 x 10~^ moles of TLD was dissolved in a
pH 6.8 0.1 M phosphate buffer and incubated with 0.5 to 1.0 mCi carrier 
125free I (New England Nuclear) to make up a total volume of 0.150 ml.
0.020 ml of 1.7 mg/ml solution of Chloramine T (freshly prepared) was 
added. The reaction was quenched with 0.050 ml of a 5 mg/ml solution of
A .
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sodium metabisulfite after 5 minutes for the iodination of TLD and after 
one minute for the iodination of proteins. The reaction mixture was
immediately chromatographed on a 1 x 10 cm Sephadex G-25 column to sepa-
125 125rate unbound K I from iodinated compounds. The I-labeled proteins
125 125eluted with the void volume of the column. The I-labeled TLD ( I-
TLD) had slight affinity for Sephadex G-25 and eluted after 2.5 to 3
125column volumes of PBS filtered through the column. The I-TLD did not
elute with the yellow colored material. The specific activity of the TLD
18 125was about 5 x 10 cpm/mole. The I-labeled protein had a specific
9activity of 4 x 10 cpm/mg.
II. Equipment
3 14Liquid scintillation counting of H and C samples was performed
in aquasol (New England Nuclear) using a Packard Scintillation Spectro-
125meter (model 3375). I counting was performed in a Scientific Products
y-counter (AW 1450). All optical density measurements were made on a 
Beckman 24 Spectrophotometer. Recording UV spectra were taken on a Cary 
model 15 Spectrophotometer. Fluorescence quenching was performed on a 
Farrand Mark I Spectrofluorometer. All pH measurements were made with a 
single calomel electrode or flat plate electrode on a Radiometer PHM62 
Standard pH meter. All intensity measurements of the darkening of film 
after autoradiography were made with a Joyce, Loeble Double Beam Recording 
Microdensitometer (Mark III CS).
III. Methods
A. Ouchterlony Double Immunodiffusion with Autoradiography 
Immunodiffusions was performed with Immuno-plates (Hyland, list no. 
085-074). Typically antiserum and antigen were placed in opposite wells 
and incubated at 37°C. After precipitin lines were observed, the agar
1
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3gels were washed in PBS containing 0.001 M  Nan for 12 hours at 4° C.
Washing was repeated three times. If the precipitin pattern only was
to be analyzed, the gel was dried on a glass microscope slide and stained
with Coomassie Brilliant Blue (Accurate Chemical and Scientific Corp.)
as described (57). If the precipitin lines were to be tested for anti-
125gen binding ability (e.g. I-TLD binding) or for the presence of deter­
minants (e.g. idiotypic determinants), the washed gel was overlayed with 
3 to 6 x 10^ cpm of iodinated hapten or iodinated Fab1 of the rabbit
antiserum. The gel was incubated for 3 hours at room temperature and
125then washed three times with PBS for 12 hours each at 4° C for I-labeled
antisera and washed three times with PBS for one hour each at room temp- 
125erature for I-labeled TLD. The gel was then dried on a glass micro­
scope slide and incubated with x-ray film (Kodak, Royal X-omat film 
RP/R-54). After autoradiography, the slides were stained with Coomassie 
Brilliant Blue to detect the precipitin lines. The film was developed 
by a Kodak X-omat.
B. Hemagglutination Titers and Hemagglutination Inhibition Assays 
Hemagglutination assays were performed in microtiter plates (Cooke 
Engineering Company). Each well contained 25 ul of PBS containing 0.1%
BSA, 25 ul of serial two-fold dilutions of antiserum, 25 ul of a 3% 
suspension of antigen coated SRBCs in PBS-0.1% BSA. For hemagglutination 
inhibition, four times the limiting dilution of antiserum was used. In 
place of the 25 ul of PBS-0.1 % BSA, 25 ul of serial two-fold dilutions 
of inhibitors were used. The endpoint was taken as the highest dilution 
giving no visable agglutination.
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C. Radio-Immuno Assay (RXA)
A modification of the solid phase tube assay of Askenase and Leonard 
(3) was used. Antisera were diluted in PBS to an O.D.^qq3 0.1.
12 x 75 mm Falcon plastic tubes were coated with 50 ul of the antiserum 
by incubation at 4°C for 18 hours. The tubes were then washed with PBS 
and re-coated with 0.5 ml of 1% BSA in PBS again for 18 hours at 4°C.
For the assay, the tubes were washed 3 times with 1 ml PBS, drained and
then a 50 ul reaction mixture was added, consisting of 10 ul (100,000 cpm)
125 9I-labeled FAB of the reference protein (4 x 10 cpm/mole) and 40 ul
of inhibitor in PBS. The tubes were incubated at room temperature for
two hours, washed 4 times with 1 ml PBS and counted. Non-specific
binding to tubes incubated with 1% BSA was never more than 1% of the
total radioactivity. Specific binding in the absence of inhibitors was
usually 30 to 50% of total added radioactivity.
A later modification of this method was also employed which greatly
increased the ease in performing the assay. 25 ul of the antiserum
solution was incubated at 4°C for 24 hours in flexible vinyl microtiter
plates (Cooke Engineering Co.). The diluted antiserum was removed and
0.1 ml of 0.1% BSA in PBS was added. The plates were again incubated
for 24 hours. The assay consisted of incubating the wells with 25 ul
125of inhibitor at 4°C for 24 hours, then adding 5 ul of I-labeled Fab
of reference protein and incubating for another 24 hours at 4°C. The
plates were then washed, dried, and individual wells were cut out and 
125the I cpm bound determined.
A modification of this RIA was used to determine the concentration 
of DNP binding antibodies present in serum. This method was developed 
by Klinman and Aschinazi (92). 25 ul of 1 mg/ml solution of DNP-BSA in
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PBS was incubated at 4°C in microtiter plates. After 24 hours, the DNP-
BSA solution was replaced with 0.1 ml of 1% BSA in PBS. After 24 hours
at 4°C, 25 ul of various dilutions of anti-DNP sera were added to the
wells. The wells were incubated for 24 hours at 4°C, washed 3 times with
1251% BSA in PBS, then 25 ul (1-10 ngm) of I-labeled Fab' of rabbit anti-
gmouse Fab serum was added (specific activity 4 x 10 cpm/mg). The plates 
were incubated for an additional 24 hours at 4°C, then washed, dried, and 
counted. Protein 460 served as the reference DNP binding protein used to 
standardize the calculation of the concentration of DNP binding anti­
bodies present in serum.
D. SDS Polyacrylamide Gel Electrophoresis
SDS-polyacrylamide gel electrophoresis was performed by the method 
of Shapiro et al. (151) to estimate the molecular weight of various 
proteins.
E. Equilibrium Dialysis and Fluorescence Quenching 
Equilibrium dialysis was performed by the method of Eisen (42).
100 ul plexiglass chambers (Gateway Immunosera) were employed for the 
dialysis measurements.
Fluorescence quenching was performed by the method of Eisen (43) 
as described by Rosenstein and Richards (145).
F. Chain Recombination
The light and heavy chain recombinants of proteins 315 and 460 and 
proteins 315 and 603 were a gift of Dr. R.W. Rosenstein. Table 11 of 
the RESULTS summarized the binding properties of the protein 315-460 
recombinants as determined by fluorescence quenching and equilibrium 
dialysis (kindly performed by Dr. R.W. Rosenstein).
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The recombinant proteins were prepared by reducing the proteins 
with 0.01 M DTT in 0.2 M Tris, pH 8 for 1 hour at room temperature and 
alkylating the proteins with a 2.2 fold molar excess of iodoacetamide. 
After dialyzing the reduced and alkylated proteins against several changes 
of PBS and then against 6 M urea- 1 M propionic acid at room temperature, 
the proteins were chromatographed on Sephadex G-100 columns (2.5 x 95 cm) 
equilibrated and eluted with 6 M urea - 1 M propionic acid to separate 
the light and heavy chains.
Chains were recombined at a heavy to light O.D.oor, ratio of 3/1ZoU
by dialysis against several changes of water, followed by several changes 
of PBS. The chain recombinant proteins were concentrated and again 
chromatographed on Sephadex G-200 and eluted with PBS. The 7S fraction, 
as judged by marker positions, was collected and concentrated. The 
yield of 7S material was about 50% of the total recombinant protein 
placed on the column.
G. Analytical Isoelectric Focusing With Autoradiography
Isoelectric focusing and autoradiography were performed as previ­
ously described (90, 177, 4, 98). A typical flat plate polyacrylamide 
gel consisted of: 12.5 ml of 8 M deionized urea; 7.5 ml of 30% (w/v)
acrylamide with 0.96% bis-acrylamide (Bio-Rad Laboratories); 3 ml of 40% 
ampholine solutions (LKB or Bio-Rad Laboratories) such that 1.2 ml is 
narrow ranged ampholine solutions (e.g. pH 3 to 5, 5 to 8 , or 4 to 6 ) 
and 1.8 ml is broad ranged ampholine solutions (e.g., pH 3 to 10); 1 ml 
of riboflavin (10 mg/100 ml saturate solution); and 26 ml distilled 
water. The gel was poured between two pieces of glass, one of which 
was siliconized (177) with a 1/16' inch tygon tubing serving as a gasket. 
The dimension of the width of the gel varied depending on the number of
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samples to be isoelectric focused. The length of the gel was 9 inches.
The gels were polymerized under a fluorescent lamp for 12 hours at room 
temperature. The glass sheets were then separated and the gel usually 
attached to the siliconized glass.
Myeloma proteins (7S) and serum samples were subjected to isoelectric
focusing by placing a piece of Whatman 3 MM filter paper about 2 inches
from one end of the gel. After the samples were blotted into the filter
paper, the gel was placed face side down onto two carbon electrodes,
-4already moistened at the anode with 5 x 10 N NaOH and at the cathode 
with 0.05 N phosphoric acid. The electrodes were 8 inches apart and 
the gel was suspended in the closed apparatus above a moisten sponge.
The isoelectric focusing was performed at 4°C. Care was taken to clean 
the electrodes before applying the gel to avoid areas of non-conductance 
which cause "warping" of the isoelectric focusing patterns.
The current was clamped at 10 mamps until the voltage exceeded 
500 V. Then the voltage was clamped at 500 V and the electrophoresis 
continued until the change in current was less than 0.5 mamp/hr (usually 
about 9 hours).
The pH gradient was measured by cutting a 1 cm wide strip along the 
length of the gel. The strip was cut into 1 cm squares and each square 
was placed in 1 ml of water for 1 hour. The pH of each section was 
measured with a single calomel electrode.
Autoradiography of immunoglobulins after isoelectric focusing was 
performed by cross-linking the immunoglobulins in the gel and then by 
exposing them to iodinated haptens.
To cross-link the immunoglobulins in the gel, the antibodies were 
first precipitated with two changes of 18% Na^SO^ and then cross-
1 .
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linked for 1 hour with a 0.5% solution of glutaraldehyde in 18% Na2S0 ,̂ 
at room temperature. The gel was washed 3 times with distilled water 
and soaked for 10 minutes with Borate Buffered Saline, pH 8.2, then soaked 
1 hour in one liter of a 20 mg/liter solution of sodium borohydride in 
Borate Buffered Saline at room temperature. The gel was then washed 
three times with PBS.
125To label the gel with I-labeled haptens, the gels were placed 
in plexiglass chambers so constructed that a minimal volume of labeled
hapten (60 ml) would submerge the gel. Typically the gel was exposed
6 125to 50 to 100 x 10 cpm of labeled hapten. The I-TLD solution had a
-10 -3concentration of 2 x 10 M and it was dissolved in PBS or a 1 x 10 M
125solution of vitamin Ks in PBS pH 7.4. The I-labeled RNase solution
-7 9was about 1 x 10 M with a specific activity of 4 x 10 cpm/mg. The
gels were incubated at 4°C and after 24 hours, they were washed 3 times
with PBS. After placing the washed gels on Whatman 3MM filter paper, the
gels were dried by a Slab Gel Dryer (Hoefer Scientific Instruments Model
SE 540). Autoradiography was then performed for two, seven and thirty
day film exposures with RP/R-54 X-omat film (Kodak). The films were
developed by a Kodak X-omat processor. The band intensities were
measured by a Joyce Loeble Microdensitometer.
H. Preparative Isoelectric Focusing In Sephadex G-75
Preparative isoelectric focusing in Sephadex G-75 was performed as 
described (113) with the exception that the G-75 slurry was connected 
to the carbon electrodes with wicks of Whatman 3MM filter paper soaked 
with 0.25% ampholine solutions. The isoelectric focusing pattern of 
immunoglobulins in the presence or absence of 2 M urea was unchanged.
After isoelectric focusing, the immunoglobulins were eluted from the
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Sephadex slurry in PBS.
I. DNP-Phage Inhibition Assay
All DNP-phage inhibition assays were kindly performed by Dr. H.
Kalasz. The DNP-conjugated phage T4 was a gift of Dr. 0. Makela (Univ. 
of Helsinki). The phage inhibition assay was performed as described by 
Makela et al. (115).
Briefly, DNP-coated phage and various dilutions of immunoglobulins 
were incubated for 30 minutes, then IS. coli in exponential growth was 
added. The mixture added to soft nutrient agar was overlayed on a 
nutrient agar plate. After 12 hours, the plate was scored for the 
number of T4 plagues. By plotting the immunoglobulin dilution against 
the number of T4 plaques, an estimate of the antibody titer can be 
made.
To determine the inhibition constants of various haptens for the 
antibody, the DNP-phage was incubated with two times the concentration 
of immunoglobulin needed to cause 50% inhibition of plaquing. This 
concentration is usually sufficient to inhibit all phage plaquing.
After 10 minutes, dilutions of inhibitors (DNP-lysine or vitamin Ks) 
were added. After 3 hrs. incubation at room temperature, IS. coli in 
exponential growth were added and the mixture in soft nutrient agar 
was plated on nutrient agar in Petri Dishes. After a 12 hour incubation 
at 37°C, the number of plaques were scored. By plotting the concentration 
of inhibitor versus the number of plaques, the concentration of inhibitor 
which causes 50% inhibition of the antibody-phage interaction can be 
determined. In this way the inhibition constant (K̂ .) of the antibody 
can be determined.
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RESULTS
The present investigation was an attempt to develop a series of 
markers which may be used to follow the expression and inheritance of V- 
region gene products in mice. The V-Regions of DNP binding antibodies 
were selected for the purposes of this study. In the first series of 
investigations, a description will be presented of the generation and 
characterization of anti-idiotypic antibodies that are directed against 
combining region determinants of the reference DNP binding myeloma 
proteins 315 and 460. After the elucidation of the determinants to 
which these anti-idiotypic reagents were directed, these antisera were 
used in radioimmunoassays to survey mouse sera for the presence of 
"idiotype positive" immunoglobulins. Below are described the studies to 
characterize the properties and inheritance of these "idiotype positive" 
immunoglobulins. Finally a series of investigations will be presented 
that attempted to identify the isoelectric focusing banding patterns of 
immunoglobulins which bind more than one antigen. This was done in an 
effort to establish a set of criteria for immunoglobulins that would 
distinguish a small number of antibodies within a large complex response. 
The isoelectric focusing patterns of double binding immunoglobulins were 
used in an attempt to study the expression and inheritance of particular 
V-region products in mice.
I. The Generation and Characterization of Antibodies Directed Against 
Combining Region Idiotypic Determinants of Protein 315 and 
Protein 460.
Anti-combining region antibodies were purified from rabbit anti-315 
or anti-460 sera by the hapten elution method of Claflin and Davie (23). 
Antisera from rabbits immunized with one of these myeloma proteins are 
absorbed onto a Sepharose column to which the reference protein was
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coupled. Those antibodies with specificity towards the myeloma protein 
are retained. The combining region complementary anti-idiotypic anti­
bodies are eluted from the column by DNP-glycine. Below the eluted 
antibodies to protein 315 ("anti-315") and to protein 460 ("anti-460") 
are shown to be combining region complementary anti-idiotypic antibodies 
which are heterogeneous in their specificity for the V-regions of immuno­
globulins. The antiserum to protein 460 purified from 460-Sepharose 
columns is composed of two populations of antibodies: those with speci­
ficity for protein 460 ("private anti-460” or "anti-IdI-460"); and those 
antibodies that bind only mouse myeloma proteins 460, 315, and S23, 
a subset of the DNP binding mouse myeloma proteins tested ("public 
anti-460" or "IdX"). Similarly, antiserum to protein 315 is composed 
of private (IdI-315) and public (IdX) idiotypic specificities. These 
three sets of anti-idiotypic antibodies (directed to IdI-460, IdI-315, 
and IdX) were found to bind determinants on the H chain of their respec­
tive reference myeloma proteins; however, the L chains of each immunoglo­
bulin modulates the quality of the interaction between the reference 
antibody and the private 460 and private 315 antisera.
A. DNP Eluted Anti-315 and Anti-460 antibodies are Specific 
Only for Idiotypic Determinants of Proteins 315, 460,
S23.
The elution of anti-460 and anti-315 antibodies by DNP-glycine is 
due to the binding of the hapten by the combining regions of the reference 
protein 315 and 460. The binding of hapten somehow displaces the 
combining region complementary anti-idiotypic antibodies off the reference 
protein-Sepharose column. The hapten elution of antibodies was shown 
not to be a salt effect by substituting t-boc-glycine for DNP-glycine.
The t-boc-glycine eluted anti-315 antibodies had only 2% of the hemagglu-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
81
tination titer of the DNP-glycine eluted antibodies anti-315 in an assay 
that measured the agglutination of 315-coated SRBCs. A similar result 
was obtained when the 460-coated SRBC agglutination titers of anti-460 
antibodies eluted by t-boc-glycine were compared to anti-460 antibodies 
eluted by an equimolar concentration of DNP-glycine.
Only anti-460 and anti-315 antibodies whose binding to the 
reference myeloma protein is inhibited by hapten should be eluted from 
the columns. Thus the hapten elution method should rid an antiserum of 
non-binding region directed antibodies. Figure 3 illustrates the immuno­
diffusion precipitation patterns obtained by three Balb/c proteins: 315
(ct,l), 460 (a,K), and S194 (cx,k ) produced by rabbit ati-315 and anti-460 
sera before and after these antisera had been purified by hapten elution. 
The "crude" anti-315 and anti-460 precipitated all three proteins; 
however, the anti-315 and anti-460 antibodies prepared by hapten elution 
precipitated both proteins 315 and 460, but not protein S194. Like 
S194, two other DNP binding Balb/c myeloma proteins, XRPC 25 (a,K) and 
J604 (cx,k ), also were only precipitated by the original antisera before 
hapten elution purification. These results show that the unpurified 
antisera have specificities for determinants common to XRPC 25, J604, 
S194, 315, 460, and S23. The antibodies that were purified by hapten 
elution are no longer directed to determinants found on XRPC 25, J604, 
and S194. The results of these immunodiffusions also suggest that 
proteins 315, 460, and S23 share common determinants, not present on the 
constant regions of the H and L chains.
To put the above observations on a more quantitative basis, hemag­
glutination inhibition assays and solid phase RIAs were also employed. 
Figure 4 shows a typical solid phase RIA that measured the binding of
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FIGURE 3
The Immunodiffusion Patterns Of Three Balb/c Myeloma Proteins 
With Rabbit Anti-460 and Anti-315 Sera.
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Ouchterlony double immunodiffusions performed as described in 
MATERIALS AND METHODS.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
FIGURE 4
The Binding of DNP-glycine Eluted Anti-315 Antibodies To Various Mouse
Myeloma Proteins
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*X chain sequence of MOPC 315
differs from that of other
mouse myeloma protein X 
sequences.
RIA was performed as described in the MATERIALS AND METHODS with 
'i-Fab 315 and DNP-glycine eluted anti-315 antibodies. The serum 
from which the antibodies were purified was obtained from a rabbit 
2 weeks after protein 315 immunization.
1
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
84
FIGURE 5
The Binding Specificities Of The DNP-glycine Eluted Rabbit 
Anti-315 and Anti-460 Antibodies For 
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RIAs performed as described in the MATERIALS AND METHODS with anti-315 
and anti-460 obtained from rabbits 2 months after immunization.
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the ^I-labeled Fab fragment of 315 I-Fab 315) to anti-315 serum
in the presence of varying concentrations of six different mouse myeloma
-9proteins. While a 1 x 10 M solution of proteins 315 and 460 both in-
125hibited over 80% of the binding of I-Fab 315 to anti-315 serum, the 
other myeloma proteins produced only incomplete inhibition in concentra-
—  8  (7tions exceeding 1 x 10 M. These other myeloma proteins produced 50%
—6inhibition only with concentrations exceeding 1 x 10 M. Both pooled
serum from unimmunized Balb/c mice and serum from a Balb/c mouse which
contained greater than 1 mg/ml (10 ^M) of myeloma proteins 603 (a,<)
caused significant inhibition in the RIA. The inhibition curves of both
serum samples were identical. This suggests that the large amount of
protein 603 present in one serum did not contribute to the inhibition 
125of the binding of I-Fab 315 in the solid phase RIA, thus Balb/c serum 
must contain antibodies which are bound by the anti-315 serum. In a 
similar experiment, shown in Figure 5a, the DNP binding myeloma protein 
S194 (a,<) and the phosphory 1-choline (PC) binding protein T15 (a,<) were 
also found not to be bound by anti-315 antibodies. Thus under the condi­
tions in which these assays were performed, myeloma proteins representing 
the major classes of H and L chain (including a,K, and X chains) are not 
bound by anti-315 antibodies purified by DNP-glycine from a 315-Sepharose 
column. This suggests that anti-315 antibodies have anti-idiotypic 
specificity for both proteins315 and 460.
Similarly, anti-460 antibodies have idiotypic specificities for
proteins 460 and 315. Figure 5c illustrates the results of a solid
125phase RIA that measured the binding of I-Fab 460 to anti-460 serum 
in the presence of various concentrations of four Balb/c IgA myeloma 
proteins: T15, S194, 460, and 315. Only protein 460 completely competes
Jtfc
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with I-Fab 460 for binding by the anti-460 antibodies. Protein 315
125is able to inhibit about 40% of the binding of the I-Fab 460. A portion 
of the inhibition curve produced by protein 315 overlaps that of protein 
460. This suggests that some, but not all, of the anti-460 antibodies 
are also directed against determinants on protein 315. In a hemagglutination 
inhibition assay, protein 603 (a,<) would not inhibit the agglutination 
of 460-coated SRBCs by anti-460 antibodies in the concentration range 
that protein 460 did. Thus anti-460 antibody purified by the hapten 
elution method are highly specific for non-a and non-K chain related 
determinants.
Three additional lines of evidence indicate that both anti-315 and 
anti-460 sera are anti-idiotypic, i.e., they do not bind to C-region 
determinants:
a. Neither anti-460 nor anti-315 antibodies inhibit the binding of
125I-Fab 460 to rabbit anti-a serum. Hapten eluted antisera therefore do 
not compete for a chain determinants found on the first domain of the 
constant region.
b* The univalent Fab' fragments of anti-460 antibodies inhibit 
the agglutination of 460-coated SRBCs by anti-460 serum. These same 
univalent Fab’ fragments do not inhibit the agglutination of 460-coated 
SRBCs by rabbit anti-a serum. The lack of Inhibition by this serum by 
the univalent fragments of anti-460 suggests that the anti-460 antibodies 
do not have specificity for a chain determinants.
c. A 2 x 10 solution of the Fab' fragment of rabbit anti-a serum 
was unable to inhibit the hemagglutination of 460-coated SRBCs by a 
2 x 10 solution anti-315 serum. If the class specific determinants 
on protein 460 had been recognized by anti-315 serum, the univalent Fab*
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fragment of anti-a serum should have inhibited this agglutination.
In conclusion it has been demonstrated that from rabbit anti-315 
and from rabbit anti-460 serum a population of antibodies can be purified 
by DNP-glycine elution from protein 315-Sepharose and protein 460- 
Sepharose columns. These purified antibodies are not directed to deter­
minants found on the constant regions of immunoglobulins but rather both 
the anti-460 and anti-315 antibodies bind to three DNP-binding myeloma 
proteind 315, 460, and S23 exclusively. These hapten eluted antibodies 
are therefore anti-idiotypic antibodies.
B. The Hapten Eluted Anti-315 and Anti-460 Antibodies Are Each Composed 
of Two Populations of Anti-Idiotypic Antibodies: One Specific
Only For its Reference Protein (Idl); and One Specific For Proteins 
315, 460, and S23 (IdX).
Before the hapten eluted anti-idiotypic antibodies may be used as 
probes for V-region determinants present in mouse serum, it should first 
be determined whether all antibodies are directed to the same determinant(s). 
Below experiments are described which demonstrated that each set of anti- 
idiotypic antibodies could be separated into a public (IdX) and a private 
(Idl) anti-idiotypic fraction.
In a number of experiments (e.g. Figure 3), both proteins 315 and 
460 produced identical inhibition curves with anti-135 serum. This anti­
serum was obtained from a rabbit only two weeks after it was first immunized 
with protein 315. With serum obtained from the same rabbit at 2 months or 
later, quantity of anti-315 antibodies in the hapten eluted fractions which
would also bind protein 460 declined with time. Figure 6 is a summary of
125three solid phase RIAs that measured the binding of I-Fab 315 to anti- 
315 sera in the presence of varying concentrations of proteins 315 and 
460. The anti-315 serum used in each assay was obtained from the same
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
89
FIGURE 6
The Decrease With Time Of The Fraction of Antibodies That 
Bind Both Proteins 315 and 460 In Anti-315 Serum.
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125RIA was performed as described in MATERIALS AND METHODS with I-Fab 
315 and anti-315 sera obtained from rabbits 2 weeks, 6 weeks, and •
4 months after first immunization.
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rabbit two weeks, six weeks, and 4 months after primary immunization.
The percentage of antibodies that bind both proteins 460 and 315 declined 
from approximately 95% to less than 15% of the total anti-315 antibodies 
purified by hapten elution. This implies that each anti-315 serum can be 
characterized in terms of two anti-idiotypic specificities: those anti­
bodies that recognize determinants common to both 315 and 460 ("public- 
315" IdX).
The binding behavior of the public anti-315 idiotypic antibodies may
125be detected by performing a solid phase RIA using the binding of I-Fab 
460 to anti-316 antibodies in the presence of varying concentrations of 
competing myeloma proteins as demonstrated in Figure 5b. While only 15% 
of hapten purified anti-315 antibodies also bind protein 460 (Figure 5a), 
this sub-population binds both protein 315 and 460 with an identical 
inhibition curve. Another DNP binding Balb/c myeloma protein, S23 
(oi,k ) also has an identical inhibition curve with the public anti-315 
antibodies to that produced by protein 315 (Figure 5b). This suggests 
that the puhlic anti-315 antibodies are recognizing common determinants 
on proteins S23, 460 and 315.
Similarly, the inhibition curves in Figures 5c and 5d show that 
anti-460 serum is also composed of a population of antibodies that bind 
only to protein 460 ("private 460" or IdI-460) and another set that binds 
to S23, 315, and 460 ("public 460" or IdX). As with the protein 315 
immunized rabbit, serum obtained 2, 8, and 12 weeks after the initial 
protein 460 immunization contained a declining amount of public anti- 
idiotypic antibodies in the population of hapten eluted anti-460 idiotypic 
antibodies.
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The sub-populations of antibodies with specificities for public (IdX) 
and private (Idl) determinants can be separated.
Figure 7 shows that by preparative isoelectric focusing in Sephadex 
G-75, the antibodies with private anti-460 specificities can be separated 
from those with public anti-idiotypic activity. At some regions of the 
pH gradient (e.g. pH 5.0 to 5.4), both proteins 315 and 460 coated 
SRBCs were agglutinated. At other parts of the gradient (e.g., pH 5.8 
to 6.2) only protein 460 coated SRBCs were agglutinated.
To isolate the public anti-idiotypic antibodies, rabbit antiserum 
is absorbed onto the heterologous myeloma protein-Sepharose column and 
then eluted with DNP-glycine. Only antibodies which bind both the reference 
and heterologous myeloma proteins will be obtained. Those antibodies 
that are not directed to "public" idiotypic determinant will not be 
absorbed into the heterologous myeloma protein column. By absorbing the 
breakthrough material from the heterologous column onto a homologous 
myeloma protein-Sepharose column, the DNP-glycine eluted antibodies should 
be specific for "private" (Idl) determinants of the reference protein.
After one such purification, the hemagglutination of protein 460-SRBCs 
by the "private" anti-460 antibodies was inhibited by a concentration of 
protein 460 only one ten thousandth that needed by protein 315 to inhibit 
the same agglutination.
The amount of "private' and "public" anti-idiotypic antibodies purified 
from columns approximates the fraction of each specificity determined by 
RIA (Figure 5). For example, in Table 6 equal amounts of anti-315 serum 
was absorbed onto protein 460 and protein 315-Sepharose columns. The 
anti-315 serum was found on RIA to have 60% of its anti-315 activity also 
directed to protein 460. As, predicted by RIA, the titer of anti-315
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FIGORE 7
The Separation Of Public And Private 460 Anti-idiotypic Antibodies 
By Preparative Isoelectric Focusing
origin STAIN of ISOELECTRIC FOCUSING BANDS
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Preparative isoelectric focusing of hapten eluted anti-460 antibodies 
was performed as described in MATERIALS AND METHODS. A strip of this 
preparation was blotted onto Whatman 3MM filter paper and stained with 
Coomassie Blue to detect the focused protein bands. Hemagglutination 
titers with 460-coated and 315-coated SRBCs were determined as described 
in MATERIALS AND METHODS.
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TABLE 6
Comparison of Yields of Rabbit Anti-460 and Anti-315 Antibodies 
Eluted by DNP-glycine from Protein 315- and Protein 460-Sepharose Columns





anti-315 0.16 5 5
anti-460 0.25 7 6
315-Sepharose Column3
anti-315 0.24 7 6
anti-460 0.28 7 6
Each column consisted of 5 ml of protein-Sepharose; 2 ml of antiserum 
were applied to each column; after exhaustive washing (>10 column 
volumes) with PBS, the column was eluted with 2 ml of 0.1 M DNP-glycine.
k Yield of immunoglobulin based on optical density at 280 nm after 
dialysis 3X with PBS.
c Titer is expressed as log2 value of lowest dilution that causes 
hemagglutination (performed as described in MATERIALS AND METHODS).
An .
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activity (agglutination endpoint) of 315-coated SRBCs of antibodies 
purified from the protein 460-Sepharose column was half that of the 
anti-315 activity of the antibodies eluted from the protein 315- 
Sepharose column. The yield of immunoglobulin (0.16 mg) from the protein 
315-column (0.24 mg). The antibodies eluted from the protein 460 column 
produced the inhibition curves of Figure 5b which show that this serum 
binds equally well to proteins 315 and 460.
Similar results were obtained when this experiment was repeated 
with anti-460 serum that had been shown by RIA to be highly cross­
reactive (>90%) with protein 315. In this case, the yields and hemag­
glutination endpoint titers of the eluted immunoglobulins from both the 
315- and 460- columns were approximately equal. Thus hapten elution of 
antiserum absorbed onto a heterologous column is able to purify a sub­
population of antibodies with public idiotypic specificity.
In conclusion, antibodies purified by hapten elution can be divided
into two populations of antibodies with "public" or "private" anti-
125idiotypic specificities. In RIAs by substituting I-labeled Fab fragments 
of the heterologous protein for that of the reference myeloma protein 
(e.g. Figure 5b and 5d), the "public" antibodies' binding specificity 
may be measured. The "public" and "private" anti-idiotypic antibodies 
can be separated by preparative isoelectric focusing or by hapten elution 
from the appropriate myeloma protein Sepharose columns.
C. The Hapten Eluted Antibodies To Proteins 315 and 460 Are Combining 
Region Complementary Anti-Idiotypic Antibodies
Below it is shown that the anti-idiotypic antibodies that were 
purified by hapten elution will inhibit antigen binding to the reference 
myeloma protein and, conversely, that antigen will inhibit the reference
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myeloma protein from being bound by these anti-idiotypic antibodies.
Thus these anti-idiotypic antibodies are complementary to combining 
region determinants.
DNP-BSA is able to agglutinate protein 460-coated SRBCs. The uni­
valent Fab' fragments of anti-315 and anti-460 antibodies were found to
inhibit this agglutination. The Fab' of anti-315 antibodies could be
-9diluted to a 4 x 10 M solution and still inhibit the agglutination of
460-coated SRBCs by DNP-BSA. Similarly the Fab’ fragments of anti-460
—8antibodies could be diluted by 2 x 10 M and inhibit this agglutination. 
This suggests that the antibodies compete with determinants in the 
combining region of protein 460 with DNP-BSA.
The anti-315 antibodies (IdX) were also demonstrated to be comple­
mentary to the combining region determinants of proteins 315 and 460 in
an experiment whose results are illustrated in Figure 8. A solid phase
125 125RIA was used to measure the binding of I-Fab 315 or I-Fab 460 to
public anti-315 antibodies in the presence of varying concentrations of
DNP-lysine. As explained in Appendix 1, if the inhibition of the binding
of the public anti-315 antibodies to the myeloma proteins is due to the
binding of DNP-lysine to each protein's combining region, then the ratio
^ 3 1 5 ^ a460 sk°u-^ be e<3ual to the ratio [DNP]^^/[DITP]^^^, where Xa^ is
the binding constant of myeloma protein x for DNP, and [DNP]x is the
concentration of DNP-lysine that inhibits 50% of the binding of the Fab
fragment of protein x to the antiserum. In this experiment, the ratio
[DNPJ.C [DNP]«1C is 114. The ratio of Ka's of 315 to 460 is about 100 4011 Jib
(79, 145). This demonstrates that the binding of the public anti-315 
antibodies to both proteins 315 and 460 is inhibitable by the binding of
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FIG URE 8
125 125The Inhibition Of the Binding Of I-Fab 315 and I-Fab 460 To
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RIA was performed as described in MATERIALS AND METHODS.
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DNP-lysine by these myeloma proteins. Thus the public anti-315 anti­
bodies are complementary to combining region determinants.
The complementarity of the public anti-idiotypic antibodies for 
combining region determinants was also determined by studying these anti­
bodies ability to bind to proteins 315 and 460 whose combining regions 
had been chemically modified. Both proteins 315 and 460 were reacted 
with the DNP-affinity labeling reagents: EfilBDF, BADL, BADE, and DNP-
azide (Table 7). The different DNP-affinity reagents bind to specific 
residues of the V-region of either the E or L chain as listed in Table 
7. Except MNBDF, for every mole of the DKP-affinity labeling reagent 
covalently bound to the combining regions o£ proteind 315 and 460, there 
is a concomitant molar decrease in antigen binding; MNBDF reduces the 
affinity of protein 315 for DNP-lysine. A s shown in Table 7, the percentage 
of binding regions blocked by these affinity reagents were approximately 
equal to the percentage of inhibition of binding of the anti-idiotypic 
antibodies to each preparation of DNP-affinity labeled myeloma proteins.
This result suggests that the affinity labeling reagents (including 
MNBDF) modify the myeloma proteins so that the binding of the public 
anti-idiotypic antibodies to the myeloma proteins are sterically inhibited.
The affinity labeled proteins 315 and 460 were also used as competitors
123 123in RIAs, measuring the binding of I-Fab 315 or I-Fab 460 to private
anti-315 or private anti-460 antibodies, respectively. The shape of the 
inhibition curves of the affinity labeled proteins were identical to 
that of the unlabeled myeloma protein controls; but the inflection points 
were decreased to lower concentrations. The difference in the concentra­
tions calculated from the RIA of the native and modified myeloma proteins 
was equal to the number of moles of these proteins modified by the DNP
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TABLE 7
Effect of Affinity Labeled 460 and 315 on the Binding of Public Anti-Idiotypic Antibodies to 460 and 315 Coated SRBC s Respectively
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a) All solutions were adjusted to about 1.0 mg/ml of protein based on optical density except 
for the BADL and BADE labeled protein 315.
1 MNBDF is m-nitrobenzenediazonium fluoroborate
2 BADL is a-N-bromoacetyl-£-2,4-dinitrophenyl-L-lysine
3 BADE is N-bromoacetyl-N'2,4-dinitrophenyl-L-ethylenediamine
4 DNP-N3 is DNP-azide or 2,4-dinitrophenyl-l-azide
b) Hemagglutination inhibition assay was performed with public anti-idiotypic antibodies puri­
fied from a one month bleed of a rabbit anti-315 serum; the assay was performed as described 
in MATERIALS AND METHODS. The % inhibition of idiotype binding is the ratio of the hemag­
glutination inhibition endpoints of the affinity labeled preparation to that of its unlabeled 
control.
c) Z sites blocked was determined by fluorescence quenching and equilibrium dialysis except for 
the MNBDF preparation which was determined by optical density.
1
JL̂
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affinity labeling reagents. This implies that only the unlabeled V- 
regions in each preparation of modified proteins were being bound by 
the public anti-idiotypic antibodies. In another experiment, the Fab 
315 was affinity labeled with DNP-azide and then passed through a DNP- 
Sepharose column to remove any unlabeled Fab. The labeled Fab 315 would 
be expected not to adhere to the column as unmodified Fab 315 does. 
Spectrotypically it was determined that one mole of DNP-azide was bound 
to one mole of Fab 315. The private anti-315 antibodies did not bind 
the DNP-azide labeled Fab-315; therefore, DNP-azide sterically hinders 
the binding of the private anti-315 idiotypic antibodies to determinants 
related to the combining region of protein 315. Thus the ability of DNP- 
affinity labeling reagents to block the antigen binding capacity of the 
reference protein and render it unable to be bound by both the public 
and private anti-idiotypic antibodies implies that the hapten eluted 
antibodies are complementary to combining region determinants.
Both proteins 315 and 460 bind DNP and menadione (vitamin Ks) 
competitively. Manjula, Rosenstein and Richards (144, 145, 120) have 
demonstrated that these two haptens are bound in spatially separated 
parts of the combining region of protein 460. It is therefore possible 
that different poupluations of anti-idiotypic antibodies may be eluted 
with DNP-glycine and vitamin Ks. Table 8 summarizes the data from an 
experiment that compares the populations of anti-315 antibodies eluted 
by DNP-glycine versus those eluted by vitamin Ks. Equal quantities of 
rabbit anti-315 serum were absorbed onto two identical protein 315- 
Sepharose columns. After each column was eluted with one hapten, the 
other hapten was then passed through the column. In this way any anti- 
idiotypic antibody that is complementary to combining region of protein
JL
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TABLE 8
Specific Hapten Elution of Anti-315 Antibodies 
Bound to 315-Sepharose Columns
a C315-Sepharose eluted with: Yield (mg) Hemagglutination titer
(A) .1 M DNP-glycine 0.33 640
(B) .08 M Vitamin Ks 0.14 320
Vitamin Ks eluate of (A) 0 0
DNP-glycine eluate of (B) 0.22 320
a) Each column (A and B) consisted of 5 ml of 315-Sepharose to which 
2 ml of rabbit anti-315 serum had been passed; the column was 
washed with 10 column volumes of PBS, then eluted with 2 ml
of hapten solution
b) Yield is measured from optical density at 280 mm after dialysis 
3X against PBS
c) Hemagglutination titer is measured as explained in MATERIALS 
AND METHODS with 315-coated SRBCs
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315 which is not eluted by the first hapten might then he eluted by the 
other hapten; DNP-glycine eluted 0.33 mg of antibodies from the column. 
Vitamin Ks did not elute any immunoglobulin from a column already treated 
with DNP-glycine. On the other hand, the yield of immunoglobulin eluted 
first with vitamin Ks (0.14 mgs) was less than that obtained from the same 
column by subsequently eluting with DNP-glycine (0.22 mg). The total 
yield of antibody from that column (0.36 mg) was essentially equal to 
the yield of immunoglobulin (0.33 mg) from the column first treated with 
DNP-glycine. Thus no population of antibodies could be eluted that was 
specific for determinants of the combining region that were involved in 
the binding of vitamin Ks, exclusive of those determinants that were 
involved with the binding of DNP-glycine.
From the above experiment, three fractions of hapten eluted anti-
idiotypic antibodies were obtained from protein 315-Sepharose columns:
1) those antibodies eluted by DNP-glycine; b) those antibodies eluted by
*
vitamin Ks; and c) those antibodies eluted by DNP-glycine from a column 
previously treated with vitamin Ks.
125In a solid phase RIA, the binding of the I-Fab 315 to each anti­
body fraction was inhibited by both DNP-glycine and vitamin Ks (Table 9). 
Thus the anti-315 serum cannot be divided into subsets of anti-idiotypic 
antibodies that are inhibitable by menadione and not by DNP and into sub­
sets that are inhibitable by DNP and not menadione.
In conclusion, the public and private anti-idiotypic antibodies to 
proteins 315 and 460 were demonstrated to be complementary for combining 
region determinants of their reference myeloma proteins. This was shown:
a) by the ability of the anti-460 (Idl + IdX) and anti-315 (IdX) anti­
bodies to inhibit the binding of antigen by protein 460; b) by the ability
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TABLE 9
Both Vitamin Kg and DNP-lysine Inhibit the Binding 
of 125i-Fab 315 to Anti-315 Antibodies
% Binding^
315-Sepharose Eluted with:a 0.1 M DNP-lysine 0.04 M Vitamin Ks
(A) 0.1 M DNP-glycine 40 33
(B) 0.08 M Vitamin Kg 33 30
DNP-glycine eluate of (B) 24 29
a) Each anti-315 fraction was the same as purified in Table 8; 
see Table 8 for details
b) The concentration of each anti-315 fraction was adjusted to
0.100 0.0280 units; 0.1 ml of the antibody fraction was placed 
in a 6 x 72 mm Falcon polystyrene tube at 4° C for 24 hrs; the 
antibody fractions were removed and 0.2 ml of 0.1% BSA in PBS 
was added and incubated at 4° C for 24 hrs; the BSA was then 
removed; tube washed one time with PBS; then 25 yl of 125i-Fab 315 
(containing V50 ng of protein; spec. act. is 4 x 10^ cpm/mg)
and 25 yl of PBS or hapten solution was added; the tubes
incubated 24 hrs at 4° C; washed 3X with PBS. The % binding
is the ratio of the cpm of the hapten inhibited tubes to the
non-inhibited tubes (with PBS) times 100%.
L
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of DNP-lysine to inhibit the binding of the public anti-315 antibodies 
(IdX) to proteins 315 and 460; and c) by the inability of the private 
and public anti-idiotypic antibodies to protein 315 and 460 to bind to 
these reference proteins that had been modified by the DNP-affinity 
reagents MNBDF, BADE, BADL, and DNP-azide. Vitamin Ks elutes from a 
protein 315-Sepharose column only a subset of the anti-idiotypic anti­
bodies that DNP-glycine elutes. Both vitamin Ks and DNP-glycine are 
able to inhibit the binding of the anti-315 idiotypic antibodies eluted 
by either hapten to the reference protein 315.
D. The Anti-Idiotypic Antibodies For Proteins 315 and 460 Are 
Directed Against H Chain Determinants Whose Expression is 
Modified by the L Chain.
Before the anti-idiotypic antibodies may be used as probes for the 
expression of V-region markers in mouse serum, it should first be ascer­
tained to which determinants these anti-idiotypic antibodies are directed. 
This was partially accomplished by testing a series of 7S light (L) and 
heavy (H) chain recombinants for the ability to be bound by the various 
anti-idiotypic antibodies.
To determine whether the L and H chains of protein 315 contribute 
structurally to both the public (IdX) and private (Idl) idiotypic deter­
minants, .a chain recombination experiment was performed between protein 
315 and the idiotype negative protein 603 (a,<). After reduction and 
alkylation, the chains of each protein were separated and mixtures of the 
separate chains were allowed to recombine ucnder renaturing conditions.
The recombinant 7S molecules were tested for the presence of both the 
private (IdI-315) and public (IdX) idiotypes by hemagglutination inhibition 
(Table 10). Both public and private 315 idiotypic determinants were
with permission of the copyright owner. Further reproduction prohibited without permission.
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TABLE 1 0
The Ability Of Chain Recombinant Myeloma Proteins To Inhibit The Binding 
Of Protein 315 And Protein 460 To Anti-315 Antibodies







315„-315 recombinant a L
315„-603 recombinant a L













no activity no activity
(a) Hemagglutination inhibition titers were determined as described
in the MATERIALS AND METHODS with either 460-coated SRBCs 
or 315-coated SRBCs.
(b) The early anti-315 antibodies were isolated from 9era of a rabbit
bled two weeks after protein 315 immunization and had greater 
than 90% of its activity against public idiotypic determinants. 
The late anti-315 antibodies were isolated from sera of a rabbit 
bled 10 weeks after initial protein 315 immunization and had 
greater than 90% of its activity directed against private 460 
idiotypic determinants.
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detectable only on those molecules that contained the H chain of 315.
The hemagglutination inhibition titers of native 7S protein 315, of 
the homologous recombinant of 315, and of the 315-603 recombinant wereh 1j
within one order of magnitude of each other. Isolated L chains of 315 
are not bound by the public anti-idiotypic serum. Isolated H chains of 
315 are bound with a lower titer. This suggests that while the L chain 
does not bear the determinants for the public idiotype, the conformation 
of the V-region of the H chain of 315 in the presence of a L chain has 
its residues exposed so they may be recognized by the public anti-idiotypic 
antibodies.
The phosphorylcholine (PC) and DNP binding activities of the 603 and
315 chain recmobinants were not detected by equilibrium dialysis. Since
the 315 -603 recombinant is bound by the public (IdX) and private (Idl)H L
anti-315 idiotypic antibodies, the complete functional integrity of the 
antibody combining region does not seem to be necessary for the expres­
sion of these idiotypic determinants. It should be emphasized, however, 
that the hemagglutination inhibition assay is only able to detect the 
ability of the chain recombinant molecules to be bound by anti-idiotypic 
antibodies. No conclusion may be made about the antigenic identity of 
these chain recombinant molecules to the native myeloma proteins.
A series of protein 315 and protein 460 recombinant molecules were 
also prepared to test the chain specificity of the antisera directed 
against the private (Idl) idiotypes of proteins 315 and 460. Each anti­
serum was purified by first absorbing the serum with the heterologous 
myeloma protein attached to Sepharose to remove public anti-idiotypic 
antibodies. A series of 7S recombinant molecules between proteins 315 
and 460 were prepared (gift of Dr. R.W. Rosenstein) and for each re-
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combinant the binding constant (Ka) and number of binding regions per 
7S molecule were determined. Table 11 shows that the homologous re­
combinant molecules have the same Ka as the native protein, but the 
heterologous recombinants (460 -315 , 315 —46QT) have a lower Ka than theti Li c l  L
native proteins. The number of binding sites per mole of all the re­
combinant molecules was found to be the same as in the native proteins.
These recombinants were then tested for the presence of the private 460 
and private 315 idiotypic determinants. All recombinant molecules were 
adjusted to the same concentration.
All of the 315-460 recombinant molecules have identical public (IdX) 
idiotypic determinants.
Figure 9a illustrates the results of an R.IA designed to detect the 
private idiotypic determinants of protein 315 (IdI-315). No molecule 
that contained the H chain of 460 had this idiotype. The shape of the 
inhibition curves produced by protein 315 and the 315 -315 homologousn L
recombinant were identical. While the 315-460. recombinant did expressn. L
the private 315 idiotypic marker, it does so with a reduced affinity of
interaction with the anti-idiotypic serum. This can be seen in the shape
of the inhibition curve of 315 -460 recombinant compared to that of theci L
125homologous recombinant, 315-315, . For 50% inhibition of I-Fab 315Q. L
binding, it takes 15 times more of the 315„-460, chain recombinant thanH JLi
the homologous 315-315, chain recombinant. Thus, the private anti-315 ri L
antibodies recognize determinants in all molecules that contain the H 
chain of protein 315. Both the 315„-460, and 315-315, chain recombinantn  L* ri L
125inhibit the binding of the I-Fab 315 to the same extent, only the shapes
of the inhibition curves differ. This suggests that the heterologous
recombinant, 315-460,, interacts with the entire population of private ii L
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TABLE 11
-1Binding Constant (M ) Determined By:
3 3 3Recombinant Molecule Fluor. Quen. Eq. Dial. # of Binding Sites/
7S Molecule
b Snative 460 not done 1.8x10 1.5
native 315 5xl06 3xl06 1.5
3150315l 5x106 3x 106 0.7C
460^460^ not done 2.0x10^ 1.7
460h 315l 0d 3.0xl04 1.5
315h460l 0 2.5xl04 1.5
Recombinant molecules were a gift of Dr. R.W. Rosenstein and all 
assays were kindly performed by Dr. R.W. Rosenstein.
b_Protein 460 fluorescence is only slightly quenched by e-Dnp lysine. 
The Q max has been determined to be only 15-20 as opposed to a Q 
max for protein 315 of 70.
cThe number of binding sites was calculated to be 0.7 by both 
equilibrium dialysis and fluorescence quenching. Q max for this 
recombinant was 30 as compared to 65 for native protein 315.
dft0 means that e-Dnp lysine did not quench the fluorescence of that 
particular recombinant molecule.
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anti-315 idiotypic antibodies but the nature of the interaction is 
changed compared to that of the homologous recombinant and native protein 
315. Thus the private 315 idiotype is present on the H chain of protein 
315, but its expression is modified by the L chain.
A similar result was obtained when this set of recombinant molecules 
was tested for the private 460 idiotype (IdI-460) (Figure 9b). The private 
idiotype of 460 was only detected in those molecules which contained the 
H chain of 460. Although the heterologous 460 -315T recombinant inhibits11 i-i
125the binding of I-Fab 460 to the same extent as the homologous 460^-
460t recombinant, the shape of the inhibition curves of the heterologous
Li
recombinant differs from that of the homologous recombinant and native
protein 460. As in the previous case, it takes 3 times more 460^-315^
125to reach 50% inhibition of I-Fab 460 than it takes of the 460^-460^ 
recombinant. Thus the antibodies directed to the private 460 idiotype 
recognize determinants on the H chain of protein 460, but the expression 
of these determinants is also modulated by the L chain.
A more extreme modification of the expression of the private 460 
idiotype is illustrated in Figure 9c. A series of S23-460 7S recombinant 
molecules were prepared (gift of Dr. R.W. Rosenstein). All recombinant 
molecules were shown to have identical public idiotypic (IdX) determinants. 
The expression of the private 460 idiotypic determinants, however, only 
was found in those recombinant molecules that contain the L chain of pro­
tein 460, regardless of the H chain of the molecule. Native protein 460,
the 460-460 homologous recombinant, and the S23 -460 heterologous re- h L n L
125combinant completely inhibited the binding of I-Fab 460 to anti-460
antibodies, while the 460 -S23T heterologous recombinant produce afci L
completely different inhibition curve. The S23jj-S23^ homologous chain
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recombinant the private and native protein S23 were not bound by anti- 
460 antibodies. The shape of the inhibition curves of the S23 -460Li L
recombinant was identical to that of the homologous 460 chain recombinant
and native protein 460. Furthermore, by hemagglutination inhibition
the amount of private 460 idiotype in the 460 -S23 chain recombinant
H  L
was determined to be only 6% that of an equimolar concentration of the 
homologous 460 chain recombinant.
On the surface, these results seem to be in conflict with those 
obtained for the set of 315-460 chain recombinant molecules. However, 
these results are consistent with two possibilities: a) the L chain
possesses the structures which are detected as the private 460 idiotypic 
determinants; or b) the L chain modulates the expression of the private 
460 idiotypic markers of the H chain, even to the extent of completely 
preventing these determinants’ detection in protein S23. The experiments 
described above with the 315-460 recombinants clearly show that the 
private idiotypic determinants are associated with the H chain. There­
fore, the H chain of S23 must contain the private idiotypic determinants 
of protein 460, but the L chain of protein S23 prevents its antigenic
expression. The L chain of protein 460 in the S23 -460 chain recombinant
H. L
"permits" the expression of this H chain associated idiotypic determinant. 
It is significant that the inhibition curve of the S23„-460 chain re-H Li
combinant is identical to that of native protein 460. This implies that 
with the appropriate L chain the surface residues of H chain of protein 
S23 are antigenically identical to those of protein 460 for these private 
460 idiotypic determinants.
In the next section, the private idiotypic marker of protein 460 is 
demonstrated to coinherit with the allotypic markers of the H chain of
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immunoglobulins. This is also indirect evidence that the private 460 
idiotypic determinants are found on the H chain.
In conclusion by chain recombination experiments it has been found 
that the residues for the private 315, private 460, and public idiotypic 
determinants are found on the H chain of the reference proteins. The 
L chain associated with the "idiotype determining residues" modulates the 
expression of the private 315 and private 460 idiotypes. The fact that 
proteins 460 (oi,k),315 (a,A), and S23 (a,<) have identical inhibition 
curves with the public anti-idiotypic antibodies implies that the L chain 
does not produlate the public idiotypes expression.
In the next section, experiments will be described that employed 
the private 315, private 460, and public anti-idiotypic antibodies as 
reagents to detect the expression and inheritance of immunoglobulins 
bearing these V-region markers.
II. The Characterization and Inheritance of Idiotype Positive Immuno­
globulins in Mice.
A. The Strain Distribution of the Idiotypic Determinants
Inbred strains of mice are homogeneous for the genetic loci that 
control the level of the immune response (H-2 region) and the structural 
genes for the constant region of the H chain of immunoglobulins (Ig-1 
loci). Below are described investigations that surveyed the sera of 
various inbred strains of mice for the presence of immunoglobulins which 
were bound by the private anti-315, public, and private anti-460 idiotypic 
antibodies. This was performed to determine if immunoglobulins with these 
V-region markers are expressed in mice and if the strain distribution of 
mice with idiotype positive immunoglobulins appears to be linked to the 
presence of any other genetic loci. Rabbit and guinea pig sera were not
,L
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bound by these anti-idiotypic antibodies.
1. The Private 315 Idiotypic Determinants (IdI-315)
No strain of mouse was found to have immunoglobulins that were bound
by the private 315 anti-idiotypic antibodies. Sera from eighteen mouse
strains including recombinant strains between Balb/c and C57BL that
resembled the strain from which the MOPC 315 plasmacytoma was induced were
surveyed for the private 315 idiotype by both RIAs and hemagglutination
inhibition assays. Table 12 lists the H-2 and Ig-1 haplotypes of some
of the strains surveyed. As illustrated in the RIA in Figure 10, as
-9little at 300 ng/ml (2 x 10 M) of immunoglobulins with private 315-like 
idiotypic determinants would have been detected. The mouse sera employed 
were pools of anti-DNP sera obtained 10 and 40 days after a single immuni­
zation with DNP-BGG. These sera were found to have an increased titer of 
anti-DNP and anti-BGG antibodies compared to the titer of the serum of 
the same mice obtained the day of immunization. Table 12 also lists the 
concentration of DNP binding antibodies in the 0 and 10 day sera. While 
each strain of mice is capable of responding to DNP-BGG, no strain produces 
immunoglobulins that have the private 315 idiotype.
2. The public 460 and 315 Idiotypic Determinants (IdX)
The anti-DNP serum of every mouse strain analyzed was found to contain 
immunoglobulins with the public 460 and 315 (IdX) idiotypic determinants.
In the RIA employed to detect the public idiotypic determinants, the idio­
type positive immunoglobulins from each strain produced identical inhibi­
tion curves. These results are summarized in Table 12. Figure 11 depicts 
some of the results of this RIA. The shape of the inhibition curves of 
the 10 day serum of DNP-immunized Balb/c (Ig-la+), BAB 14 (Ig-1*3)* and
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TABLE 12
Strain Distribution of 460-like Idiotypic Determinants in Mice




















Balb/cN ' 52 85 • 350 75 (B) 38 (B) a+ d 24 556
SJA/9 72 65 300 105 (B) 37 (B) a+ a 24 3700
C58/J 68 56 300 84 (B) 22 (B) a+ k 20 1778
B-C/9 55 30 350 140 (B) 32 (B) a+ b b 2668
C57BL/6 n.d. 20 n.d. 4 (C) b b n.d. n.d.
SJL 8 26 50 4 (C) 4 (C) b s 7 667
C*B 17 7 11 50 6 (C) 0 (C) b d 24 890
BAB 14 22 28 240 567 (B) 14 (B) b d 29 2440
AL/N 13 0 240 14 (C) 0 (C) d a 17 556
C'AL/9 20 6 240 14 (C) 14 (C) d d 24 711
A/He 15 0 240 12 (C) 0 (C) e a 20 200
NZB 25 24 240 18 (C) 0 (C) e d 289 4000
DBA (C) c d
CBA (C) a k
C3H <C) a k
AKR (C) d k
a) The majority of the idiotype positive immunoglobulins in the unimmunized sera possessed 
only the public idiotypic determinant(s). All concentrations in this table were calcu­
lated based on the serum dilution required to inhibit 50% of the binding of ‘-3I-Fab
460 to an anti-idiotypic serum. The "ug/ml" units is calculated from the concentration 
of protein 460 needed to cause the same amount of inhibition.
b) The anti-460 idiotypic serum employed had both public (IdX) and private (IdI-460) 
specificities such chat 60% was anti-IdX. The IdX concentration was calculated by sub­
tracting the value of the concentration of IdI-460 like determinants in the 10 day bleed 
from the concentration of total 460-like idiotype in the 10 day bleed. The value obtained 
for the public (IdX) idiotypic determinants are therefore only estimates but it is valid 
in demonstrating that the concentration of immunoglobulins bearing the public idiotype
in a day 10 bleed is less than that in a 40 day bleed.
c) Determined from a solid phase RIA with public anti-idiotypic antibodies and *25I-Fab
315 as described in the MATERIALS AND METHODS.
d) Determined from a solid phase RIA with the private 460 anti-idiotypic antibodies and
125I-Fab as described in the MATERIALS AND METHODS.
e) Determined by solid phase RIA described in MATERIALS AND METHODS.
f) All mice were immunized s.c. at 6 to 12 weeks of age with 0.5 mg of DNP-BGG in Complete
Freunds Adjuvant and Bled at 0, 10, and 40 days after immunization.
n.d. -- not done
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FIGURE 10
The Binding Of Private 315 Anti-Idiotypic Antibodies To 










Mouse sera tested includes those 0, 10, and 40 day bleeds summarized in 
Table 12. RIA was performed as described in the MATERIALS AND METHODS 
with -^I-Fab 315 and DNP-glycine eluted anti-315 antibodies that had 
been pre-absorbed with 460-Sepharose.
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FIG UR E 11
The Binding Of Public 460 Anti-Idiotypic Antibodies To 
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125RIA was performed as described in the MATERIALS AND METHODS with I-Fab 
315 and DNP-glycine eluted anti-460 Antibodies.
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C56LB (Ig-1^) resembles the lower half of the inhibition curves of prote ns 
460 and 315. The mouse sera were not diluted enough in this assay to 
obtain a complete curve. Both the mouse sera and the myeloma proteins have 
the same extent of inhibition. Thus the public anti-idiotypic antiserum 
is recognizing antigenically identical determinants on the immunoglobulins 
from the three strains which may be antigenically identical to proteins 
315 and 460.
The concentration of immunoglobulins bearing the public idiotype is 
only slightly increased in the serum obtained 10 days after DNP-BGG
1 immunization compared to the serum from the day of immunization (day 0).
iI
i  The concentration of immunoglobulins bearing this idiotype is much greater
in the 40 day serum. Mouse strains can be divided into three groups based 
on the concentration of public idiotype positive immunoglobulins as sum- 
| marized in Table 12: a) those strains whose pre-immune sera have a
significantly elevated level of public idiotype positive immunoglobulins 
| (>50 ug/ml) and whose immune titers of idiotype is higher than other
l strains (>300 ug/ml); b) those strains which have a much lower level of
' public idiotype positive immunoglobulin in the pre-immune serum and which
!
I produce a low concentration (<100 ug/ml) of idiotype positive immuno­
globulin in their 40 day anti-DNP response; and c) those strains whose 
initial concentration of idiotype positive immunoglobulin is low, but 
which produce a large quantity (^200-300 ug/ml) in the fortieth day of 
their anti-DNP response. Only strains with the Ig-1 allotypic locus
are in the first group. Strains with the Ig-1^ allotypic locus except 
*fbr BAB 14 are in the second group and all other strains including BAB
* BAB 14 is a recombinant inbred strain between C56BL and Balb/c mice which 
has the allotype of C56BL and apparently a cross-over in the region of the 
loci that code for the Vy genes, thus producing immunoglobulins with both 
C56BL and Balb/c V-region determinants (36).
. L
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14 are in the third group. Assuming that all public idiotype positive 
immunoglobulins bind DNP, it is to be noted that the public idiotype is 
found at most on 5 to 25% of the DNP-binding antibodies in the serum of 
each strain (Table 12). Thus this marker which is common to myeloma 
proteins 315, 460 and S23 is represented on only a fraction of the DNP 
binding antibodies present in an anti-DNP serum.
The public idiotype was found on immunoglobulins of the a,
y and p subclasses of each strain. As illustrated in Figure 12, each
pool of mouse anti-DNP serum was precipitated in an Ouchterlony double
immunodiffusion assay with rabbit anti-mouse subclass sera. After washin
125with PBS, the gel was overlayed with I-labeled Fab' fragments of the 
public anti-idiotypic antibodies. Autoradiography of the washed gel 
revealed intensely radioactive bands over each precipitin line, thus 
demonstrating that each H chain subclass of mouse immunoglobulin of every 
strain tested had the public idiotype. Balb/c, DBA, C3H, SJL, C56BL, and
AKR mice were tested by this technique.
Thus the public idiotypic determinants of protein 460 and 315 are 
inducible by DNP immunization in every strain of mouse tested and these 
V-region markers are found on immunoglobulins of every C-region H chain 
subclass tested.
3. The Private 460 Idiotypic Determinants (IdI-460)
Anti-DNP serum from every strain contains immunoglobulins that 
are bound by the private 460 anti-idiotypic antibodies, however, the 
nature of this interaction differs in quality from strain to strain. As
depicted in Figure 13, the shape of the inhibition curves of the various
mouse strains in a solid phase RIA can be divided into two groups: a)
those strains whose sera's inhibition curves almost completely inhibits
!A
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FIGURE 12
The Heavy Chain Isotypes Of The Public And Private 460 
Idiotype Positive Mouse Sera
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U> yl, y2a, y2b, a are rabbit anti-Heavy chain isotypic sera that were 
employed in Ouchterlonly immunodiffusion against various mouse sera 
as described in MATERIALS AND METHODS. DNP-BGG immune sera from 
DBA, C3H, SJL, Balb/cN, C57BL/6, and AKR mice gave same patterns. 
Proteins. 603 and 315 are two IgA mouse myeloma proteins.
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FIGURE 13












The 10 and 40 day anti-DNP sera described in Table 12 was employed in a 
RIA which was performed as described in the MATERIALS AND METHODS with 
I-Fab 460 and anti-IdI-460 antibodies.
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125the binding of I-Fab 460 to the private 460 anti-idiotypic antibodies, 
but the shape of the inhibition curve is not identical to protein 460’s 
inhibition curve in the same assay; and b) those strains whose antisera 
have a different inhibition curve with a less steep slope. Since no 
inhibition curve of any strain is identical to that of protein 460, the 
concentration of 460-like determinants calculated from the Inhibition 
curves can only be estimates. Even though the immunoglobulins of the 
anti-DNP sera of group (a) interact with most, if not all, of the private 
anti-460 antibodies, it can not be determined from this assay how anti­
genically similar the "idiotype positive" determinants of immunoglobulins 
in these sera are to the private idiotypic determinants of protein 460.
As long as two sera produce the same shaped inhibition curves in a RIA, 
the relative concentration of antigenic determinants can be reliably 
calculated. The mouse sera, however, do not have identical inhibition 
curves compared to protein 460. The concentration of "460-like" deter­
minants was estimated based on the dilution of serum required to prevent
125the binding of 50% of I-Fab 460 to anti-460 serum in the solid phase 
RIA. The concentration of 460-like determinants will be expressed in 
terms of "ug/ml of protein 460 equivalents" even though the "actual" 
concentration of the antigen positive immunoglobulins is not known.
The units are calculated based on the concentration of protein 460 
which would cause 50% Inhibition in this assay. These units are only 
valid in the context of the comparison of sera with the same shaped 
inhibition curves within the same RIA.
As summarized in Table 12, anti-DNP sera from strains that have 
the Ig-1 allotypic locus have the Inhibition curves described in group 
(a). The only other strain to have this shaped inhibition curve is BAB
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14, the C56BL x Balb/c recombinant strain. Sera from strains with the 
Ig-l*3, Ig-lC , Ig-l**, and Ig-l6 loci were found to be in the second group. 
Thus the 460-like private idiotype appears to be associated with the 
Ig-l allotype.
This association was also tested by mating C57BL (Ig-l*3) and Balb/c
3"̂(Ig-l ) mice. As illustrated in Figure 14a, the anti-DNP sera from six
FI mice yielded inhibition curves identical to that of the parental
Balb/c mouse. The assay presented in Figure 14b shows the offspring of
the back-cross mating of FI x C57BL. These offspring had anti-DNP sera
with inhibition curves that resembled either the C57BL or Balb/c curves.
The appearance of either inhibition curve is independent of sex. Thus
the inheritance of the Balb/c 460-like idiotypic determinants appears
to be autosomal dominant. The allotypic composition of these recombinant
mice are currently being determined. Unitl further matings are performed
and assayed for the private 460-like idiotype, these conclusions must be
viewed as preliminary.
Ouchterlony immunodiffusion was employed to determine the subclass
distribution of the 460-like determinants of each strain. Each serum
125was precipitated with anti-subclass serum and overlayed with I- 
labeled Fab fragments of private anti-460 antibodies. As shown in Figure 
12, after a two day incubation, intense autoradiographic bands were noted 
over the precipitin lines of the mouse anti-DNP serum with rabbit antisera 
for the y, a and subclasses. After 30 day film exposure to auto­
radiography, faint lines were detected over the precipitin bands for the 
Y2a> and the subclasses. Every strain yielded the same results by 
this method. This assay does not reveal anything about the nature of 
interactions between the mouse immunoglobulins and the private anti-460
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FIGURE 14 
.a+The Inheritance Of The Ig-laT Linked Private 460-like Idiotype 
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RIA was performed as described in ^^ERIALS AND METHODS with private 
460 anti-idiotypic antibodies and I-Fab 460. The sera used were 
from mice bled 10 days after DNP-BGG immunization.
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antibodies. From this experiment it can only be concluded that anti­
bodies from every subclass tested are bound by the private anti-460 anti­
bodies. This experiment does not reveal whether antigenically identical 
V-regions are found on immunoglobulin with more than one subclass.
Table 12 summarizes the concentration of private idiotypic markers 
in the sera of mice bled 0, 10, and 40 days after DNP-BGG immunization.
No serum from unimmunized mice of any strain contains more than a back­
ground oncentration (1 to 10 ug/ml) of the private 460-like idiotypic 
markers. Unlike the public (IdX) idiotype, the concentration of immuno­
globulins that are bound by the private 460 anti-idiotypic antibodies 
reached a peak concentration 10 days after immunization and then declined 
by day 40. Only a minority of the DNP binding antibodies of each strain 
have the private 460-like idiotypic determinants. While the public (IdX) 
and private (IdI-460) idiotypic markers are both found on protein 460, 
the different kinetics of induction of immunoglobulins bearing these two 
determinants suggests that in mice, clones of DNP-binding antibodies are 
induced that have one idiotypic marker and not the other. This is con­
firmed in later sections.
In conclusion, it has been shown that:
a) no mouse serum tested has a detectable quantity (>300 ug/ml) of 
immunoglobulins that are bound by the private 315 anti-idiotypic antibodies;
b) all strains of mice contain immunoglobulins that have the public 
idiotype. The shape of the inhibition curves of mouse immunoglobulins 
are identical to the inhibition curves of proteins 315, 460, and S23.
Each strain of mice produces a concentration of public idiotype positive 
immunoglobulins in its pre-immune and anti-DNP sera that is characteristic 
of that strain. Immunoglobulins representing every H chain isotype contain
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V-regions with the public idiotypic markers;
c) all strains of mice contain immunoglobulins that are bound by 
the private 460 anti-idiotypic antibodies; however, some immunoglobulins 
from anti-DNP sera of mice that have the Ig-l H chain allotypic locus 
have a characteristic inhibition on RIA which distinguishes it from the 
"idiotype positive" immunoglobulins from other strains. No strain of 
mice tested produces immunoglobulins that have an identical inhibition 
curve to protein 460. The inheritance of the Ig-l allotype associated 
private 460-like idiotype appears to be inherited as an autosomal dominant 
trait. The immunoglobulins that are bound by the private 460 anti-idio­
typic antibodies are mostly of the a, u, and y^ H chain isotypes in the 
serum of the mouse strains tested; and
d) the kinetics of induction of immunoglobulins that are bound by 
the private 460 and public anti-idiotypic antibodies differ thus implying 
that V-regions are present in the sera which have one set of idiotypic 
determinants and not the other.
Below some of the factors involved in the induction of these 460-like 
idiotype immunoglobulins of Balb/c mice will be discussed, as well as the 
properties of the idiotype positive immunoglobulins of Balb/c mice will 
be described.
B. The Influence of Carrier and Hapten On the Induction of 460-like 
Determinants In Balb/c Mice.
Balb/c mice were chosen for this study for two reasons: a) the
plasmacytoma, MOPC 460, was induced in a Balb/c mouse; therefore, the 
V-region of protein 460 may resemble the V-region of a DNP binding anti­
body coded in the genome of Balb/c mice; and b) Balb/c mice were found to 
produce 460-like idiotypic determinants whose inhibition curves were
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characteristic of mice with the Ig-l allotypic locus.
1. All Balb/c Mice Produce Immunoglobulins That Have 460-like
Idiotypic Determinants
The results of the previous section were derived from pools of sera
of mice from the same strain. Table 13 presents data which show that
individual mice produce significant levels of 46Q-llke determinants in
125its anti-DNP response. In an assay that measured the binding of I- 
Fab 460 to anti-460 antibodies specific for both public and private idio­
typic determinants, each mouse serum had an identical inhibition curve.
With the exception of one mouse (6 LII 1), the concentration of 460-like 
idiotype in each serum spanned a range of 35 to 95 ug/ml with an average 
of 54 ± 17 S.D. ug/ml (n=23) in mice immunized by DNP-BGG in "Protocol I".
A pool of 90 mice immunized by the same protocol produced an identical 
inhibition curve with a concentration of 460-like determinants of 48 ug/ml.
Similarly, DNP-BGG immunization of mice by another protocol (#11) 
induced immunoglobulins whose inhibition curves in the same RIA were 
identical to each other and identical to the Balb/c sera of mice immunized 
by Protocol I. The concentration of 460-like determinants of eight indivi­
dual mice immunized by Protocol II ranged from 109 to 268 ug/ml with a 
mean of 181 ± 63 S.D. ug/ml, while that of a pool of sera of 200 mice 
immunized the same way was 160 ug/ml. Thus the range of the 460-like 
idiotype seen in individual mice includes the values seen in pooled serum. 
Pooled sera may be used to reflect the antibody response of individual 
mice to different immunological stimuli.
2. Sequential Immunization of DNP and Menadione Containing Antigens
Preferentially Induces Immunoglobulins With the 460-like Idio­
typic Determinants
Protein 460 binds both DNP and menadione (vitamin Ks). The binding of
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TABLE 13
ToCal Concentration of 460-Like Idiotypic Determinants (IdX + Idl) In 
Individual Balb/c Mice Immunized With DNP-BGG
Protocol la Protocal 11̂
Mouse Concentration (uK/ml) Mouse Concentration Mouse Concentration
(ug/m) (ug/ml)
6 B ^ 65
6 B* 40 15 B ̂ 35 9** 2406 L II t 1 250 15 BJF» 43 9? 1726 X 3 60 3 b £ 50 15 o' 1506 -? 4 65 3 B o* 75 15* 1728 B o*> 50 10 Bf 50 14*9 1098 B £ 50 1 B*» 35 14 * 2688 LI £ 2 40 2 Bf 40 6* 100
8-? 1 56 2 B<* 50 66? 24011 B«f» 75 13 Bf 43 average * 181 ±63 (n=8)
HB * 12 B *
13 Btf*
ug/ml
95 45 pool of 200 mice50 Immunized by = 160 ug/ml
12 B tf* 40 Protocol II
average'” 62 ± 44 S.D. (n=23) ug/ml
average (excluding 6L II -t 1) = 54 ± 17 (n-22) ug/ml
pool of 90 mice immunized by protocol I = 48 ug/ml
a) Protocol I is s.c. injection of 0.5 mg DNP-BGG into 6 week old Balb/c mice in Complete 
Freunds ADjuvant on day 0; 0.5 mg of Men-BGG in Complete Freunds Adjuvant on day 30; 
bleed day 40.
b) Protocol II is s.c. injection of 0.5 mg of RNase into 6 week old Balb/c mice in Complete 
Freunds Adjuvant on day 0; 0.5 mg of DNP-BGG in Complete Freunds Adjuvant on day 30; 
bleed on day 40.
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the menadione moiety by protein 460 has been shown by Rosenstein and 
Richards (145) to be deep in the combining region cleft of the V-
O-region. Menadione attached to a solid support with less than a 22 A 
spacer will not be bound by protein 460. Table 14 is a summary of the 
results of an experiment that tested the ability of two different' 
menadione conjugated proteins, Men-BGG and Men-Spacer-BGG, to induce 
460-like idiotypic determinants. The distance of the naphthoquinone
Oring to the protein carrier in Men-BGG is on the order of 10 A and in
0Men-Spacer-BGG is greater than 22 A. The primary and secondary responses 
of mice immunized with Men-BGG had little or no stimulation of an anti-DNP 
response and induced very little of immunoglobulins that were bound by the 
anti-460 idiotypic antibodies (IdX and Idl). On the other hand, the con­
centration of DNP binding antibodies and of immunoglobulins with 460- 
like idiotypic markers in response to Men-Spacer-BGG immunization was very 
similar to the response to DNP-BGG immunizations. DNP-BSA, DNP-RGG, and 
DNP-KLH also induced DNP binding antibodies and immunoglobulins with the 
460-like idiotypic determinants. Thus antigens that can be bound by 
protein 460 are able to induce immunoglobulins bearing 460-like idiotypic 
determinants. Work is in progress to determine the concentrations of 
immunoglobulins which have the public (IdX) and private (IdI-460) idio- 
types induced by each antigen. Below the properties of the Balb/c immuno­
globulins that are bound by the anti-idiotypic antibodies are described.
C. Properties of the 460-like Idiotype Positive Immunoglobulins 
From Balb/c Mice.
1. Idiotype Positive Immunoglobulins Bind DNP and Menadione
Four lines of evidence have demonstrated that immunoglobulins with 
the 460-like idiotypic determinants bind DNP and menadione:
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TABLE 14
The Concentration of DNP Binding Antibodies and Immunoglobulins With 
The 460-Like Idiotypic Determinants
SL b eAntigen Protbcol 460-Like Idiotype DNP-binding
Day 0 Day 30 Day 40 (ug/ml) antibodies
(ug/ml)
saline bleed 60 20
saline saline bleed 60 20
DNP-BGG bleed 139 700
DNP-BGG DNP-BGG bleed 281
Men-BGG bleed 75 40
Men-BGG Men-BGG bleed 75
Men-Spacer-BGG bleed 140 1100
Men-Spacer-BGG Men-Spacer BGG bleed 180
DNP-BGG Men-BGG bleed 1000
DNP-BGG Men-Spacer-BGG bleed 2000
Men-Spacer-BGG DNP-BGG bleed 150 600
a) All immunizations were performed as described in MATERIALS AND METHODS with 6 
week old BALB/c mice.
b) Solid phase RIA was performed as described in MATERIALS AND METHODS. Quantitation 
done at serum concentration giving 50% inhibition of binding of 125I Fab 460 to 
anti-460 idiotypic antibodies that have both public and private specificities.
c) Solid phase RIA was performed as described in MATERIALS AND METHODS.
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a) Both DNP and menadione inhibited the binding of an immunoglobulin
fraction from Balb/c anti-DNP serum to public anti-idiotypic 
antibodies.
b) The passage of anti-DNP serum through a hapten-Sepharose column
removed the majority of the public and private 460-like idio­
type positive material.
c) DNP-glycine was able to elute immunoglobulins from a protein 460
anti-idiotypic antibody Sepharose column onto which Balb/c DNP 
binding antibodies were absorbed; and
d) Isolated 460-like idiotype positives immunoglobulin were demon­
strated to bind both DNP and vitamin Ks in a DNP-phage inhibition 
assay.
In the first experiment, a fraction of immunoglobulins from DNP-
immunized mice was isolated from a Men-Spacer-Sepharose column* by DNP-
glycine elution. This should elute antibodies that bind both DNP and
menadione. The eluted immunoglobulins were attached to a solid support
125and used in a RIA. This assay measured the binding of I-labeled Fab'
fragment of public anti-idiotypic antibodies to the solid support. As
summarized in Table 15, 1 x 10 DNP-glycine and 1 x 10 vitamin Ks
125both inhibit greater than 40% of the binding of the I-labeled Fab' 
fragments to the purified double binding immunoglobulins. Thus immuno­
globulins from DNP immunized mice that have the public idiotype bind 
both DNP and menadione.
Additional evidence that immunoglobulins with 460-like idiotypic 
determinants bind DNP and menadione is summarized in Table 16. Sera
* The Spacer consists of N-acetyl homocysteine ornithine which is at 
least 22 A long.
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TABLE 15
The Hapten Inhibition of Binding of Public Anti-Idiotypic 
Antibodies to Mouse Immunoglobulins
Hapten solution % Binding
PBS 100
0.1 M DNP-glycine in PBS 33
0.01 M DNP-glycine in PBS 40
0.02 M Vitamin Kg in PBS 20
0.001 M Vitamin K in PBS s 56
a) Solid phase RIA performed as described in MATERIALS AND 
METHOD. A fraction of mouse immunoglobulins were attached 
to the polystyrene tubes. This fraction was purified by passing 
BALB/c anti-DNP serum through a Menadione-Spacer-Column.
After washing with 10 column volumes, the column was eluted 
with DNP-glycine. The DNP-glycine was removed by extensively 
dialyzing the sample against PBS and by checking the optical 
density at 280 nm and 360 nm. The assay measured the binding 
of Fab' fragments of public anti-idiotypic antibodies
to this fraction of DNP and menadione double binding antibodies 
attached to this polystyrene tubes.
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TABLE 16
Adsorption of 460-Like Idiotypic Positive 
Immunoglobulins to Hapten Sepharose Columns
460-like Idiotype(ug/ml)a % bound by columns^
1) Balb/c serum 50
2) #1 after DNP-column 27 46%
3) Concentrated Break- 60
through of #2
4) //3 after DNP-column 35 42%
5) //I after menadione- 47 6%
homocysteine-ethylene 
diamine-Sepharose 
column (19 A spacer)
6) //I after menadione- 35 30%
homocys t eine-o rnithene- 
Sepharose column 
(23 A spacer)
a) Solid phase RIA was performed as described in MATERIALS AND 
METHODS. Quantification was done at concentration giving
50% inhibition of binding of -^I-Fab 460 to anti-460 idiotype 
antibodies that have both public and private specificities
b) % bound is ratio of idiotype of starting serum to amount of 
idiotype bound to column.
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from DNP-immunized mice were passed through Sepharose columns to which 
various DNP and menadione haptens were attached. While 30% of the idio-
O
type positive immunoglobulins were bound to a column with a 25 A spacer 
between the menadione moiety and Sor'harose, only 6% was bound to a
Pcolumn with a 19 A spacer. This r- ̂ .lt shows that of the antibodies
capable of binding to such a column, many of the idiotype positive immuno-
0
globulins are like protein 460 in requiring at least a 22 A spacer for 
menadione to be bound.
Only 46% of the idiotype positive immunoglobulins are bound to a DNP- 
column. To test whether the 54% which did not bind to the DNP-column 
actually binds DNP, the breakthrough from the DNP-column was concentrated 
to the original concentration, then passed through another DNP-column. Of 
this concentrated immunoglobulin, 44% was bound. This suggests that both 
affinity and antibody concentration had an effect on the percentage of 
idiotype positive immunoglobulins bound to the DNP-column. The lower 
percentage of immunoglobulins bound by the menadione columns could also 
reflect the concentration of immunoglobulin used in this experiment and/ 
or reflect the affinity of the immunoglobulins for menadione. This point 
was not investigated.
The third line of evidence that idiotype positive immunoglobulins 
bind DNP is based on the finding that DNP-glycine can elute an antibody 
fraction from a protein 460 anti-idiotypic antibody-Sepharose column 
to which anti-DNP serum had been absorbed. The anti-460 antibodies attached 
to the Sepharose column were directed against both public and private 460 
idiotypic markers. After the eluted immunoglobulins were extensively 
dialyzed to remove the DNP-glycine hapten, it was demonstrated by
125Ouchterlony double immunodiffusion that the immunoglobulins bound I-
JL
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12 5labeled DNP (. I-TLD). These eluted immunoglobulins were mainly
composed of the IgGl, IgA, and IgM subclasses. A minor component was
also IgG2a and IgG2b. As demonstrated in Figure 15, autoradiography 
125demonstrated that I-TLD was bound in a pattern that overlay the pre­
cipitin lines caused by anti-subclass serum and the eluted immunoglobulins. 
Thus Balb/c immunoglobulins with the 460-like determinants bind DNP.
When this experiment was repeated with a private 460 anti-idiotypic 
antibody-Sepharose column, the class distribution of the DNP-glycine 
eluted material was different from the above experiment. The most intense 
radioactive bands were found over the precipitin lines for the IgGl,
IgM, and IgG2b subclasses. The radioactivity over the IgA precipitate 
was faint and no radioactivity was detectable over the IgG2a line. This 
result suggests that the two idiotypes may exist on at least two different 
populations of antibodies.
In conclusion, the Balb/c immunoglobulins that are bound by the 
public and private 460 anti-idiotypic antibodies were demonstrated to 
bind both DNP and menadione in the following manner:
a) both haptens inhibit the binding of the public anti-idiotypic 
antibodies to these immunoglobulins;
b) either hapten attached to Sepharose will absorb idiotype positive
O
material from sera. A 25 A spacer between the menadione ring and Sepharose
O
will absorb more idiotype positive immunoglobulines than a 19 A spacer;
c) DNP-glycine can elute the idiotype positive immunoglobulins which 
had been absorbed onto a Sepharose column to which both public and private 
460 anti-idiotypic antibodies had been attached. The H chain subclass 
distribution of the eluted immunoglobulins differs when a column with 
only the private 460 anti-idiotypic antibodies attached is used instead
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Ouchterlony double immunodiffusions were performed as described in 
the MATERIAL AND METHODS with Balb/c immunoglobulins that had been 
eluted from anti-460 (IdX and IdI)-Sepharose and anti-IdI-460-Sepharose 
columns by DNP-glycine and had been dialyzed to remove the DNP-glycine.
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of one with both the public and private anti-idiotypic antibodies. This 
suggests that some Balb/c immunoglobulins may contain the determinants 
for one marker and not the other.
Below the 460-like idiotype positive immunoglobulins were isolated by 
preparative isoelectric focusing and characterized.
2. The Isolation and Characterization of Balb/c Immunoglobulins 
Which Have the 460-like Idiotypic Determinants
Sephadex G-75 preparative isoelectric focusing was employed to 
separate and isolate the immunoglobulins that had different 460-like 
idiotypic determinants. As illustrated in Figure 16, the isoelectric 
points (pi) of idiotype positive immunoglobulins from pools of mice 
immunized with DNP-BGG were identical to that of a single mouse immunized 
with DNP-BGG. Although small quantities of idiotype positive immuno­
globulins were detected throughout the pH gradient, two major peaks of 
idiotype positive immunoglobulins were detected at pH 4.5 to 5.0 and at 
pH 6.7 to 7.0. Ouchterlony immunodiffusion of the immunoglobulins from 
these bands with anti-subclass sera revealed that the immunoglobulins 
from the first peak were of the IgA iso type and the material from the pH 
6.7 to 7.0 area was of the IgGl subclass.
The immunoglobulins from these peaks were demonstrated to bind DNP
by three methods: a) the immunoglobulin’s ability to bind DNP in a phage
125inhibition assay as illustrated in Figure 17; b) the binding of I-TLD 
by the precipitated immunoglobulins in agarose; and c) the ability of the 
immunoglobulins to bind to DNP-columns as summarized in Table 17.
The DNP-coated phage are able to form plaques unless antibody binds 
to the DNP-coated tail fibers of the phage. Based on the ability of DNP- 
lysine and of vitamin Ks to inhibit the binding of pH 6.7 to 7.0 peak
k
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FIGURE 16
The Preparative Isoelectric Focusing of Balb/c Immunoglobulins To Isolate
460 Idiotype Positive Antibodies
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After three salt precipitations with 18% Na2S0 4 , the sera were subjected to 
preparative isoelectric focusing as described in the MATERIALS AND METHODS. 
One half cm. wide strips were pooled and the antibodies were eluted and 
adjusted to 1 ml after dialysis against PBS. The hemagglutination inhibition 
assay was performed as described in the MATERIALS AND METHODS with anti-460 
antibodies with both public and private 460 specificities and 460-coated 
SRBCs.
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FIGURE 17
DNP-Phage Inhibition Assay Of 460 Idiotype Positive 
Immunoglobulins Eluted From pH 6.7 To 7.0 Region 
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Phage inhibition assay was performed as described in MATERIALS AND 
METHODS.
JL
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TABLE 17
The Binding of the Preparative Isoelectric Focusing Purified 
460-Like Idiotype Positive Balb/c Immunoglobulins to 
DNP-Sepharose Columns






200 (therefore % bound to column was 48%)
pH 6.7-7.0 
immunoglobulins
a) before column 115 ^
b) after column 20 and 70 (therefore % bound to column was
between 40% to 83%b)
a) Solid phase RIA was performed as described in MATERIALS AND 
METHODS. Quantitation was done at concentration giving 50% 
inhibition of binding of 125i-Fab 460 to anti-460 idiotype 
antibodies with both public and private specificities.
b) Experiment performed twice
t
L
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immunoglobulins to the DNP-coated phage, an average avidity constant of
these immunoglobulins for DNP-lysine and vitamin Ks was calculated to be
5-1 3 - 11 x 10 M and 3 x 10 M at room temperature, respectively. This is
shown in Figure 17.
The immunoglobulins from the pH 4.5 to 5.0 region of the pH gradient
were bound by both public and private 460 anti-idiotypic antibodies and
produced inhibition curves in RIAs identical in shape to those produced by
Balb/c serum. On the other hand, the pH 6.7 to 7.0 peak material was only
bound by the private 460 anti-idiotypic antibodies and not by the public
anti-idiotypic antibodies.
Immunoglobulins eluted from the pH 4.5 to 5.0 range of the preparative
isoelectric focusing gradient, not only have the same Idiotype, isotype,
and DNP-apecificity as protein 460, but the immunoglobulins also have
the same isoelectric point as protein 460, but the immunoglobulins also
have the same isoelectric point as protein 460. Figure 18a shows the
results of Sephadex G-75 preparative isoelectric focusing of protein
460. The pi of protein 460 lies between pH 4.5 and 5.0. The isoelectric
point of protein 460 was determined by the position of 460-like idiotypic
determinants measured by a hamagglutination inhibition assay and by the
3position of H-DNP-azide labeled protein 460. Both the affinity labeled 
protein 460 and the 460-like idiotype positive material have the same pi.
3Thus H-DNP-azide labeled 460 can be used as a means for following a trace 
quantitiy of protein 460.
The following experiments were performed to determine if the 460-like 
idiotype positive immunoglobulins of Balb/c sera could be affinity labeled 
by DNP-azide. Anti-DNP serum absorbed onto a public and private anti-idio­
typic antibody-Sepharose column was eluted with DNP-glycine.
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FIGURE 18
(a) Preparative isoelectric focusing of protein 460 and H-DNP azide 
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The eluted immunoglobulins were found to be mostly IgGl, IgA, and IgM,
although immunoglobulins with the IgG2a and IgG2b subclasses could be
detected. The eluted immunoglobulins were dialyzed to remove DNP-gly-
3cine, reduced and alkylated, and photoaffinity labeled with H-DNP-azide. 
Using SDS polyacrylamide gel electrophoresis, the eluted material' was 
found to consist of four bands with the molecular weights approximately 
25K, 50IC, 60K, and 72IC. This corresponds to the molecular weights of the 
L, y> « and P chains, respectively. The a chain of protein 460 has 
a molecular weight of 5QK (Dr. R.W. Rosenstein, pers. comm.). Only 
the 25K and 50K peaks contained tritium label. This implies that the 
L and y chains (and possibly a chains) of the 460-like idiotype posi­
tive immunoglobulins are able to be affinity labeled. When this affi­
nity labeled antibody preparation was subjected to isoelectric focusing,
3the pH distribution of the H-label was found only between pH 4.5 and 5.0, 
exactly as determined for protein 460 (Figure 18b). Interestingly, no
3H-label was detected at the pH 6.7 to 7.0 region of the gradient where 
the 460-like idiotype positive IgGl is found.
Thus, Balb/c mice contain two immunoglobulins in its anti-DNP serum 
that make up the majority of the immunoglobulins positive for the 460- 
like idiotypes: a) an IgGl DNP and menadione binding antibody with a
pi between pH 6.7 and 7.0 that has only the private 460-like idiotypic 
marker of Balb/c mice; and b) an IgA DNP and menadione binding antibody 
that is bound by both public and private 460 anti-idiotypic antibodies 
and that has a similar pi to protein 460, the same H chain subclass to 
460, and a similar ability to be photoaffinity labeled by DNP-azide like 
protein 460.
.L
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D. Lymphocytes From Balb/c Mice Have 460-like Idiotypic Deter­
minants on Their Surface.
The induction of 460-like idiotype positive immunoglobulins in a 
humoral response implies that the clones of lymphocytes that produce 
the idiotype positive immunoglobulins have been stimulated. B cells and 
possibly T cells have immunoglobulin on their surfaces. It would there­
fore be expected that some lymphocytes from mice that produce idiotype 
positive immunoglobulins would have on their surfaces material that is 
bound by the anti-idiotypic antibodies to the V-region of protein 460.
Below is presented evidence that some Balb/c splenic lymphocytes have 
public 460 idiotypic determinants on their surface and the percentage 
of such lymphocytes increases after immunization with DNP-BGG.
Lymphocytes from the spleen cells of 6 Balb/c mice immunized with 
DNP-BGG were eluted through nylon wool columns (85) to obtain an enriched 
T cell fraction and an enriched B cell fraction. The cells were incu­
bated either with rabbit public 315 anti-idiotypic antibodies or with 
rabbit anti-mouse immunoglobulin serum. The cells were then "stained" 
with fluorescein-conjugated goat anti-rabbit serum. As summarized in Table 
18, about half of the lymphocytes from the spleen cells were labeled 
by the anti-mouse immunoglobulin reagent. This is to be expected since 
about half of the splenic lymphocytes are B cells with immunoglobulin 
on their surface. While 1.5% of splenic lymphocytes from the unimmuni­
zed mice stained positive for the public idiotype, 17% of all the lympho­
cytes were positive for the public idiotype. No fluorescence could 
be detected on the non-adherent (T cell) fraction, while the adherent 
lymphocytes (B cell enriched) had an increase in the percentage of 
lymphocytes with mouse immunoglobulin on their surface and an increase 
in the percentage of the public idiotype positive lymphocytes. Normal
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TABLE 18
The Presence of Public Idiotypic Determinants On The Surface Of Splenic
Lymphocytes Of Balb/c Mice
"Staining Reagent":





Percentage of Fluorescent Labeled Cells










Nylon Wool Adherent 
Fraction (B cell 
enriched fraction)
Nylon Wool Non-Adherent 







(a) The lymphocytes from six mice were pooled. After harvesting the
lymphocytes from teased spleens by low speed centrifugation, 
1 x 1()6 cells were incubate with 0.1 mg/ml solution of one 
of the reagents in Eagles Minimal Medium for 1 hr. at 0° C. 
The cells were washed once with Eagles Minimal Medium; then 
incubated with 0.5 mg/ml of fluorescein-labeled goat anti­
rabbit Fc antibodies for 1 hr. at 0° C. The cells were then 
washed 3x with PBS; then the percentage of fluorescent cells 
in 200 lymphocytes was determined under a fluorescent 
microscrope.
(b) The DNP-BGG immunized mice were injected with 0.5 mg of DNP-BGG
in Complete Freunds Adjuvant 10 days prior to sacrifice.
(c) The spleen cells from the DNP-BGG immunized mice were separated
by the Nylon Wool Technique of Julius et al (85). 1 x 10^
cells of each fraction were treated as above.
JL
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rabbit serum substituted for rabbit anti-mouse immunoglobulin did not 
enable the lymphocytes to be fluorescently labeled, thus demonstrating 
that "Fc-receptors" on lymphocyte surfaces did not influence the scoring 
of lymphocytes as positive for a surface marker in this experiment. This 
work is now being repeated with the private 315 and private 460 anti- 
idiotypic antibodies.
In conclusion, in this section the rabbit public, private 315, and 
private 460 anti-idiotypic antibodies were employed as reagents to detect 
mouse immunoglobulins that have the V-region antigenic determinants to 
which these rabbits antibodies were directed. Of 18 strains surveyed, 
no serum was found to contain immunoglobulins that are bound by the 
private 315 anti-idiotypic antibodies. All strains of mice produce 
immunoglobulins with the public idiotype. All strains of mice produce 
immunoglobulins that are bound by private 460 anti-idiotypic antibodies. 
Based on the shape of the various inhibition curves in RIAs, the mouse 
immunoglobulins which are bound by the private 460 anti-idiotypic anti­
bodies are antigenically dissimilar to protein 460. The private 460-like
3.“f"
idiotype positive immunoglobulins from mice that have the Ig-1 allo­
typic locus differ antigenically with the immunoglobulins of other 
strains of mice that are bound by the private 460 anti-idiotypic anti­
bodies. The 460-like idiotype positive V-region marker associated with
ei't"the Ig-1 locus appears to be inherited in an autosomal dominant pattern. 
In Balb/c mice both DNP containing antigens and menadione containing
O
antigens with a 22 A spacer between the carrier and the naphthoquinone 
ring are able to induce immunoglobulins with the public and private 
460-like idiotypes. These same antigens are bound by these idiotype 
positive Balb/c immunoglobulins. The majority of 460-like idiotype
L
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positive immunoglobulins in Balb/c anti-DNP sera consists of two DNP 
and menadione binding immunoglobulins: a) an immunoglobulin that is
bound by both the private 460 and public anti-idiotypic antibodies and 
whose isoelectric point, subclass, and ability to be labeled by DNP- 
azide is identical to protein 460; and b) an immunoglobulin that is 
bound only by the private 460 anti-idiotypic antibodies and which has a 
different isoelectric point and subclass than protein 460. Some Balb/c 
splenic lymphocytes have surface determinants that are bound by the 
public anti-idiotypic antibodies. The percentage of such lymphocytes in 
the spleen increases after DNP-BGG immunization.
In the next section attempts to develop other sets of V-region 
markers for DNP binding immunoglobulins will be discussed. The iso­
electric focusing patterns of double binding immunoglobulins were used 
to distinguish one antibody from another.
III. Attempts at Employing the Isoelectric Focusing Patterns of Double 
Binding Antibodies of Immune Serum as V-Region Markers
In the previous two sections, rabbit antibodies to reference 
mouse myeloma proteins were employed to characterize a minor set of 
V-region determinants in mouse anti-DNP sera. A limitation of this 
approach is that the only V-region determinants studied are those 
that are bound by the anti-idiotypic antibodies. The antigen specifi­
city of most mouse myeloma proteins are unknown or are directed against 
a few antigens (Table 1, INTRODUCTION). Furthermore, among mice only 
the Balb/c and NZB strains produce plasmacytomas with high frequency. 
Only recently have techniques been developed to isolate homogeneous 
antibodies from any mouse strain by performing cell fusion between 
splenic lymphocytes and stable myeloma cell lines (107, 96, 175). Thus
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until recently the majority of V-regions of most mouse strains could 
not be studied by the idiotypic approach.
Another approach to characterize the combining regions of immuno­
globulins has been to identify them by their specificity for a defined 
set of antigens. This work includes that of MSkela's group (71, 116) 
who studied the inheritance of immunoglobulins with similar binding 
preferences for related antigens (fine specificity). Recently various 
investigators have attempted to correlate the fine specificity pre­
ferences to isoelectric focusing pattern (114) and idiotypic determinants 
(77). The assumption behind these studies has been that very few immuno­
globulins possess both identical isoelectric points (pi) and antigen 
binding properties or both identical pi and idiotypic determinants.
Eisen ert a]L. (40) were the first to demonstrate that myeloma pro­
teins may bind many chemically dissimilar moieties. For example, protein 
460 has been shown to bind DNP and menadione in two spatially separated 
regions of its combining region (144, 145, 120). Johnston and Eisen 
(83) have demonstrated that rabbits immunized with either DNP or mena­
dione conjugated proteins will have an immune response of which 25 to 
75% of the antibodies bind both antigens. Varga al. (168) have 
shown that by sequentially immunizing rabbits with both antigens, 
the early response to the second injection contains an increased amount 
of antibodies directed against both antigens. This preferential stimu­
lation of multispecific antibodies was not only restricted to DNP and 
menadione binding antibodies. Double binding immunoglobulins were 
induced by the sequential Immunization of DNP and inosine, uridine, or 
bovine pancreatic RNase. In a subsequent paper, Czaja et al. (20) 
found that the sequential immunization of mice with RNase and DNP-BGG
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caused a concomitant increase of the cell surface receptors of splenic 
lymphocytes that bind both antigens.
Concurrent with the idiotypic work described in the preceding two 
sections of the RESULTS, an attempt was made to identify sets of V- 
regions for possible genetic study by analyzing the isoelectric focusing 
patterns of multispecific antibodies in mouse sera. In this approach, 
the method of Varga et ̂ 1. (168) was followed, i.e., mice were sequen­
tially immunized with two antigens and the "early" serum was assayed 
for the presence of antibodies which bind both antigens. For example, 
mice were injected with RNase, then with DNP-BGG 30 days later and bled 
10 days after the second immunization. This "early" serum had a higher 
proportion of RNase and DNP double binding immunoglobulins in its anti- 
DNP response compared to serum from mice immunized with DNP-BGG alone.
The serum from the sequentially immunized mice were subjected to iso­
electric focusing in flat plate polyacrylamide gels. The gels were 
preferentially precipitated with sodium sulfate and cross-linked in the
gel with glutaraldehyde. Thus, prepared, the gels were exposed to a solu- 
125tion of I-labeled hapten in the presence and absence of cold compe­
titor. In this way, a comparison of the radioactive banding pattern 
(spectrotype) of the gels developed with or without competitor allowed 
detection of double binding immunoglobulins. Those bands which contained 
immunoglobulins that bind both competitor and radioactive hapten were 
less intense in the gels exposed to cold competitor. The analytical 
method therefore allowed a quick identification of both the isoelectric 
points and the binding specificities of a large number of immunoglobu­
lins present in small quantities of mouse serum.
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Below are descrihed attempts by this method of analytical iso­
electric focusing to characterize the V-regions of multispecific 
antibodies that also bind DNP.
A. Antibodies Retain Their Antigen Binding Specificity While 
Cross-Linked in Polyacrylamide Gels After Isoelectric 
Focusing.
The method of isoelectric focusing and cross-linking of immuno­
globulins in polyacrylamide gels was shown not to affect the binding
properties of immunoglobulins in the experiment illustrated in Figure
12519. Autoradiography of monomeric protein 315 exposed to I-TLD in 
a polyacrylamide gel after isoelectric focusing revealed a series of 
five bands. Three of these were prominent. Although the monomeric pro­
tein 315 that was subjected to isoelectric focusing has a homogeneous 
amino acid sequence, the multiple banding pattern may be due to slight 
changes in the pi caused by differences in carbohydrate content, 
deamination or allomorphism (178). Protein 315 binds both DNP and 
vitamin Ks. By incubating the polyacrylamide gels containing the cross- 
linked protein 315 with various concentrations of vitamin Ks, the amount 
of the radioactivity in these bands was affected. A plot of the 
intensity of each autoradiographic band versus the logarithm of the 
concentration of vitamin Ks allows an estimation of the inhibition 
constant (K̂ .) of vitamin Ks for the protein 315 bound in a polyacryla­
mide gel after isoelectric focusing. As shown in Figure 19b, the inhi­
bition constant for vitamin Ks was calculated to be between 0.3 to 
4 -11 x 10 M based on the decrease in band intensity which increasing 
vitamin Ks concentration. Figure 19 also shows that all three bands 
have within experimental limits the same Kj. for vitamin Ks, thus 
further strengthening the argument that isoelectric focusing does not
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FIGURE 19
(a) Densitometer tracing of a 7 day film exposure of the isoelectric^
focusing pattern of monomeric 315 that was incubated with 10 M 
I-TLD in the presence of varying concentrations of . v 




(b) A plot of peak intensity versus Vitamin Ks concentration. The 
concentrations noted are those of Vitamin Ks that produce 
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affect antigen binding. The inhibition constant of vitamin Ks for
3 -1monomeric 315 in solution was found to be 3 x 10 M by a DNP-phage 
inhibition assay (kindly performed by Dr. K. Kalasz). Thus protein 
315 was unaffected by isoelectric focusing and cross-linkage in a poly­
acrylamide gel.
To show that TLD binding to antibodies fixed in gels is due to
125their specificity for the DNP moiety of I-TLD, DNP-caproic acid was
125used as a competitor for I-TLD. Figure 20 illustrates the autoradio-
125graphic pattern of I-TLD binding antibodies in the presence and 
-4absence of 10 M DNP-caproic acid. Whole serum was subjected to iso­
electric focusing. The prominant bands in the pH 4.9 to 5.2 region 
are albumin. While the intensity of the albumin bands are little 
affected by the presence of DNP-caproic acid, most of the immunoglobu­
lin bands have been "washed" out by the cold hapten. Albumin binds
4 -1DNP-lysine with a Ka about 5 x 10 M and it is present m  serum at 
a concentration of 2 to 5 mg/ml. Undoubtedly the small change of 
intensity of the ablumin band in the presence of the cold competitor 
is not detectable because the large amount of radioactivity present.
This is due to the high concentration of albumin in the band. As 
explained in Appendix 2, by selecting a concentration of radioactive 
hapten and of cold inhibitor to be used in developing the analytical 
isoelectric focusing gels, a sub-population of double binding immuno­
globulins can be detected after autoradiography. Below the attempts 
to employ two sets of antigens to characterize multispecific antibodies 
in mouse serum will be presented.
The presence of multispecific antibodies were detected by auto-
125radiography of antibodies that had bound I-labeled haptens. The
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FIGURE 20
125The Inhibition of I-TLD Binding Of Mouse Immunoglobulins By 
1 x 10“^ M DNP-caproic Acid
PH
125I-TLD
























Analytical isoelectric focusing, gel processing, and autoradiography 
were performed as described in the MATERIALS AND METHODS.
L
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intensity of a band is a function of the number of molecules undergoing 
radioactive decay, and is dependent upon the exposure time of the x-ray 
film to the radioactive gel. Figure 21 shows the results of an experi­
ment designed to test these variables. Strips of filter paper ( 1 x 6
125mm) were impregnated with different quantities of I-labeled TLD 
125( I-TLD). The film that was incubated to 180 cpm could be detected
after 7 days; film which was exposed to 18 cpm was barely detectable
after 30 days. Thus at least 180 to 1800 cpm per 1 x 6 mm band is
125required for detection after a two to seven day film exposure to I- 
autoradiography.
The amount of radioactivity present in a particular band is also a 
function of the amount if immunoglobulin present, the affinity of the 
immunoglobulin for the hapten, and the specific activity of the hapten.
As explained in Appendix 2, the amount of immunoglobulin present in a 
given band can be estimated by the band's intensity after autoradiography 
if an assumption is made regarding the antibodies affinity for the hap­
ten. In most instances, this information is not known, so this estimate 
cannot be made accurately. Thus a range of concentrations and affinities 
spanning three or four orders of magnitude can yield the same amount 
of film darkening in each band under the conditions in which the gels 
were processed.
It is possible that autoradiography will not reveal all antibodies
that have binding specificity for the radioactive hapten, either
because the amount of immunoglobulin present in the band is too low
or the affinity for the hapten is not high enough. In many instances,
mouse anti-DNP sera were found to agglutinate DNP-coated SRBCs and to
125contain 460-like idiotype, yet these same sera failed to have I-TLD
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FIGURE 21 
125Film Darkening Observed With I Containing Bands After 
2, 7, and 30 Days Autoradiography
film
exposure 2 day 
cPm/strip
7 day 30 day
18,000
^ 8 0 0 -:’rn
180
Details for this experiment are described in the RESULTS.
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binding bands on autoradiography after isoelectric focusing. Some of
these sera when precipitated by specific anti-subclass sera in an
125Ouchterlony immunodiffusion were demonstrated to bind I-TLD by auto­
radiography. The separation of the different immunoglobulins by iso­
electric focusing may have resulted in the amount of immunoglobulin 
in any band to be sufficiently low so that not enough radioactivity was 
present to be detected under the conditions in which the autoradiography 
was performed.
In conclusion, analytical isoelectric focusing gels may be used to 
detect antibodies that bind more than one ah+if*.r\ . Many factors 
affect the detection of immunoglobulins cross-linked inside the gel 
including the concentration of immunoglobulin present, the affinity of 
the immunoglobulin for the hapten, the specific activity of the labeled 
hapten, and the exposure time of the film to the labeled gel.
Below experiments will be described that employed this analytical 
technique to detect the isoelectric focusing patterns of double binding 
antibodies induced by the sequential immunization of antigens. This 
was done in an effort to identify different V-region gene products of 
mice.
B. The Study of DNP and Menadione Multispecific Antibodies by 
Isoelectric Focusing Patterns Analysis
The characterization of DNP and menadione binding antibodies by 
isoelectric focusing pattern analysis was wrought with many difficulties. 
Most of the studies which attempted to induce DNP and menadione multi­
specific immunoglobulins were performed by sequentially immunizing mice 
with DNP-BGG and Men-BGG. It was only later that work was produced 
that demonstrated that Men-BGG is not antigenic for most menadione
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binding antibodies. As shown in section II.B.2. (Table 14), Men-BGG
was barely antigenic for an anti-DNP response or for a response of
immunoglobulins bearing the 460-like determinants in Balh/c mice. Men-
Spacer-BGG* is more antigenic for both types of responses. This may
be so because Balb/c immunoglobulins like proteins 460 and 315 bind the
0
menadione moiety "deep" in the combining region cleft. A 22 A spacer
must exist between the naphthoquinone ring and the protein for the
menadione moiety to be bound by these immunoglobulins. This was shown
in section II. C.l. (Table 16). Furthermore, Men-Spacer-BSA with a 23 
0 0
A spacer and not Men-RGG with a 10 A spacer is precipitated by proteins 
315 and 460 and Balb/c anti-DNP serum in an Ouchterlony immunodiffusion. 
Thus Men-BGG did not serve as an antigen for the induction of DNP and 
menadione binding multispecific immunoglobulins. Any DNP and menadione 
multispecific immunoglobulin induced by a protocol of the sequential 
immunization with DNP-BGG and Men-BGG was solely due to the injection of 
DNP-BGG.
The immunization protocol employed in these studies, called the 
"DM protocol", consisted of a DNP-BGG injection followed by a Men-BGG 
injection 30 days later. The mice were bled 10 days after the second 
injection. Since the Men-BGG is not antigenic, the sera obtained by 
this protbdol are equivalent to sera obtained from mice bled 40 days 
after a DNP-BGG immunization with a second boost of BGG. As noted in 
sections II.A.2. and II.A.3. (Table 12), by the fortieth day of an anti- 
DNP response in Balb/c mice the serum concentration of the clones of 
immunoglobulins with the private 460-like idiotype were declining while
*Men-Spacer BGG is menadione-acetyl homocysteine-BGG.
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the concentration of immunoglobulins with the public 460 idiotype were 
increased. This means that the isoelectric focusing pattern of DNP 
binding immunoglobulins observed in the serum of mice immunized by the 
DM protocol should reflect a large set of DNP binding antibodies, all of 
whose concentrations are changing.
Depending on the kinetics of the induction and inhibition of indi­
vidual antibody producing clones, it might be expected that differences 
in banding intensity would be observed in the isoelectric focusing
125spectrotypes of sera from different mice of the same strain. The I-
TLD autoradiography of the serum from Balb/c mice immunized by the DM
protocol revealed banding differences among individuals. For example,
in Figure 22a the ^^I-TLD banding pattern of B0*and B-£ sera were
identical except between pH 5.6 and 5.9. Figure 22b is a superimposi-
tion of the densitometer tracings of the 2 day film exposure of these
sera. Note that with B0*a faint band can be detected between peaks 3
and 4 that coincides with peak 4* in B-f. A 30 day film exposure of
125the gel (Figure 22a) reveals more I-TLD binding bands. Now there are 
more resemblances in the banding pattern of the two sera. A densito­
meter tracing of the banding patterns of Btf*and Bj sera after a 30 day 
film exposure (Figure 22c) now reveals that both sera have mostly identi­
cally positioned peaks with variations of peak intensity between two sera. 
The sera obtained from Balb/c mice immunized with the DM protocol does 
not represent an "early" response to the second antigen. Although mice 
made the same antibodies, the serum concentration of each antibody varied 
from mouse to mouse, as judged by the intensity of bands after isoelec­
tric focusing. The intensity differences may have represented slight
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FIGURE 22
125The Autoradiographic I-TLD Binding Patterns Of The "DM" Sera From 
From Two Balb/cN Mice After A 2 Day and 30 Day Film Exposure
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FIGURE 22 (continued)





















(c) Densitometer tracings of the 
30 day film exposure
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5.6
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125differences in the kinetics of expression of the I-TLD binding anti­
body clones.
The different banding intensities observed among the various inbred 
mice are analogous to those seen with the banding patterns of sera 
obtained from the same mouse at different times after immunization.
Figure 23 compares the banding patterns of sera from B 0*10 days and 47 
days after sequential injection of DNP-BGG and Men-BGG. The position 
of the bands are the same, only the intensities of each band are 
different.
To detect DOT and menadione binding multispecific antibodies,
menadione bisulfite was employed in most of the investigations to
125inhibit the binding of I-TLD by the isoelectric focusing bands of
125sera of Balb/c mice immunized by the DM protocol. Very few I-TLD 
binding spectrotypes were found to be inhibited by menadione bisulfite.
It was finally determined that most menadione binding antibodies have 
a much higher affinity for vitamin Ks (menadione thiopropionic acid) 
than menadione bisulfite. This enabled a significant number of multi­
specific clones to be detected.
In Figure 24, two autoradiographic film exposures are presented to
125illustrate the change in intensity of I-TLD binding bands in the
presence and absence of vitamin Ks. Each autoradiographic film had its
darkness (band intensities) measure by a densitometer. The intensities
125of each band for the gels incubated only with I-TLD were measured from
the density tracings, as well as, the intensity of the bands from the
125Identical gel exposed to I-TLD and vitamin Ks. A ratio of these two 
intensities (called the "Ks/TLD ratio") provides a rough guide to identify 
those bands which bind both haptens competitively. Arbitrarily, a Ks/TLD
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
161
FIGURE 23
A Comparison Of The Autoradiographic Patterns Of A Mouse Bled 10 Days 
And 47 Days After DNP-BGG Immunization
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FIGURE 23 (continued)
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125The Inhibition Of I-TLD Binding Bands By Vitamin Ks
(a) The 7 day autoradiographic film exposure.
PH











Analytical isoelectric focusing, gel processing, and autoradiography 
were performed as described in MATERIALS AND METHODS.
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FIGURE 24 (continued)
125(b) A comparison of the densitometer tracings of the I-TLD binding
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FIGURE 24 (continued)
(c) A comparison of the densitometer tracings of the I-TLD binding 
patterns of ^  4, $ 5  with and without Vitamin Ks.
pH 49 5-1 53 54 55 5.9 61 62 65 6.7 70 71 7.5 7.6
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ratio greater than 0.5 was interpreted to mean that the I-TLD 
binding band was not inhibitable by vitamin Ks. Conversely, a Ks/TLD 
binding band less than or equal to 0.5 was taken to mean that the 
immunoglobulins bound both TLD and vitamin Ks competitively.
The Ks/TLD ratio varied from band to band in any serum sample.
For example, in B»*of Figure 24 the Ks/TLD ratio was less than 0.5 
only in those TLD binding bands whose pi was greater than pH 6.0.
The Ks/TLD ratio of the bands of B^, £  4, and %- 5 in the same pH 
range were closer to 1.0. Thus only one of these four Balb/c mice 
produced a detectable vitamin Ks and TLD double binding spectrotype 
in this pH range.
The significance of this result is unclear. Not enough of the
immunoglobulins subjected to analytic isoelectric focusing could be
eluted from the polyacrylamide gel for further characterization. In
125addition, attempts to label individual bands with I-labeled Fab' 
fragments of anti-idiotypic and anti-isotypic antibodies were unsuccess­
ful. The pore size of the gel was too small to allow sufficient diffu-
125sion inside the gel of the I-labeled Fab fragments to produce decent 
labeling.
To try to circumvent this inability to characterize the idiotype 
and isotype of the immunoglobulins cross-linked in analytical polyacryla­
mide gels, the anti-DNP serum from one mouse was subjected to isoelectric 
focusing in Sephadex G-75. This mouse (6L 1 1 ^  1 of Table 13) had been 
immunized by the DM protocol and found to have an unusually large response 
of 460-like idiotype positive immunoglobulins that bind DNP. Five 
regions of the gradient representing a range of 0.03 to 0.05 pH units were 
isolated from regions where intense TLD binding bands were observed in
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the analytical isoelectric focusing gels. All five fractions of eluted
material were found by Ouchterlony imraunodiffusion to be composed of
immunoglobulins of more than one heavy chain isotype; although in four
125of the five samples only one isotype bound I-TLD. This implies that
while more than one immunoglobulin is present in each fraction, in
four of the five fractions tested immunoglobulins with only one sub-
125class possessed detectable I-TLD binding activity. Using a phage 
inhibition assay (kindly performed by Dr. H. Kalasz), the inhibition 
curves seen with four of the five fractions were interpreted as being 
consistent with antibodies possessing a single DNP binding constant.
The fifth fraction produced an inhibition curve whose shape was indica­
tive of the presence of more than one DNP binding specificity. While 
these results suggest that four of the five fractions may have contained 
only one DNP binding immunoglobulin, this conclusion cannot be made 
until the immunoglobulins which comprise these bands are further charac­
terized. More than one antibody with the same subclass and antigen binding 
specificity can have the same pi (183) .
These results showing that only one Balb/c mouse of four contains
125a set of vitamin Ks inhibitable I-TLD binding antibodies can be 
interpreted in two ways: a) all mouse sera have the same immunoglobulins
in each band but the expression of each clone of immunoglobulin varies 
from mouse to mouse. Thus a band that contains both an immunoglobulin 
specific for both DNP and vitamin Ks and an immunoglobulin that binds 
only DNP will have a different Ks/TLD ratio from mouse to mouse depen­
ding on the relative expression of the two immunoglobulins; or b) the 
expression of individual clones of antibodies in inbred mice is variable 
so that different Ks/TLD ratios for bands at the same pH represents the
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125the presence of different I-TLD binding antibodies in each band
from mouse to mouse.
In order to test these hypotheses, nine sets of mice were mated,
producing a total of 43 offspring. These mice were immunized with the
DM protocol to determine if recognizable patterns of vitamin Ks inhibi- 
125table I-TLD binding bands could be seen. Such patterns in Balb/c 
mice might be indicative of a similar set of immunoglobulins from mouse 
to mouse in this highly inbred strain.
The Ks/TLD ratio of the two and seven day film exposures were 
determined for each band and the frequency of bands show Ks/TLD ratio 
was less than 0.5 was noted. Table 19 lists the average Ks/TLD ratio 
of all the mice at a particular pH and the number of mice whose Ks/TLD 
ratios were less than or equal to 0.5 at that pH. Based on these deter­
minations plotted in Figure 25, three positions of the pH gradient were
selected in which the largest group of distinguishable vitamin Ks inhi- 
125bitable I-TLD binding bands could be detected. These vitamin Ks
inhibitable bands with a Ks/TLD ratio less than 0.5 were called:
"DM 1" for bands in the region of pH 6.5 to 6.6; "DM 2" from pH 5.9
to 6.0; and "DM 3" from pH 5.7 to 5.8. Table 20 summarized the inci-
125dence of finding an I-TLD binding band in one of the three pH
regions. 53% of the mice had TLD binding bands detectable in all three
regions of the gel after 7 days incubation. The incidence of vitamin 
125Ks inhibitable I-TLD binding bands at these locations of the pH
gradient is summarized in Table 21. 77% of the mice had at least one
125vitamin Ks inhibitable I-TLD binding band in one of three pH regions 
in which "DM" bands were identified. Of the 43 mice surveyed, 9 mice had 
only the DM 2 pattern of inhibition. Six mice had both the DM 1 and DM 2
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TABLE 19
A Survey of the Vitamin Ks Inhibitable I-TLD Binding Bands 
of 43 BALB/c Mice Immunized by the "DM" Protocol3
£H
No. of mice Mean KS/TLD No. of mice % of bands
with Ks/TLD ratio of with band with KS/TLD
ratio < 0.5 all mice at this pH ratio < .05
5.30 4 0.4 4 100
.35 3 0.7 5 60
.40 1 1.5 2 50
.45 2 0.6 3 67
.50 6 0.5 8 75
.55 2 0.7 4 50
.60 6 0.7 9 67
.65 4 0.3 4 100
.70 10 0.4 12 83
.75 8 0.5 12 67
.80 13 0.4 17 76
.85 11 0.4 16: 69
.90 9 0.5 12 75
.95 14 0.4 16 88
6.00 7 0.5 12 58
.05 7 0.5 11 64
.10 13 0.5 18 72
.15 8 0.6 13 61
.20 5 0.5 9 56
.25 4 0.5 7 57
.30 5 0.6 9 56
.35 9 0.4 12 75
.40 7 0.6 17 4.1
.45 5 0.7 13 38
.50 4 0.6 15 27
.55 11 0.5 17 65
.60 2 0.8 10 20
.65 9 0.6 17 53
.70 4 1.0 15 27
.75 0 0.7 11 0
.80 3 1.1 11 27
.85 0 0.6 7 0
.90 2 0.9 8 25
.95 5 0.7 9 45
7.00 0 1.0 1 0
.05 0 0.5 3 0
.10 1 0.3 3 33
.15 1 0.7 3 33
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TABLE 19 (continued)
A Survey of the Vitamin Ks Inhibitable -*-^I-TLD Binding Bands 
of 43 BALB/c Mice Immunized by the "DM" Protocol3
No. of mice Mean KS/TLD No. of mice % of bands
pH with KS/TLD ratio of with band with KS/TLD











a Ks/TLD ratio is the ratio of the intensity of the vitamin 
inhibited gel to the non-inhibited gel as measured by the 
Joyce-Loebl Microdensitometer. All mice were 6 weeks old 
BALB/cN mice from 9 different litters.
i
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FIGURE 25
The Results Of A Survey Of 43 Balb/cN Mice For Vitamin Ks Inhibitable
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Data derived from Table 19.
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TABLE 20
1 25Number of Mice with I-TLD Binding Bands in pH Regions 
Where the "DM" Peaks Are Located3
Number of mice with bands in:
only DM1 region only DM2 region only DM3 region .
3 4 0
DM1 and DM2 regions DM1 and DM3 regions DM2 and DM3 regions
7 5 1
DM1, DM2, DM3 regions total
23 43
same mice as surveyed in Tables 19, 21, 22
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TABLE 21
Number of Mice with Vitamin Ks Inhibitable 
125i-TLD Binding Bands in the "DM" Regions3

















number gels with DM1=15 
DM2=24 
DM3=15 
DM1, DM2= 6 
DM1, DM3=10 
DM2, DM3=10
a Kg/TLD ratio _< 0.5 is scored as a Vitamin Ks inhibitable 
125j-TLD binding band. Same mice were surveyed as in 
Tables 19, 20, 22.
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patterns in their serum and another six had both the DM 2 and DM 3 
patterns. The numbers are too small to determine whether there is 
linkage between the two DM patterns.
The sera of mice having the same "DM" pattern were pooled in order 
to obtain sufficient quantity of multispecific immunoglobulins for 
characterization. Before performing quantitative separations of these 
immunoglobulins, each pool was subjected to isoelectric focusing by 
the analytical flat plate gel technique and the Ks/TLD ratio was deter­
mined for each band (Table 22). None of the pools of sera had the Ks/TLD 
ratios predicted of them. For example, the pools of sera which had 
a Ks/TLD ratio less than 0.5 for only the DM 1 bands had a Ks/TLD ratio 
less than 0.5 in the regions for both the DM 1 and DM 2 bands. This 
result calls into question the validity of classifying Balb/c mice into
groups based upon the pattern of "DM" bands present in their serum. As
125stated in Section III.A., not all I-TLD binding bands are detectable
under the conditions in which the experiments were performed. By pooling
the sera of different mice, the concentration of "non-detectable" immuno-
125globulins may have increased enough to have its I-TLD binding detecta­
ble by autoradiography. If these "non-detectable" immunoglobulins have 
the same pi as other TLD binding immunoglobulins, the ratio of Ks/TLD 
of a particular band will now be changed. Thus the classification of 
mouse serum in terms of their "DM" patterns may be an artifact of the 
immunization protocol and of the assay used to distinguish one serum 
from another.
The hypothesis that the differences in DM banding patterns were due 
to some inherited mechanism which modulated the expression of particular 
clones of mice and which was not uniformly operative in Balb/c mice was
te
fL
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TABLE 22
The KS/TLD Ratios of the "DM" Regions of Pools of Sera which were 
Scored as Having the Same Vitamin Ks Inhibitable 
125i_tld Binding Band Patterns3
Expected pattern of 
Vitamin Ks inhibitable 
125i-TLD binding bands DM1











no peak observed 
no peak observed
3 sera from same mice as in Tables 19, 20, 21; 5 pL of pooled sera 
were processed in the analytical isoelectric focusing technique 
with 125I-TLD and Vitamin Ks as desctibed in MATERIALS AND METHODS.
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tested. Eight pairs of six week old Balb/c mice were mated. Four weeks 
after the first litter was born, both breeders and litters were immunized 
by the DM protocol and bled. After the breeders were bled, they were 
mated again and the second set of offspring were challenged by the DM 
protocol. The DM patterns of both litters and offspring are summarized 
in Table 23. One breeding pair (//ll) had offspring with a "DM" pattern 
not present in the serum of its parents. Not enough mice were examined 
to come to any conclusions regarding the inheritance of the patterns.
Work is in progress to perform spectrotype analyses of the serum 
of Balb/c mice immunized sequentially with DNP-BGG and Men-Spacer-BGG.
It is expected that the early anti-menadione response of mice challenged 
this way will contain the DNP and menadione multispecific immunoglobulins 
that are selectively stimulated. These multispecific immunoglobulins 
will be screened by analytical isoelectric focusing and then characterized 
by elution from Sephadex G-75 isoelectric focusing preparations.
In conclusion to detect the preferentially stimulated clones of 
DNP and menadione double binding immunoglobulins in sera from mice that 
had been immunized with DNP-BGG and Men-BGG were subjected to the 
analytical isoelectric focusing gel technique. Since Men-BGG is not 
antigenic for an anti-menadione response, the sera from "DM" immunized 
mice is equivalent to a 40 day immune response to a single DNP-BGG 
injection. In order for this work to be interpretable, this work has 
to be repeated with Men-Spacer-BGG which is antigenic for anti-menadione 
and anti-DNP responses. Furthermore, most of the analyses were performed 
with a water soluble derivative of menadione (menadione bisulfite) that
is not bound with much affinity by menadione binding immunoglobulins.
125Despite these faults, it was found that the I-TLD binding patterns
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TABLE 23
Location of Vitamin Ks Inhibitable 125I-TLD Binding Bands
Breeding b £ B <r* Litter I Litter II
pair V* * £designation
2 ( 1 , 2 ) ( 2 ) 2 x  ( 2 ) 1 X ( 1 , 2 )
2  x ( 2 )
13 ( 2 ) ( 2 ) 1 x  ( 0 ) 1 X ( 2 )
3 ( 1 , 2 ) (0) 1 x(0)
1 x  ( 1 ) 1 X ( 1 , 2 )
10 ( 1 , 2 ) ( 1 ) 1 X ( 1 ) 1  X ( 0 )
6 ( 2 ) ( 1 ) 1 X ( 1 , 2 ) 3 x  ( 2 )
1 x  ( 2 ) 1 x  ( 0 )
1 x  ( 2 )
11 ( 1 ) ( 0 ) 1 x  ( 1 , 2 ) 1  X ( 1 ) 4 x (0) 1 x  ( 0 )
1 x  ( 0 ) 1  X (0)
12 ( 1 , 2 ) ( 1 , 2 ) 1 x  ( 1 , 2 ) 1 X ( 0 ) 2 x  (0 ) 4 x  ( 0 )
1  X ( 1 , 2 ) 1 x  ( 1 )
2 x  ( 1 , 2 )
15 ( 1 ) ( 1 , 2 ) 1 x  ( 2 ) . 1  X ( 0 ) 2 x  ( 1 , 2 ) 3 x  ( 1 , 2 )
1 x  ( 1 ) 2 x  ( 2 )
a )  ( ) —  means pattern of vitamin Ks inhibitable band.
0 —  means no Ks/TLD ratio <_ 0.5 in any "DM" region.
1> 2, 3 —  means Ks/TLD ratio £ 0.5 in DM1, DM2, or DM3 regions, respectively. 
2 x —  means 2 mice with same pattern.
in
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
of different individual Balb/c mice varied. This was partly due to con-
125centration differences of immunoglobulins in each I-TLD binding band.
125By measuring the change in I-TLD binding band intensity in gels that
were incubated with vitamin Ks, three sets of vitamin Ks inhibitable 
125I-TLD binding bands were detected. Hot all Balb/c mice contained 
all three bands, but most mouse sera had at least one of these bands.
Not enough mice were mated and surveyed for the presence of these 
double binding spectrotypes for any conclusions to be reached regarding 
a hypothesis that genetic differences may exist among the Balb/c mice 
which could account for the varied expression of immunoglobulin clonal 
products observed. One major limitation of the analytical isoelectric 
focusing technique is that immunoglobulins that are cross-linked inside 
the polyacrylamide gels cannot have their idiotypes and isotypes detected 
directly by autoradiography. Thus while the analytical isoelectric 
focusing gel technique provides a rapid screening method for the presence 
of particular antigen binding antibodies with a specific isoelectric 
point(s), other techniques are required to isolate the immunoglobulins 
for further characterization.
Below it is shown that the analytical isoelectric focusing technique 
may be used to detect RNase and DNP double binding immunoglobulins 
that are preferentially induced by the sequential immunization of RNase 
and DNP-BGG.
C. The Pattern Analysis of the Serum of Balb/c Mice Imramunized 
Sequentially with RNase and DNP-BGG
A second immunization protocol resulting in the referential induc­
tion of multispecific antibodies is the RNase - DNP system. A spectro- 
type analysis similar to that described above for mice immunized by the
JL.
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DM protocol was performed to induce antibodies that bind DNP and
RNase. Balb/c mice were sequentially immunized by RNase on day 0,
then with DNP-BGG on day 30, and bled on day 40. Analytical isoelectric
focusing in polyacrylamide gels as performed with this "RD" serum.
125 125The gels were incubated with either I-TLD or I-labeled RNase.
125While the intensities of each I-TLD binding bands varied from mouse to
mouse after a two day film exposure, the banding patterns of the different
mice resemble each other more after a 30 day incubation. Many sera did not
125 125produce detectable I-TLD or I-labeled RNase binding patterns
125at all or in parts of the pH gradient. For example in Figure 26, no I- 
TLD binding bands are found in serum #2 even after a 30 day film expo­
sure. More bands are seen in the 30 day film of #3 and #4 sera compared 
to the two day film.
For the purposes of analysis, either antigen can be iodinated and
used as the labeled probe for double binding immunoglobulins. Figure
12527a shows that non-radioactive RNase can inhibit the binding of I-TLD
in the analytical isoelectric focusing gel of RD serum. Clearly peaks
1, 2, and 3 are DNP and RNase double binding bands, while 4 through 10
are not. Similarly Figure 27b shows that DNP-caproic acid can inhibit 
125the binding of I-labeled RNase by the same RD serum after it had been
subjected to isoelectric focusing in an analytical gel. Bands 1, 2, and
-47 have their binding of RNase inhibited by 10 M DNP-caproic acid.
Work is in progress to characterize the RNase and DNP multispeci­
fic immunoglobulins in the analytical isoelectric focusing gels.
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FIGURE 26
A Comparison Of A 2 Day and 30 Day Film Exposure of "RD" Sera Subjected 
To Analytical Isoelectric Focusing
albumin/
-  6.0 -  . #
2 day fj|m  . 30 day film
exposure exposure
Analytical isoelectric focusing, gel processing, and autoradiography 
were performed as described in MATERIALS AND METHODS.
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_4 FIGURE 27
(a) 1 x 10 M DNP-caproic acid inhibition of I-RNase binding bands
in sera of "RD" immunized mice.
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DISCUSSION
The mechanisms of the expression and inheritance of immunoglobulin 
genes are still one of the great problems in immunology. The large 
number of different antibodies that bind the same antigens and which are 
simultaneously induced in an immune response precludes the use of amino 
acid sequences as a means of identifying immunoglobulin gene products in 
the sera of individual mice. The purpose of this thesis is to develop a 
series of V-region markers which may be used to detect individual immuno­
globulin gene products in serum. The identification of V-region deter­
minants in serum was established in two ways: a) an idiotypic approach
in which immunoglobulins were identified by their interactions with an 
antiserum directed against the combining region determinants of a reference 
myeloma protein that binds the same antigens as the naturally raised 
immunoglobulins; and b) a fine specificity approach in which double 
binding antibodies were induced by the sequential immunization with two 
antigens and the double binding immunoglobulins were identified by their 
isoelectric focusing patterns in polyacrylamide gels.
The anti-DNP response of mice was selected for analysis for a number 
of reasons including: a) many techniques have been developed to produce
antigens and haptens that contain the DNP moiety (41) ; b) many DNP 
binding antibodies have been demonstrated to bind more than one hapten 
(168); c) many Balb/c myeloma proteins have been shown to bind DNP (173, 
104); d) much work has been performed to analyze the cellular interactions 
required for an anti-DNP response to occur (50); and e) while much work 
(38, 47, 112, 158) has been performed to characterize the DNP binding 
properties of all the antibodies present in the anti-DNP sera, little work 
(133) has been performed to characterize the
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expression and inheritance of individual V-region gene products in this 
complex immune response. By studying the validity of using either 
the isoelectric focusing approach or the idiotypic approach to analyze 
the anti-DNP response in mice, a basis for understanding the inheritance 
of particular V-region gene products in this response was obtained.
For the idiotypic approach, the rabbit anti-idiotypic antibodies 
directed to the combining regions of proteins 315 and 460 were isolated 
and characterized. Proteins 315 and 460 are two IgA Balb/c myeloma pro­
teins that bind the haptens, DNP and menadione, and are probably two 
of the most extensively studied mouse myeloma proteins (12, 35, 39, 55,
62, 84, 155, 163, 173, 174). The anti-idiotypic antibodies directed 
to these proteins were then used as reagents for the detection of "idio- 
type positive" immunoglobulins in mice. In the fine specificity-iso­
electric focusing approach, the isoelectric focusing patterns of DNP and 
menadione (DM) and RNase and DNP (RD) double binding immunoglobulins 
were characterized. Below will be discussed the major findings of these 
studies based upon both approaches and the merits of using either approach 
to study an immune response.
A. The Idiotypic Approach
The two major thrusts of the investigations presented in this thesis 
were: a) to understand to which determinants the anti-idiotypic anti­
bodies to proteins 315 and 460 were directed and to understand how 
changes in the immunoglobulin molecules affect the detection of the 
idiotypic determinants by these antisera; and b) to use these anti- 
idiotypic reagents as markers for V-region gene products in sera. The 
idiotype of an immunoglobulin molecule is detected by its interaction 
with anti-idiotypic antibodies. Idiotypic determinants are most probably
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those residues exposed to the surface of an immunoglobulin. The expre­
ssion of idiotypic determinants is therefore both a function of the 
primary sequence and tertiary structure of the V-region of an immuno­
globulin.
Anti-idiotypic sera are like most antisera in being composed of many 
different antibodies that recognize various determinants of the reference 
proteins to which the antisera were made. To limit the heterogeneity 
of the population of anti-idiotypic antibodies used in these studies, the 
hapten elution method of Claflin and Davie (23, 25) was employed. This 
enabled the isolation of combining region complementary anti-idiotypic 
antibodies to proteins 315 and 460. Both reference myeloma proteins 
315 and 460 bind DNP and menadione. Compared to the amount of combining 
region complementary anti-idiotypic antibodies eluted by vitamin Ks 
and DNP-glycine, an equivalent concentration of t-boc-glycine eluted 
negligible amounts of anti-idiotypic antibodies. This shows that the 
anti-idiotypic antibodies eluted with specific haptens compete with 
the hapten for binding to the combining region.
Anti-315 and anti-460 idiotypic antibodies purified by the hapten 
elution method have the following properties: a) they do not compete
with anti-a serum for the reference myeloma proteins 315 (a, X) and 460 
(a, k); also, b) they do not bind to other myeloma proteins, even with 
the same H and L chain isotypes as the reference proteins (Figures 4 and 
5). The strongest evidence that these antibodies are indeed directed 
against the V-regions of the reference proteins is the demonstration 
that hapten could inhibit the antibodies binding to the reference mye­
loma proteins. Additional evidence of the antibodies/idiotypic speci­
ficity is that of the six DNP binding myeloma proteins surveyed (315,
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460, S23, J604, XRPC25, 195), only three interacted with the hapten 
eluted antisera (315, 360, S23).
It should be emphasized that only twelve myeloma proteins* were 
surveyed in this thesis. This represents a very small sample of the 
known myeloma proteins. It is not known if hundreds of myeloma proteins 
are surveyed whether "idiotype" positive proteins will be found that do 
not have the same antigen speicificity as proteins 315 and 460. How­
ever, evidence has been presented that the antisera to proteins 315 and 
460 can also bind to immunoglobulins in Balb/c sera that bind both DNP' 
and menadione, the same antigen that the reference proteins do. Further­
more, both DNP and menadione containing antigens are able to induce these 
"idiotype positive" immunoglobulins. Like proteins 315 and 460, the idio­
type positive immunoglobulins require at least a 22 A spacer between the 
carrier and the menadione moiety before the antigen can induce idio­
type positive immunoglobulins (Table 14) and before the antigen can be 
bound by these idiotype positive immunoglobulins (Tables 16, 17).
In addition, it has been found that the vitamin Ks eluted anti- 
idiotypic antibodies from a protein 315-Sepfearose column are a subset of 
those anti-idiotypic antobidies that DNP-glycine elutes. The yield 
of vitamin Ks eluted antibodies is half that of DNP-glycine eluted 
antibodies. Furthermore, while DNP-glycine can elute immunoglobulin 
from a column previously treated with vitamin Ks, vitamin Ks is unable 
to elute antibodies from a column previously treated with DNP-glycine 
(Table 8). Both haptens are bound by protein 315 with the same affi­
nity (145). The anti-idiotypic antibodies which are eluted by DNP-gly­
cine have their binding to protein 315 inhibited by both DNP-glycine and
* Proteins 315, 460, S23, 603, XRPC25, UPC10, T15, S194, 104c, 195, 
FL0PC21, J604.
O
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vitamin Ks (Table 9). Similarly, the vitamin Ks eluted anti-idiotypic 
antibodies have their binding to protein 315 inhibited by either hapten. 
Rosenstein and Richards (145) have demonstrated that DNP and menadione 
moieties are bound at spatially separated sites of the combining region
of protein 315. The naphthoquinone rin^ is bound about 10 A "deeper" 
from the surface of the molecule than DNP. The haptens probably inhibit 
the binding of anti-idiotypic antobidies by: a) causing a change in the 
V-region so that certain amino acid residues are no longer exposed to 
the anti-idiotypic antibodies; or b) by competing with the hapten for 
"site" specific residues. No anti-idiotypic antibodies were eluted by 
vitamin Ks from a column previously treated with DNP-glycine (Table 8).
This demonstrates that negligible anti-idiotypic antibodies to protein 
315 recognize parts of the combining region for vitamin Ks, exclusive 
of those parts involved with DNP-glycine binding. Since the amino acid 
residues to which the anti-idiotypic antibodies are directed are not 
yet known, the reason why vitamin Ks elutes a subset of the anti-idio­
typic antibodies that DNP-glycine elutes remains speculative.
As in other antigen-antibody systems, notably the p-azophenylarso- 
nate (ARS) (99, 167), £(2-*l) levan (110, 173), and a(l->3) dextran (60,
61, 170, 173) idiotypic systems, the anti-idiotypic antibodies to pro­
teins 315 and 460 could be classified into public and private anti-idio­
typic specificities. In this thesis, this classification was based on 
a survey of only twelve myeloma proteins. The "public" anti-idiotypic 
antibodies to proteins 315 and 460 produced identical inhibition curves 
with proteins 460, S23, and 315, and with a sub-population of DNP 
binding antibodies from any mouse strain tested (Figures 5, 11). Further­
more, by chain recombination experiments between the public idiotype
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positive protein 315 and the public idiotype negative protein 603, the
residues which constitute the idiotypic determinants were shown to
reside only on the H chain of immunoglobulins (Table 10). While there
is an absolute requirement of a L chain for the expression of the public
idiotype, the type of L chain (from proteins 603 or 315) did not affect
this expression. The fact that proteins 315 (a, X), 460 (a, k), and
S23 (a, k), which contain completely different L chains (Table 24),
gave identical inhibition curves in a RIA that measured the binding of 
125I-Fab of 315 or 460 to the public anti-idiotypic antibodies also 
shows that the L chain does not affect the expression of the H chain- 
related public determinants (Figure 5).
The public idiotype positive 315U-603T chain recombinants did notn. L
bind hapten. Here, the expression of the public idiotype was not 
dependent upon a functionally intact combining region for DNP.
Table 24 is a comparison of the H and L chain N-terminal sequences 
of proteins 460, 315, and S23. The L chains of the three myeloma pro­
teins are markedly different in sequence. The H chains of these pro­
teins, however, are very similar and are members of the V subgroupHI
(88). The H chain sequences for proteins S23 and 460 are identical for 
at least the first 20 amino acid residues. (The H chains of proteins 
S23 and 460 have only the first 20 and 40 N-terminal amino acids 
sequenced, respectively). The sequence of the H chain of protein 315 
differs from proteins 460 and S23 by only 4 amino acid residues within 
the first 20 amino acids. Proteins 315 and 460 differ by an addi­
tional 6 amino acid residues within the next 20 amino acid sequences. 
Based on these sequence similarities in the first 20 N-terminal amino 
acids of these three myeloma proteins, it is not surprising that these
f\;;V
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TABLE 24
A Comparison of the Amino Acid Sequences 
of Proteins S23, 460, and 315.
1
Heavy Chain:
2 3 4 5 6 7 8 9 10 11 12 13 14 15
315 asp val gin leu gin glu ser giy pro giy leu val lys pro ser
460 glu val gin leu gin glu ser giy pro ser leu val lys pro ser
S23 glu val gin leu gin glu ser giy pro ser leu val lys pro ser
Light Chain:
315 pea ala val val thr glu glu ser ala leu thr thr ser pro
460 asp val val met thr gin thr pro leu ser leu thr val ser pro
S23 asp ile val leu thr gin ser pro ala thr leu ser val thr pro
16 17 18 19 20 21 22 23 24 25 26 27 27A 27B 27C
Heavy Chain:
315 gin ser leu ser leu thr cys ser val thr giy tyr
460 thr leu ser leu giy ser
S23 gin thr leu ser leu
Light Chain:
315 giy giy thr leu thr cys arg ser ser thr
460 giy asp ala ser ile ser cys arg ser ser gin leu val
S23 giy asp ser val ser leu ser cys
27D 27E 27F 28 29 30 31 32 33 34 35 36 37 38
Heavy Chain:
315 ser ile thr ser giy tyr Phe tr£ asn trp
460 asx ile thr asn giy tyr met asx trp
Light Chain:
315 giy ala val thr thr ser asn tyr ala asn trp ile glx glx
460 ser thr asx giy asx tyr leu his trp tyr leu glx
Sequences were obtained from Kabat et AL (88). The residues underlined 
are those which differ from the sequences in the other myeloma proteins1 
chains.
*
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proteins share common antigenic determinants. However, the hard 
conclusion that the first 20 amino acid residues contribute the deter­
minants that the public anti-idiotypic antibodies recognizes must await 
further data.
The public anti-idiotypic antibodies were also used as V-region 
markers in the study of the expression and inheritance of mouse immuno­
globulins that were bound by these antibodies. Inbred strains of mice 
were employed because each individual of a strain has the same genetic 
composition. The different traits among the various strains were deri­
ved by segregation from a common gene pool over many generations. Thus 
differences in expression of immunoglobulin gene products between two 
individuals of different strains could reflect genetic differences in 
structural or regulatory genes. The public idiotypic determinants are 
present in all inbred strains tested including strains that are separated 
from a common ancestor by at least a hundred generations (Table 12).
This implies either that a common V-region with this public idiotypic 
marker is maintained in these strains or that more than one V-region 
structure in DNP binding antibodies gives an identical interaction with 
the public anti-idiotypic antibodies. While it was shown that some 
natural DNP binding antibodies have the public idiotype, it is not 
known whether all public idiotype positive immunoglobulins bind DNP.
Even though the public idiotype can be found in all mouse strains, 
individual strains do not produce after immunization the same concentra­
tion of immunoglobulins that have the public idiotype (Table 12). Further­
more, this determinant can be found only in mouse sera. The public 
idiotypic determinants are not detected in rabbit and guinea pig anti- 
DNP sera. This suggests that in all strains of mice tested some of the
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DNP binding immunoglobulins are part of a family of related V-region 
structures that are different from that of rabbit and guinea pig DNP 
binding immunoglobulins. These results are very similar to those of 
Claflin and Davie (22, 23, 24) who developed an anti-idiotypic serum 
to the phosphorylcholine binding mouse myeloma protein HOPC 8. Their 
antiserum bound to anti-phosphorylcholine antibodies from other rodents.
In addition to antibodies with public anti-idiotypic specificities, 
antibodies directed to private idiotypic determinants of proteins 315 
and 460 were isolated. Public and idiotypic determinants can be found 
on many immunoglobulins with the same antigenic specificities, while 
private idiotypic determinants are found only on a few or just one 
immunoglobulin. In most studies including this one, the number of 
myeloma proteins tested was limited. As discussed in the INTRODUCTION, 
the induction of tumors is not a random process. Thus the scoring of a 
determinant as "private" or "public" is a reflection of the skewed popu­
lation of hapten binding myeloma proteins surveyed by the anti-idiotypic 
serum. This classification into private and public idiotypic determinants, 
however, may have some validity since in the case of the f3(2-KL) levan 
(110), ct(l->-3) dextran (136), ARS (167), and DNP idiotypic systems, more 
immunoglobulins bear public than private idiotypic markers in an immune 
response.
What is implied when two immunoglobulins that bind the same antigens 
are determined not to share the same private idiotypic determinants? The 
expression of idiotypic determinants is dependent upon the presence of 
certain residues on the surface of the immunoglobulin. This is a func­
tion of both amino acid sequence and tertiary structure. A protein may 
contain the primary structure for an idiotypic determinant, but lack
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
19 1
the appropriate conformation for its expression. In this study, both 
the private 315 and private 460 idiotypic markers were shown to be 
located on the H chain, but their expression was found to be modulated 
by the L chain. Protein S23 is an example of this point. The L chain 
of this immunoglobulin has a completely different sequence from the L 
chain of protein 460. The H chain sequence of both immunoglobulins 
are identical for at least the first 20 amino acid residues. Native 
protein S23 does not interact with the private 460 anti-idiotypic anti­
bodies. The H chain of S23 in combination with the 460 L chain does 
interact with the private 460 anti-idiotypic antibodies in an identical 
manner to that of native protein 460 (Figure 9). Furthermore, the L 
chain of S23 can alter the expression of the private 460 idiotypic deter­
minants in the 460„-315 chain recombinant (Figure 9). It is therefore
ri L
clear that the absence or alteration of an interaction of a given immuno­
globulin with the private 460 or pirvate 315 anti-idiotypic antibodies 
does not rule out the presence of the amino acid sequences responsible 
for those determinants recognized by these antibodies. Since the public 
idiotypic determinants are not dependent on the type of L chain for 
their expression (Table 10, Figure 5), the absence of an interaction 
with the public anti-idiotypic antibodies implies that the heavy chain 
structure required for that idiotype is not present.
The two techniques commonly employed to measure idiotypic deter­
minants are RIAs and hemagglutination inhibition assays. The RIA con­
veys three essential pieces of information about the nature of the 
interaction between the antigen and the antibody: a) the shape of the
inhibition curve is a test of the antigenic identity of two antigens; 
b) the position of the curve (50% inhibition point) is a measure of the
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quantity of antigen present; and c) the extent of inhibition seen with 
a competitive antigen is a measure of the amount of antibodies that 
recognize common determinants between the radioactively labeled anti­
gen and the competitive antigen. These studies demonstrated the impor­
tance of using a RIA to measure antibody-anti-idiotypic antibody inter­
actions. If only a hemagglutination inhibition assay is used, no informa­
tion about the qualitative nature of the interactions between the anti- 
idiotypic antibodies and the recombinant molecules can be determined.
For example, by using the private 460 anti-idiotypic antibodies in a
hemagglutination inhibition assay, the titer of the 460-315 chain
ri L
recombinant molecule would be four times lower than that of an equi- 
molar solution of native protein 460 and of the homologous chain recom­
binant of protein 460. These lower titers would then be attributed 
either: a) to the "denaturation" of the combining region during the
process of chain recombination so that less "intact" V-regions are 
present that are bound by the anti-idiotypic antibodies; or b) to the 
formation of new combining region structures that interact differently 
with the anti-idiotypic antibodies than the combining region determinants 
of the native proteins do with the anti-idiotypic antibodies. By RIA, 
it is observed that the shapes of the inhibition curves are different
between native protein 460 and the chain recombinant, 460„-315T . Thus
ri L
the latter possibility (b) is the most likely explanation. If a percentage 
of the reconstituted 7S molecules were denatured and no new "idiotype 
positive" structures are formed (possibility "a"), the shape of the 
inhibition curves would be identical to that of the native protein but 
the curve should be displaced to higher concentrations. This in fact 
was observed with the solutions of the DNP-affinity labeled preparations 
of proteins 315 and 460 (page97).
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Manjula et al. (119) assayed the chain recombinants of the B(l->6) 
galactan binding mouse myeloma proteins for their ability to bind hap­
ten and to interact with anti-idiotypic sera. A hemagglutination 
inhibition assay was employed to test the chain recombinants for idio­
type. Most of the chain recombinants were shown to be bound by the 
antiserum. Because a hemagglutination inhibition assay only detects 
the binding of antigen by antibody, nothing can be concluded about 
the nature of the binding detected in this study. From this study it 
is not known how antigenically similar the idiotypic determinants of 
the V-regions of the recombinant immunoglobulins are to the original 
molecules, even though the recombinants still bind hapten. In Figure
9, the 460U-315T chain recombinant is shown to be antigenically different 
n  L
from the 460„-460T chain recombinant, even though both still bindri L
DNP-glycine (Table 11).
Huser jet al. (70) employed a RIA to determine whether chain recom­
binants of various rabbit anti-pneumococcal antibodies retained their 
idiotypic determinants. In this case, the recombinant molecules either 
have an identically shaped inhibition curve or they were not bound by 
the antiserum. By employing a RIA, Carson and Weigert (19) were able 
to conclude that a(1-K3) dextran binding mouse myeloma proteins, J558 
and M104e were antigenically dissimilar, but they were bound by the 
same anti-idiotypic antibodies.
In an earlier study, Bridges and Little (11) observed that the 
homologous chain recombinants of protein 315 and 460 retained their
affinity for DNP-lysine. They showed that the 460„-315T recombinant
ri L
has an affinity for DNP-lysine about the same as the native protein, 
but the 315-460, recombinant has a binding constant for DNP-lysine
ri L
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at least two orders of magnitude lower than native protein 315. Results 
obtained by equilibrium dialysis to calculate the binding constant and 
number of sites per molecule for the protein 315-460 chain recombinants 
presented in this thesis agree with that of Bridges and Little (11) 
except that the binding constant of the 460„-315T recombinant was one-
ri L
tenth their value. The reason is not clear for this difference in 
binding constants between these two studies. No example could be 
found of an immunoglobulin molecule that possesses the private 315 or 
private 460 idiotypic marker, but lacked a functionally intact combining 
region.
Having developed two sets of private anti-idiotypic antibodies, 
they were then used to survey inbred mouse strains for the presence of 
immunoglobulins possessing V-regions that are marked by these antibodies 
The results of this survey must be interpreted in light of the effect 
of the L chain on the expression of these private 460 and private 315 
idiotypic markers. No mouse strain tested produced immunoglobulins 
that were bound by the private 315 anti-idiotypic serum. This lack of 
interaction may be due to: a) the absence of the structural genes for
the idiotype positive V-regions; b) the immunization protocols were 
unable to induce these idiotype positive V-regions; or c) the masking 
of these idiotype positive residues by the presence of the "wrong" L 
chain as in the 46CL-S23, chain recombinant (Figure 9). A series ofri L
experiments are in progress to rule out the third possibility (c) by 
making H and L chain recombinants between mouse immunoglobulins and 
protein 315. Conceivably, a recombinant molecule between the H chain 
of mouse immunoglobulins and the \ chain of protein 315 may possess the 
private 315 idiotype. This result would then be analogous to the find­
ing of Jack jjlt al. (77) that SJL (Ig-1^) mice lack the heteroclitic anti
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IdNP response which other mice with the Ig-1 allotype can make. This is 
so because SJL mice may not contain the genetic information for the X 
chain needed for these antibodies. The FI offspring of an SJL and Balb/c 
(Ig-l ) mating are able to make the heteroclitic anti-NP antibodies. 
Presumably the Balb/c parent provides the information for the X chain 
and the SJL parent provides the information for the H chain of the 
heteroclitic anti-NP response. In this thesis an analogous experiment with 
anti-DNP serum from the offspring of a C57BL x Balb/c mating were tested 
for the presence of the private 315 idiotype. No serum from the off­
spring was found to contain this private 315 marker. Thus the private 
315 idiotypic determinants on the H chain were either not expressed in 
these mice or they were masked by the L chain. The chain recombination 
experiments described above should rule out one of these possibilities.
In contrast to the results obtained with the private 315 idiotype, 
all strains of mice tested produce some immunoglobulins in their anti- 
DNP response that are bound by the private anti-460 idiotypic serum.
Such immunoglobulins were mostly of the yl, p, and a isotypes, although 
some immunoglobulins with the y2a and the y2b isotypes could be detected 
(Figure 12). The shapes of the inhibition curves obtained by RIA, how­
ever, distinguished the 460-like immunoglobulins of mice into two 
groups: a) those immunoglobulins from strains that possess the Balb/c H
chain immunoglobulin genes (the Ig-1 locus); and b) immunoglobulins 
from strains that have all other H chain loci (except BAB 14 which 
possesses part of the genome for the V-regions of the H chains of Balb/c 
mice). It is clear from Figure 13 that immunoglobulins from Ig-la+ posi­
tive mice in RIAs that measure the private. 460 idiotypes produce better 
inhibition than immunoglobulins from other mice. The shape of the
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cirHinhibition curve of immunoglobulins from these Ig-1 positive strains
is not identical to that of protein 460 and it resembles that of the
460„-315t chain recombinant (Figure 9). The reason for this is consis- H L
tent with two possibilities: a) in mice the "wrong" light chain is
paired with the "right" heavy chain containing the amino acid sequences 
both which are identical to part of protein 460 and which the anti-idio- 
typic serum recognizes; or b) different idiotypic determinants in the H 
and L chains of the mouse immunoglobulins are present compared to protein 
460. In the initial studies presented in this thesis, by testing the 
anti-DNP sera from recombinant inbred strains (Table 12) and from the 
offspring of the FI and F2 matings of the C57BL and Balb/c mice for the
ct’t’private 460-like idiotypic determinants (Figure 14), this Ig-1 linked
idiotype appears to be inherited as an autosomal dominant trait. More
ct*i"matings between Ig-1 positive and negative strains are being performed 
to confirm this finding.
The results clearly show that the 460-like immunoglobulins from the
3ri~Ig-1 positive strains differ from those of the non-Ig-1 strains.
The simplest explanation for this is that the V-region sequences of the 
H chains are different. The apparent linkage of the 460-like inhibi­
tion curves to an H chain allotypic marker supports this explanation; 
however, it is also possible that differences in the L chains modify the 
expression of the same idiotype determining residues of the H chain 
of the immunoglobulins of different strains. As summarized in Tables 
3, 4, and 5, other V-region markers have been shown to be linked to the 
I H.chain allotypic loci of mice. Work is in progress to perform chain
recombination experiments between protein 460 DNP binding immunoglobu- 
lins from non-Ig-1 mice to determine whether 460-like H chain deter-
b
JL̂
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ainants were not detected because of the absence of the "right" L chain.
In Balb/c mice, the majority of immunoglobulins with the 460-like 
Idiotypes bind DNP and menadione, but not all of these immunoglobulins 
possess both the public and private 460-like determinants. The data 
presented in this thesis show: a) a difference in the kinetics of
induction of the public and private idiotypic markers in the sera of 
mice immunized with DNP; b) a difference in the H chain isotype distri­
bution of immunoglobulins with the public idiotype (mostly yl, a, y with 
a minor fraction that is y2a and y2b) and with the private idiotype 
(mostly yl, y2a, y and a minor fraction that is a); and c) the isola­
tion by preparative isoelectric focusing (Figure 16) of two DNP and mena­
dione binding Balb/c immunoglobulins; an IgA, which contains both public 
and private 460 idiotypes, and an IgGI, which contains only the private 
460 idiotypes. The immunoglobulin A resembles myeloma protein 460 by
having an identical isoelectric focusing point and by being able to be 
3labeled by H-DNP-azide. DNP-azide has been demonstrated to react with 
two tyrosine residues of the V-region of the H chain of protein 460 as 
well as with an unidentified residue of the L chain (184). Since the 
residues that determine the public and private 460-like idiotypic markers 
are not known, it is not yet clear if the ability to be affinity labeled 
by DNP-azide is related to the residues that are recognized by these 
anti-idiotypic antibodies. Work is in progress to further characterize 
these yl and a chain containing idiotype positive immunoglobulins.
Having shown that the anti-idiotypic reagents may be used to study 
the expression of V-region gene products in sera, these antibodies were 
then employed to detect the public idiotypic determinants on the surface 
of splenic lymphocytes. This was done in an effort to link the expres-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
sion of specific V-regions in serum with the cellular processes involved 
with immunoglobulin production. As shown in Table 18, 1.5%. of normal 
splenic lymphocytes from unimmunized mice (12 week old) possess 
public 460-like idiotypic markers on their surface. After the sequential 
injection with DNP-BGG and Men-BGG by the "DM" protocol, the,number of 
idiotype positive lymphocytes increases to 17%. The results presented 
In Table 18 also show that Fc-receptors are not playing a role in the 
fluorescent staining of the splenic lymphocytes. The fact that the 
number of the idiotype positive lymphocytes increases with DNP-BGG 
immunization implies that the idiotype positive cell surface markers 
reflect a change in the lymphocyte composition of the spleen in response 
to antigenic challenge. The idiotype positive surface markers were not 
isolated and the marker’s antigen binding activity was not determined 
in this experiment. It is conceivable that proteins other than the V- 
•regions of immunoglobulins may contain structures that may be bound by 
the-public anti-idiotypic antibodies. This is not likely in this experi­
ment for two reasons: a) the public anti-idiotypic antibodies have
already been shown to recognize DNP and menadione binding immunoglobu­
lins in the serum of these immunized mice; and b) it is unlikely that 
-lymphocytes which possess non-DNP combining region determinants and 
which are also "idiotype positive" are stimulated by the DNP-BGG 
-immunization. - - . .
- r xhe fractionation of splenic lymphocytes into enriched T and B 
cell subsets by nylon wool adherence (85) (Table 18) failed to demon­
strate public idiotypic determinants on the surface of the enriched T 
cell fraction (the non-adherent fraction). This result, however, does 
not rule out the possibilities that: a) the density of idiotype posi-
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tive immunoglobulins on the T cell surface is so low that they cannot 
be detected (for example, the la antigens cannot be detected by fluo­
rescent labeling (161)); and/or b) some T cells are adherent to the 
column and that these T cells include those with idiotypic determinants 
on their surface. It was determined that the nylon wool column enriched 
the B cell fraction by 48% (from 48 to 71%, Table 18), yet the column 
enriched the percentage of public idiotype bearing lymphocytes by 88%
(from 17 to 32%). This difference suggests that a fraction of the nylon 
wool adherent idiotype positive cells may in fact be T cells.
In conclusion, the idiotypic approach has been successful in purifying 
three reagents (the private anti-315, the private anti-460, and the 
public anti-315 and 460 idiotypic sera) that are complementary to the 
combining regions of DNP and menadione binding immunoglobulins. The 
reagents were able to be used as probes to characterize sub-populations 
of..DNP and menadione binding antibodies in an immune response. No mouse 
serum has been found that interacts with the private 315 anti-idiotypic 
antibodies. The public 315 and 460 anti-idiotypic antibodies were 
shown to be species specific, i.e., all mouse strains contained DNP 
binding immunoglobulins that have the public idiotype. While all strains 
contain immunoglobulins that are bound by the private 460 anti-idiotypic 
antibodies, one private 460-like idiotypic determinant for the H chain 
of DNP binding immunoglobulins is linked to the Ig-1 H chain allo­
typic, locus. This determinant(s) appears to be inherited as an autoso­
mal dominant trait. These reagents can also be employed to study lympho­
cyte.surface markers. - .
Like most serological techniques the value of the idiotypic approach 
is dependent upon how well defined the specificity of the anti-idiotypic
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reagents are. Before antibodies may be used as probes for the unequi­
vocal identification of an antigenic determinant(s), it must be estab­
lished to what determinant(s) on the reference protein the antibodies 
bind and whether the antibodies bind to determinants not found on the 
reference protein. In this thesis, the chains which contain the amino 
acid residues to which the anti-idiotypic antibodies are directed were 
determined. The actual sequences were not determined. The results of 
the chain recombination experiments emphasize the importance of the RIA 
in the detection of the antigenic identity between two "antigenic" pro­
teins. Like most immunoassays, the RIA measures the ability of the anti­
bodies to bind to the antigens, but unlike most other assays the RIA 
reveals the shape of the inhibition curve which provides a sensitive 
indication of the antigenic identity between two proteins that are 
bound by the same antibodies. The results of the RIAs of the chain 
recombination experiments demonstrates that the residues on the H chain 
that are recognized by anti-idiotypic antibodies may not be "expressed" 
if the chain is associated with the "wrong" chain. Thus the absence of 
a serological marker for the V-region of an immunoglobulin does not 
imply that the particular V-region sequences are not present. After 
having separated the anti-idiotypic antibodies into groups based on their 
specificity (public and private) and after characterizing the specifici­
ties of these antibodies, RIAs using these reagents were shown to be very 
sensitive, highly specific, as well as, relatively easy to perform and 
interpret.
The work presented in this thesis with the DNP binding myeloma 
proteins helps to lay a foundation for future work with anti-idiotypic 
antibodies to other antigen binding myeloma proteins and homogeneous
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antibodies a) by emphasizing the importance of the RIA in the interpre­
tation of the quality of interaction between antibody and antigen; and 
b) by demonstrating the effect of one immunoglobulin chain on the anti­
genic expression of determinants on the other immunoglobulin chain. As 
demonstrated in this thesis, more than one immunoglobulin in a given serum 
may contain idiotype positive determinants in their V-regions. This means 
that other techniques (such as isoelectric focusing) must be used to 
characterize the proteins that are bound by the anti-idiotypic reagents.
Below are discussed the results and implications of the approach to 
characterize DNP binding antibodies by isoelectric focusing and fine 
antigen specificity analysis.
B. The Fine Specificity and Spectrotype Analysis Approach
The antigenic specificity of an antibody is a function of the 
structure of the combining region of the immunoglobulin. The isoelectric 
point of an immunoglobulin is a function of the charge of the amino acid 
residues exposed to the surface of the entire molecule. These two pro­
perties of an immunoglobulin are not related to each other. Thus a 
technique that identifies both the isoelectric point and antigen speci­
ficity of immunoglobulins should reduce the number of different anti­
bodies in a complex immune response which have these properties. In this 
thesis, a foundation was layed for future investigations of double binding 
immunoglobulins by their isoelectric focusing patterns in polyacrylamide 
gels.
Most of the work described on the isoelectric focusing patterns of
multispecific immunoglobulins was performed before the results of the
idiotypic approach had been obtained and before Rosenstein and Richards
0
(145) had determined that a 22 A spacer between a solid support and mena-
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dione was required by proteins 315 and 460 for the binding of this 
haptenic moiety. Only later was it found out that despite the large 
number of DNP binding antibodies that mice can make, most DNP and menadione 
binding immunoglobulins have spatial requirements for the menadione moiety 
similar to proteins 315 and 460. This was determined by their ability 
to precipitate only menadione containing antigens that have at least a
O
22 A spacer and by their binding only to menadione-Sepharose columns
O
with at least a 22 A spacer (Table 16). Thus as explained in the RESULTS 
section (III.B.), the "wrong" antigen (Men-BGG) was employed to induce 
menadione binding antibodies. Furthermore, the "wrong" hapten (menadione 
bisulfite) was employed to detect DNP and menadione double binding anti­
bodies. Menadione bisulfite was initially employed because of its high 
solubility in aqueous buffer. Only after hundreds of sera from "DM" 
immunized mice had been analyzed had it been determined that vitamin Ks, 
another highly soluble form of menadione, was a better hapten for the 
detection of menadione binding immunoglobulins. Thus most of the data 
presented on the DNP-BGG and Men-BGG double immunized mice must be viewed 
as preliminary. Only the data from the vitamin Ks inhibited gels are 
presented in this thesis. Work is in progress to study the isoelectric 
focusing patterns of the DNP and menadione binding immunoglobulins by 
sequentially immunizing mice with the antigens, DNP-BGG and Men-Spacer-
BGG, and by detecting these double binding immunoglobulins by the vitamin 
125Ks inhibition of I-TLD binding bands in isoelectric focusing poly­
acrylamide gels.
Two different immunization protocols were employed to preferentially 
induce double binding immunoglobulins in the early immune response: the
"DM" protocol which consisted of the sequential injection of DNP-BGG and
if'"
t
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Men-BGG; and the "RD" protocol that involved the sequential injection of 
RNase and DNP-BGG. Previous studies by Varga et al. (168) and by Czaja 
et (20) have shown that significant amounts of double binding antibodies 
could be raised by these protocols.
One fascinating finding of the isoelectric focusing pattern analysis 
of sera from "DM" and "RD" immunized Balb/c mice was that the individual 
mice of the same inbred strain produced different isoelectric focusing 
banding patterns. While it has long been known that not all mice from 
highly inbred strains respond identically when antigenically challenged, 
this result is still surprising. Members of the same inbred strain of 
mice should be genetically homogeneous. Each strain was derived after 
many brother - sister matings. Theoretically immune responses of all the 
Balb/c mice should be identical if they were all identically immunized.
Thus the differences of the antibody isoelectric focusing bands observed 
among the different Balb/c mice might be due to: a) environmental factors
not controlled for by the experiment (e.g. hormonal levels of the mice, 
viral infections); b) heterogeneity in the population of the individual 
mice for the genes that code for the immunoglobulin molecules or that 
code for regulatory factors that affect the expression of individual 
immunoglobulin genes; and/or c) "maternal suppression" (91), the ability 
of a pregnant female to suppress the expression of particular clones 
of antibodies in her offspring.
While all the Balb/c mice were immunized by the same batches of 
antigens under the same conditions, it is possible that some non-control- 
led environmental factors affected the expression of specific immuno­
globulin gene products. One such factor was recently identified by 
Dowsett e£ al. (173) who found that the IgGl and IgG2a concentrations in
ty
\!'P'
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female BAB 14 mice decrease during pregnancy. This decrease is only 
found in the BAB 14 strain and is not found in adult male BAB 14 mice 
made pseudopregnant. It is quite possible that other physiological 
states in Balb/c mice affect the antigen responsiveness.
While environmental factors most likely determine the variation of 
antigen responsiveness observed among highly inbred mice, another possible 
source of variation is suggested by the provocative paper of Yamazaki 
et al. (182). These workers demonstrated that male mice preferentially 
mate with female mice that have a different H-2 locus. Apparently the 
male mice are able to smell differences among females with different H-2 
loci and the males tend to prefer the females with a non-identical H-2 
locus linked odor. According to this paper, since mice do not mate "at 
random", but by odor preferentially endeavor to maintain a heterogeneous 
composition of the genome of their offspring for certain loci (e.g. the 
H-2 loci), it is quite possible that even after multiple generations of 
inbreeding some genetic loci are still not homogeneous among the popu­
lation of highly inbred mice. The inbred mice were selected by criteria 
that isolated mice with homogeneous loci in the major H-2 region; there­
fore, it is doubtful that these highly inbred strains are heterogeneous 
for this locus. On the other hand, it is theoretically possible that 
other non-H2 linked loci may be related to the factors involved with 
mating preferences and also may be closely linked to genes that modulate 
the immune response of mice (e.g. minor histocompatibility loci). A 
heterogeneous distribution of "minor" loci among individuals of highly 
inbred strains could therefore also account for the differences in
immune responses observed. Thus environmental and genetic determinants
125 125could be factors for the heterogeneous I—TLD and I-RNase binding
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patterns observed in Balb/c mice.
Another possible source of variation of antigenic responsiveness 
in inbred mice was suggested by Kindred and Roelants (91) who showed 
that female mice immunized with TNP-BGG and DNP-BGG can suppress the anti- 
DNP immune response of their offspring. This suppression does not affect 
all DNP binding immunoglobulins, but most DNP binding antibodies. The 
offspring's DNP binding isoelectric focusing patterns are highly restricted 
and differ from one another. "Maternal suppression" might therefore be 
a source of the variable antigenic responsiveness observed among indivi­
duals of the same inbred strain. In some early experiments with the "RD"
125protocol, it was observed that the I-TLD binding patterns after iso­
electric focusing of sera from certain offspring were greatly suppressed 
compared to the parental patterns. Later it was realized that these "non­
responder" mice were the offspring of parents who had been previously 
immunized by the "RD" protocol, suggesting that in this case "maternal 
suppression may be operating. Subsequently, all matings were performed 
with unimmunized mice to avoid the "maternal suppressive" effect on the 
offspring.
Another source of isoelectric focusing banding pattern differences 
observed among the Balb/c mice is inherent to the analytical isoelectric 
focusing technique employed to detect double binding immunoglobulins.
As explained in Appendix 2 and shown in Figures 21, 22, and 23, not all 
hapten binding immunoglobulins are detectable under the conditions in 
which the gels were processed and autoradiographed. The inability to 
detect a band can be due to: a) insufficient quantity of immunoglobulins
present in the band; b) insufficiently high enough affinity of the immuno­
globulins for the labeled hapten; and/or c) insufficiently high enough
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specific activity of the labeled hapten. Thus variations in the banding 
125 125patterns of I-TLD and I-RNase binding immunoglobulins of indivi­
duals of the same strain may in large part be due to concentration dif­
ferences of the same immunoglobulins among the various mice. These 
points have already been discussed in section II.A. and II.B. of the 
RESULTS. The take home lesson is that the analytical isoelectric 
focusing method cannot detect all immunoglobulins present and, therefore, 
cannot rule out the presence of particular immunoglobulins in a given 
serum sample. Thus the usefulness of the analytical isoelectric focusing 
pattern method is that of being a quick screening method for the presence 
of immunoglobulins whose properties must be examined by other techniques.
Keck et al. (90) and Kreth and Williamson (98) were the first to 
utilize this analytical isoelectric focusing technique for the detection 
of individual antigen binding immunoglobulins. Varga e£ al. (168) adapted 
this technique for detecting DNP and RNase binding immunoglobulins. These 
workers did not demonstrate that the immunoglobulins whose double binding 
specificity was detectable in the polyacrylamide gels actually represented 
the binding activity of these immunoglobulins in solution. B.N. Manjula 
at Yale (pers. comm.) was able to show that proteins 315 and 460’s 
affinities for DNP-lysine are unaffected by being cross-linked in the 
polyacrylamide gel. In this thesis, it was shown that, after iso­
electric focusing and cross-linkage in the gel, the affinity of the
monomeric protein 315 for vitamin Ks is not affected (Figure 19). Thus
125the detection of vitamin Ks-inhibitable I-TLD binding bands, of RNase- 
125inhibitable I-TLD binding bands, and of DNP-caproic acid-inhibitable 
125I-RNase binding bands are not artifacts. Since bands may contain more 
than one immunoglobulin that binds the radioactive hapten, not all bands
I
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that contain double binding immunoglobulins may be detected. Thus the 
lack of observable inhibition by hapten does not rule out the presence 
of a double binding immunoglobulin.
The immunoglobulin composition of each hapten binding band would 
be better elucidated if the isotypic and idiotypic determinants of the 
antibodies cross-linked inside the polyacrylamide gels could be determined. 
Unfortunately to date all such efforts have been unsuccessful. Until 
such techniques are developed, the immunoglobulins from interesting 
bands must be isolated by preparative isoelectric focusing which is both 
very time consuming and costly in terms of the quantity of serum needed 
for an analysis. For example, the f>np<r*.+ivc isoelectric focusing method 
employs 100 to 250 pi of serum. The maximum amount of serum isolatable 
from a non-lethal bleed of a mouse is about 500 yl. Thus any preparative 
isoelectric focusing analysis greatly limits the number of experiments 
that can be performed with a given sample of mouse serum.
Another difference between the preparative and analytical isoelectric 
focusing techniques is that while all immunoglobulin species in mouse 
sera are separated by preparative isoelectric focusing, the polyacrylamide 
gel in the analytical technique excludes all non-monomeric immunoglobulins. 
This means that the mixed population of immunoglobulins eluted from a 
band after preparative isoelectric focusing may include many immuno­
globulins not present in the antigen binding band observed in the analyt­
ical gel. For example, five of five bands eluted after the preparative 
isoelectric focusing of an anti-DNP serum contained immunoglobulins with
more than one heavy chain isotype (page 166). Four of the five bands 
125contained I-TLD binding immunoglobulins restricted to one H chain 
isotype and the immunoglobulins from these bands produced inhibition
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curves In phage inhibition assays that were consistent with the presence
of only one antigen binding specificity. On the other hand, the fifth
band had immunoglobulins with more than one H chain isotype which bound 
125I-TLD. The immunoglobulins from this band produced an inhibition
curve consistent with the presence of a mixture of DNP binding antibodies.
It is, therefore, not clear how the immunoglobulins eluted from preparative
125isoelectric focusing relates to the I-TLD binding bands observed after 
analytical isoelectric focusing.
While the analytical isoelectric focusing method of detecting double 
binding immunoglobulins did not use much mouse serum, the variable quality 
of a given run often required the same serum sample to be processed two 
or three times. In the study presented in section II.B. of the RESULTS 
(Figure 25 and Table 22), the data from 78 mice representing 11 other 
litters had to be excluded because the poor quality of the gels precluded 
their analysis with the densitometer. The two factors that mostly affect 
a gel's quality were: a) the ’’age" of the iodinated hapten; and b) the
"cleanliness" of the carbon electrode. A spotting pattern was often 
observed on the autoradiograms of gels that were incubated with radioactive 
haptens that had been iodinated and stored for more than ten days before 
the gel was subjected to isoelectric focusing. Figure 20 shows a trivial 
example of this spotting pattern. Often the spots obscurred the banding 
pattern of the immunoglobulins, thus making the gels unsuitable for analy­
sis. If the carbon electrodes were not assiduously cleaned before each 
isoelectric focusing run, the gel often developed unequal conductance 
along its width. This resulted in a non-parallel pH gradient along the 
width of the gel and "warping" of the isoelectric patterns of the dif­
ferent serum samples across the width of the gel. The resulting auto-
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radiograms were unsuitable for analysis.
Provided that the appropriate precautions are taken, the analytical 
isoelectric focusing technique provided a relatively fast technique for 
screening multiple serum samples for the presence of particular double 
binding immunoglobulins. The radioactive hapten binding detected-in the 
gels is. an accurate reflection of the binding affinity of the immuno­
globulins cross-linked in the gel. Furthermore, the technique is re­
producible. Identical isoelectric focusing patterns have been observed 
for the same serum sample subjected twice to analysis with a year interval 
between each sample's processing. The weakness of the technique lies in 
its inability in most instances to detect the very small quantities of 
immunoglobulins that other techniques like RIA can. Another weakness of 
this procedure is that no technique has yet been developed for eluting 
sufficient quantities of the immunoglobulins from the polyacrylamide gels 
after isoelectric focusing which accurately reflects the antibody compo­
sition of these bands.
In conclusion, the sequential immunization of mice with DNP and 
menadione conjugated proteins and with RNase and DNP-BGG preferentially 
stimulates double binding antibodies which may be detected by analytical 
isoelectric focusing in polyacrylamide gels. While these double binding 
antibodies may be detected by this method, additional techniques are 
required for the further characterization of the proteins that compose 
interesting bands. One curious finding has been that individual Balb/c 
mice challenged by identical immunization protocols produce different 
isoelectric focusing spectrotypes of hapten binding immunoglobulins.
This is partly due to concentration differences of each immunoglobulin 
present in the sera of the various Balb/c mice. The value of the analy-
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tical isoelectric focusing technique is that it provides a rapid screen­
ing method for the presence of double binding immunoglobulins. Undoubtedly 
a combination of the analytical isoelectric focusing - fine specificity 
approach and the idiotypic approach will enable the expression and inheri­
tance of V-region gene products to be studied. This thesis lays the 
foundation for such studies.
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APPENDIX I
Below it is explained why the relationship 
[DNP]^q/[DNP]^,. = Ka3^5/Ka^6Q’ emPloyed in Figure 8 is valid. [DNP]X 
is the concentration of DNP-lysine which inhibits half of the binding of 
myeloma protein X by the public anti-idiotypic antibodies. K is the
ci
affinity constant of myeloma protein X for DNP-lysine.
The binding constant, Ka, is defined as: Ka = S,/C-Sf; where S,
b b
is the concentration of combining regions occupied by ligand and also the 
concentration of ligands bound by antibody; where is the concentra­
tion of unoccupied combining regions; and c is the concentration of 
unbound ligands.
Figure 8 represents a solid phase RIA which measured the binding
125of I-labeled Fab fragments of proteins 315 and 460 to public anti-315
idiotypic serum in the presence of various concentrations of DNP-lysine.
If the binding of ligand by the Fab fragments prevents the Fab fragments
from being bound by anti-idiotypic antibody, then at 50% binding of the
125Fab by the anti-idiotypic antibody, half of the I-labeled Fab frag­
ments will have bound hapten.
Thus, S, = S., and b £
Ka = 1/c or Ka*c = 1. Thus at 50% inhibition:
1 - Ka315-[DHP1315 = Kaw 0 -lrap]460, or
* W fc460 ’
As shown in Figure 8,
[DNP]^q/[DNP]^5 = 114 = 100 = ^ 3 1 5 / ^ 4 6 0  (reference 145).
Thus the public anti-idiotypic antibodies are directed against combining 
region determinants.
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APPENDIX I I
Below it is explained how an estimation of antibody concentration 
and binding constant can be made based on the intensity of bands after 
autoradiography. The binding constant, Ka, is defined by the relation­
ship :
§1 Ka = S/c-S ; whereb r
is the concentration of binding sites filled by hapten and also the
concentration of hapten bound by antibody;
is the concentration of binding sites not filled by hapten; and
c is the concentration of hapten not bound by antibody.
Under the conditions in which the analytical isoelectric focusing
was performed only 7S immunoglobulin penetrated the gel. It can be
assumed that these have two binding regions per immunoglobulin; therefore
the total concentration of antibody in the gel [x] is defined by:
[x] = (Sb + Sf)/2 or
Sr = 2*[x] - S, . Therefore substituting in #1,t b
Ka = S,/c*(2*[x] -S.) or b b
#2 [x] = S,/(2-Ka-c) + S./2b b
can be estimated from the darkening of the autoradiographic film.
For example in Figure 21, it was estimated that a 1 x 6 mm filter
125paper impregnated with 1800 cpm of I produces a well defined band
after a 2 day film exposure. Most antigen binding bands observed after
autoradiography have an average dimension of 1 x 4 mm and the gel is about
2 mm thick. The amount of radioactivity to produce a well defined band
2 2after a 2 day film exposure would be about: (4 mm /6 mm ) *1800 cmp =
1251200 cpm. If this band represented the binding of I-TLD in a typical
experiment in which 5 pi of serum was isoelectric focused, the gel would
212
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-10 125have been incubated with a 2 x 10 M solution of I-TLD (sp. act.
185 x 10 cpm/mole). would be equivalent to 1200 cpm which is equi-
3 8 —11valent to 1200 cpm/8 mm = 1.5 x 10 cpm/L = 3 x 10 M. Substituting in
relationship #2; [x] = (3 x 10~1:LM)/(2-(2 x 10_10M)-Ka) + (3 x 10_11M)/2,
or [x] = (7.5 x 10“2)/Ka + 1.5 x 10-11M. If Ka is less than 1012M_1
then (7.5 x 10-2)/Ka »  1.5 x 10_11M. Thus
#3 [x] = (7.5 x 10-2)/Ka.
But [x] is the concentration of antibody in the gel. To determine 
the initial concentration of antibody in the serum ([Ab]):
[Ab]•(serum volume) = [x]•(gel volume); or 
[Ab] = [x]*(gel volume)/(serum volume) =
([(7.5 x 10 2)/Ka]*8 yl)/5 yl or
#4 [Ab] = 0.12/Ka.
Thus for an analytical isoelectric focusing gel in which 5 yl of serum is
processed, a given intensity of atuoradiographic film may be produced by
a wide range of antibody concentrations depending on the binding constant
125of that antibody for the labeled hapten, I-TLD.
Based on the above calculations, below is listed the concentrations of
immunoglobulins that must be present in the mouse serum to produce a well
defined band after a 2 day film exposure if the antibodies have a parti-
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It should be noted that both proteins 315 and 460 bind TLD with a
lower Ka than they do DNP-lysine. For example, the Ka^,. for TLD is
7 x 10^M  ̂ (as determined by equilibrium dialysis), while for DNP-
lysine is 6 x 10^-1 (as determined by both equilibrium dialysis and
fluoresent quenching). According to the above, a solution of protein 315
should have between 18 and 180 yg/ml for 5 yl to be subjected to isoelectric
125focusing and produce a well defined I-TLD binding band after a 2 day
film exposure. In Figure 19, 5 yl of a 5 mg/ml solution of monomeric
protein 315 produced five major bands and many minor bands after analytical
125isoelectric focusing with the gel being incubated with I-TLD. Each
major band, therefore, was derived from a little less than 1000 yg/ml
concentration of protein in the original protein 135 solution and was
therefore easily detectable fater a 2 day film exposure.
125Similar calculations may be performed with the I-RNase incubated
125gels by using the specific activity and concentration of the I-RNase 
employed to develop the gels.
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APPENDIX I I I
Below is described the relationship that determines the ratio of 
antigen concentrations required for a reduction of radioactive hapten 
binding by a double binding immunoglobulin. At equilibrium, for two 
ligands competing for binding to the same site (111):
#1 <SL) /(SL)2 = K1*c1/(K2-c2) ; where,
(SL)^ is the concentration of combining regions filled by ligand x;
K^ is the binding constant of the antibody for ligands x; and 
cx is the free hapten concentration of ligand x.
At 50% inhibition of one hapten by the other, (SL)^ = (SL)2> Substi­
tuting in relationship #1:
{2 K j /K j  - c 2 /V
If at concentration c^' more than 50% of the ligand 1 is inhibited by
ligand 2, then
#2a K./K. < c '/ 1.1 2  2 c
In the experiments described in section III.B. of the RESULTS, vitamin 
125Ks inhibitable I-TLD binding bands were interpreted as bands whose
-3intensity of film darkening in the presence of 1 x 10 M vitamin Ks
was less than or equal to half the intensity of darkening of the band
125produced when the gel was incubated only with I-TLD (i.e., the Ks/TLD
ratio was less than or equal to 0.5). Thus for a vitamin Ks inhibitable 
125I-TLD binding band to be detected, the ratio of binding constants of 
the antibody for both haptens should have the following relationship:
#2b Kx /K2 < c2/cr
Under the conditions in which the gels were processed, c ^ ^  * 2 x 10 ^  M
—3 6
and = 1 x IQ' M. Thus ^ l d ^̂ Scs —   ̂X ^  * i,e*' an antib°dy t îat
g
binds TLD with an affinity greater than 5 x 10 times that for vitamin
215
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Ks would not scored as a double binding immunoglobulin.
From relationship #2b, it is obvious that by incubating the analy­
tical gels with different concentrations of ligand 1 and 2, different
populations of "double binding" antibodies will be detected.
125The intensity of the I-TLD binding bands will only follow this
relationship if the band is composed of one TLD binding immunoglobulin.
If two antibodies have the same pi and one does not bind vitamin Ks
125then the detection of vitamin Ks inhibitable I-TLD binding bands is 
dependent upon the relative binding constants and concentrations of 
both these immunoglobulins in the band. (See appendix 2.)
Of course, the same relationships apply for the DNP-caproic acid
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